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The increase in dietary-intake-related illnesses, such as obesity, 
cardiovascular diseases, hypertension, diabetes and cancer, have made in 
recent years the development of health-and-wellness promoting foods a 
priority of the food industry. Clinical studies have demonstrated tangible 
health benefits that may be derived from the intake of bioactive compounds. 
However many difficulties are associated with their inclusion in food 
matrices, due to a very low solubility in water and easy degradation by 
hostile environmental conditions once extracted from plant tissues. 
Furthermore, poor solubility also means lower absorption in the 
gastrointestinal tract and, therefore, limited bioavailability. In the food 
industry, it has become apparent that there is a pressing need for edible 
delivery system to efficiently encapsulate, protect and release bioactive 
compounds when developing functional foods. 
This thesis was addressed to the study and engineering of 
nanoencapsulation systems, above all nanoemulsions and solid lipid 
nanoparticles, with superior capabilities of a) protecting the encapsulated 
bioactive compounds from interaction with food ingredients, keeping their 
functional properties and preventing the deterioration of the food itself (i.e. 
oxidation of fat), b) reducing the impact on the organoleptic properties of 
food and c) improving the absorption and bioavailability of the bioactives, 
due to the subcellular size of the nanocapsules, which may potentially 
enhance passive transport mechanisms (i.e. related to the concentration 
gradient) across the intestinal wall. 
The research activity has contributed to the advance of the knowledge in 
the field of the science of colloids, through the specific investigation of the 
effects of formulation and process parameters, which influence 
nanoemulsion production, as well as to a deeper comprehension of the 
technological and biological aspects of the incorporation of the 
nanoencapsulated compounds in food matrices and explication of their 
activity.  
Three different classes of bioactive compounds were chosen as model 
systems of the experimental work, namely curcumin, resveratrol and 




with markedly low solubility both in aqueous and lipid phase, hence 
requiring the development of specific formulations. In contrast, essential oils 
can be easily blended with oils, but require their diffusion through the 
aqueous phase to attack the cell membrane of microorganisms and act as 
antimicrobials. 
Therefore, novel formulations were developed using a combination of 
hydrophilic (sugar ester, defatted soy lecithin, polysorbate 20) and lipophilic 
emulsifiers (soy lecithin, glycerol monooleate) to encapsulate resveratrol in 
peanut oil droplets and disperse it in aqueous systems at a concentration of 
100 mg/L, ten times higher than the therapeutic blood concentration. In the 
same way, curcumin has been encapsulated in solid lipid particles, using 
stearic acid as lipid phase, at a maximum concentration 1600 times higher 
than the solubility of curcumin in water (0.6 mg/L). 
Once the formulation was defined, the issue of the actual fabrication of 
the nanometric delivery systems was faced from a fundamental point of 
view. In particular, the production of food nanoemulsions by high pressure 
homogenization (HPH) has been investigated, focusing on the effect on 
droplet nanonization of emulsifier type and concentration, as well as of the 
geometry of the homogenization chamber. The reported results showed that 
the kinetic parameters of the emulsification process can be primarily 
correlated with the interfacial and dynamic properties of the emulsifiers, 
while the fluid-dynamics regime established in the homogenization chamber 
contributes only to a lesser extent. Nevertheless, the correct design of the 
homogenization chamber may help in obtaining uniform fluid-dynamic 
conditions, which ensure a narrow droplet size distribution.  
The issues related to the physicochemical stability of nanoencapsulated 
bioactive compounds was faced for resveratrol and curcumin, trying to 
improve the formulation based on the inputs derived from accelerated ageing 
studies, that could simulate the food processing and the shelf life of the final 
product. The results obtained demonstrated that the nanoemulsions based on 
soy lecithin/sugar esters and Tween 20/glycerol monooleate can better 
encapsulate resveratrol in the lipid matrix, protecting it both during 
accelerated ageing and gastro-intestinal digestion and promoting a sustained 
release. Moreover, these formulations, having smaller mean droplet 
diameters (below 200 nm), remained physically stable also after the 
digestion process, allowing the resveratrol to reach the intestinal wall 
entrapped in the lipid droplets.  
The subcellular dimension and the compatibility with cell membranes of 
the developed formulations also resulted in a higher permeability through the 
intestinal wall, which was simulated studying the transport through Caco-2 
cell monolayers grown on permeable supports. Generally, the apparent 
permeability of most compounds falls in a range of 1×10-7 cm/sec (poorly 
transported compound) to 1×10-5 cm/sec (well-transported compound). The 
apparent permeability of resveratrol encapsulated in different nanoemulsion-
 Nanoencapsulation of bioactive compounds for food applications 
 XIII
based delivery systems resulted always in the range indicated, demonstrating 
that nanoencapsulation can improve passive transport mechanisms. In 
particular, soy lecithin/sugar esters-based formulation showed an higher 
permeability due to the presence of soy lecithin, which, having a structure 
similar to the phospholipid bilayers of the cellular membrane, favours the 
absorption and the entrapment of the oil droplets in the microvilli and their 
consequent transport through the cell membrane. 
Another remarkable result of the present thesis is that for the first time the 
effect of the delivery systems on the antioxidant activity of 
nanoencapsulated compounds was investigated, using a biological-based 
approach that integrated the classical chemical approaches. More 
specifically, an improved cellular assay was developed, that enabled to 
measure exclusively the residual activity of nanoencapsulated bioactive that 
penetrated inside Caco-2 cells, giving precious information on the 
combination of the mass transfer promotion and protection by the delivery 
systems. 
Finally, the technological issue related to the incorporation into fruit 
juices of essential oils encapsulated into nanometric delivery systems was 
investigated, having as goal the design of systems that are able to enhance 
antimicrobial activity of the bioactive compounds, while minimizing the 
impact on the quality attributes of the final product. The results showed that, 
due to the higher antimicrobial activity of the nanoencapsulated essential 
oils, lower antimicrobial concentrations are required for a bactericidal action 










I.1 Interest of the study 
Several factors sustain the exponential growth of functional foods and 
nutraceuticals registered during the last years in the world food market, such 
as the increasing demand of the Western societies for natural products, 
together with the increasing consumers’ awareness that eating habits should 
not be merely based on the nutritive aspects of the food, but also on the 
health-beneficial effects that may derive from its consumption. 
Therefore, incorporation in foods and in nutraceutical formulations of 
bioactive compounds, in order to improve food quality, such as shelf-life, 
taste or aspect, without the need of synthetic additives, as well as to develop 
novel functionalities, especially related to health promotion, such as 
antioxidant, antiradical and antitumor abilities, is highly desired from 
manufacturing companies and is object of intensive investigations from food 
scientists, food engineers and food technologists. 
In particular, the issues related to efficiently delivering bioactive 
compounds through the food matrices, improving their uptake and 
bioavailability, while minimizing the impact on the organoleptic and 
qualitative properties of the products, call for a heavy involvement of 
nanotechnology in the development of suitable encapsulation systems. 
Currently, the market of nanotechnology products in the food industry is 
worth about US$ 1 billion, including mainly nanometric delivery systems of 
bioactive compounds, applied to packaging coatings, to health promoting 
products, as well as to beverages, and it is foreseen to grow to more than 
US$20 billion in the next decade (Chau et al., 2007). 
In this chapter, the nanometric size delivery systems most suitable for 
food applications will be discussed, such as nanoemulsions and solid lipid 
nanoparticles, focusing on high pressure homogenization as production 
method. Finally, it will be highlighted the ability of the nanoencapsulation to 
increase the dispersion in aqueous systems of bioactive compounds, which 
are poorly soluble in water, to protect them from chemical degradation, to 
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improve their antioxidant and antimicrobial activities and to increase their 
bioavailability. 
 
I.2 Food-grade nanometric delivery systems 
The development of functional foods through the addition of bioactive 
compounds holds many technological challenges. There is a pressing need 
for edible delivery system to encapsulate, protect and release bioactive 
compounds within the food industry. From a technological point of view, an 
efficient nanometric size delivery system should benefit from the following 
characteristics (McClements et al., 2007): 
• Food grade ingredients: the delivery system should be formulated 
with food-grade, possibly all-natural, ingredients using solvent-free 
fabrication methods. In particular, one major challenge is to replace 
some of the polymers and surfactants used in the pharmaceutical 
industry with food-grade alternatives (Acosta, 2009). 
• Food incorporation: the delivery system should be able to 
incorporate the bioactive compounds into the food matrices with 
high physicochemical stability and minimal impact on the 
organoleptic properties of the product (Donsi et al., 2011a). 
• Protection against degradation: the delivery system should be able 
to protect the encapsulated bioactive compounds from the 
interaction with other food ingredients, as well as from degradation 
due to temperature, light, pH, during food manufacturing, storage, 
and preparation (McClements et al., 2007). 
• Uptake and bioavailability: the delivery system should maximize 
the uptake of the encapsulated compounds upon consumption and 
their transport to the sites of action (Acosta, 2009). In addition, 
controlled release in response to specific environmental stimulus 
may be desirable (McClements et al., 2007). 
• Industrial scalability: the fabrication of the delivery systems should 
be easily scalable to industrial production (Donsi et al., 2010a, Donsi 
et al., 2010d). 
 
In the following, the nanometric size delivery systems most suitable for 




Nanoemulsions are heterogeneous systems consisting of two immiscible 
liquids, with one liquid phase being dispersed as nanometric droplets into 
another continuous liquid phase and stabilized through an appropriate 
emulsifier. In particular, O/W nanoemulsions, which are of prevalent interest 
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for food delivery systems, are composed of oil droplets dispersed in an 
aqueous medium and stabilized by a food-grade surfactant or biopolymeric 
layer, with mean droplet size typically ranging from 20 to 200 nm 
(Sagalowicz and Leser, 2010, Chen et al., 2011). The selection of emulsifier 
type is important to control the interfacial properties (charge, thickness, 
droplet size and rheology), as well as the response of nanometric oil droplets 
to environmental stresses (pH, ionic strength, temperature and enzyme 
activity). 
Differently from microemulsions, which are thermodynamically stable 
systems and form spontaneously, nanoemulsions are kinetically stable and 
require energy to be formed. Due to their being metastable systems, 
nanoemulsions can be diluted with water without any change occurring in 
the droplet size distribution. Nanoemulsions are in fact highly stable to 
gravitational separation thanks to the small droplet sizes, which means that 
Brownian motion effects dominate over gravitational forces (McClements, 
2005). In addition, nanoemulsions show a lower tendency to droplet 
aggregation than conventional emulsions, because the strength of the net 
attractive forces acting between droplets usually decreases with decreasing 
droplet diameters (McClements, 2005). However, coalescence phenomena 
due to Ostwald ripening can affect nanoemulsions stability, leading to a 
significant growth in droplet size over time. Ostwald ripening is a 
mechanism whereby the larger droplets grow at the expense of the smaller 
ones because of molecular diffusion of oil between droplets through the 
continuous phase. This process is driven by the Kelvin effect where the 
small lipid droplets have higher local oil solubility than the larger droplets, 
because of the difference in Laplace pressure (Wooster et al., 2008). 
Therefore, being its rate dictated by the solubility of the oil in the 
continuous phase, Ostwald ripening can be kept at minimum by selecting oil 
with low aqueous phase solubility. More specifically, the aqueous phase 
solubility of oils decreases linearly with increasing oil molar volume: 
therefore, nanoemulsions based on low molar volume oils are more likely 
subjected to Ostwald ripening destabilization than nanoemulsions based on 
large molar volume oils consisting of long chain triglycerides. When 
formulation with an oil relatively soluble in the continuous phase cannot be 
avoided, such as in the case of essential oils nanoemulsions, Ostwald 
ripening can be reduced by adding a second oil with lower water solubility, 
in order to change the partitioning of the most soluble oil between lipid and 
aqueous phase (Sagalowicz and Leser, 2010). 
The nanoencapsulation of bioactive compounds in O/W nanoemulsions is 
an effective approach for incorporating poorly water-soluble compounds in 
foods. The bioactive molecules, depending on the formulation used, in terms 
of ingredients and composition, as well as preparation procedures, might 
have different localizations within an O/W nanoemulsion. For example, the 
bioactive compound can be entrapped in the inner oil phase (bioactive-
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enriched core) or can diffuse into the outer stabilizer film (bioactive-
enriched shell), as shown in Figure I.1. Its localization influences the 
stability, release and the bioavailability of the nanoencapsulated compound. 
The migration of the bioactive molecules from the inner oil phase to the 
stable surfactant layer of O/W nanoemulsions, as a consequence of more 
intense production conditions by high pressure homogenization (increasing 
number of passes and higher processing temperatures) is reported to increase 
the protection of bioactive molecules against chemical degradation (Baspinar 
et al., 2010). On the other side, the entrapment of the bioactive molecules in 







Bioactive-enrichedcore Bioactive-enriched shell  
Figure I.1 Possible localizations of bioactive molecules into O/W 
nanoemulsions. 
 
In general, the immobilization of bioactive compounds in the lipid matrix 
of the nanoemulsions, thanks to the nanometric size of the encapsulation 
system, can potentially contribute: (a) to improve the dispersibility of poorly 
water soluble compounds in aqueous solutions, minimizing the tendency to 
separate the different phases (aqueous and lipid); (b) to protect the bioactive 
compounds by interaction with food ingredients, keeping their functional 
properties and preventing the deterioration of the food itself (i.e., oxidation 
of fat); (c) to reduce the impact on the organoleptic properties of food; (d) to 
improve the absorption and bioavailability of the encapsulated bioactive 
compound, thanks to the subcellular size of the nanocapsules, which 
enhances passive transport mechanisms (related to the concentration 
gradient) across the cell membrane. 
In Table I.1, some example of applications of nanoemulsions to the 
delivery of bioactive compounds are reported, with special emphasis on 
some of the above aspects.  
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For example, O/W nanoemulsions produced by high pressure 
homogenization technique were reported to improve the solubility in water 
of carotenoids, such as β-carotene (Yuan et al., 2008).  
Alcohol-free O/W nanoemulsions, using hyaluronic acid as stabilizer, 
were developed for transdermal delivery of lipophilic active ingredients, 
such as α-tocopherol (Kong et al., 2011), demonstrating that, without any 
chemical enhancers, a good skin permeability can be achieved, with 
improved mass transfer through the stratum corneum and deep diffusion into 
the dermis. 
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methylene chloride 
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Nanoemulsions were also shown to enhance the beneficial effects of 
encapsulated bioactive compound when orally administered. For example, 
using a mouse ear inflammation model, anti-inflammation activity of 
curcumin was shown to be better targeted, when encapsulated in O/W 
nanoemulsions. In particular, the synergistic combination of two key features 
of the nanoemulsion-based delivery system, such as the nanometric droplet 
size and the presence of a lipid (medium chain triglycerides) in the emulsion 
formulation, enhanced both the transport through the intestinal walls and cell 
uptake, allowing the orally-administred curcumin to reach the target sites 
(the mouse ears) to explicate their full anti-inflammation activity (Wang et 
al., 2008). 
Additional nanoemulsion applications involve sublingual and intranasal 
delivery of drugs, exploiting the mucoadhesive properties and the ability to 
enhance the permeability of the mucous layer through an adequate interfacial 
formulation (Kumar et al., 2008). 
The deposition of a multiple layer of emulsifiers and/or polyelectrolytes 
around nanoemulsion oil droplets via layer-by-layer electrostatic deposition 
technique may positively affect the absorption properties in the 
gastrointestinal tract (McClements and Li, 2010).  
Different types of primary stabilizers as well as biopolymers for 
subsequent layer-by-layer deposition were used in order to provide the right 
properties to emulsion droplets for successful applications, such as low 
molecular weight surfactants, proteins, polysaccharides.  
 
I.2.2 Solid lipid nanoparticles 
Solid lipid nanoparticles (SLNs) are similar to the nanoemulsions, 
consisting of emulsifier coated lipid droplets dispersed within an aqueous 
phase, with the main difference that the lipid phase is at the solid or semi-
solid state.  
In general, to produce loaded SLNs, a lipid phase, where the bioactive 
compounds have been dispersed, is emulsified in aqueous phase at about 
10 °C above the melting point of the lipid, via common dispersing 
techniques, such as colloid milling, ultrasound, solvent evaporation and high 
pressure homogenization (HPH).  
In particular, the HPH technique has emerged as the most reliable and 
powerful technique for the preparation of SLNs (Mehnert and Mader, 2001), 
with two approaches being mainly used: hot and cold homogenization. Hot 
homogenization is carried out at temperatures above the melting point of the 
lipids obtaining an hot O/W nanoemulsion, which is then rapidly cooled at 
room temperature to induce fat crystallization. In contrast, in cold 
homogenization a coarse dispersion of lipids at solid state is mechanically 
comminuted to the nanosize and subsequent dispersed in a aqueous solution 
in presence of a suitable emulsifier. With the cold homogenization method, 
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the thermal exposure of the encapsulated compounds is minimized, but 
larger particles and broader size distribution are obtained, in comparison to 
hot homogenization (Mehnert and Mader, 2001).  
The main difficulty associated with the repeatability of the SLNs 
production is associated to the control of the lipid crystallization, which is 
significantly dependent on the temperature history of the system, on the 
presence of impurities in the lipid phase, as well as on droplet size 
(Sagalowicz and Leser, 2010). 
In comparison to nanoemulsions, SLNs exhibit an increased chemical 
protection against degradation, a higher encapsulation efficiency (> 90%) 
and a better controlled release, due to the immobilization of the encapsulated 
bioactive compound in the solid lipid matrix. As schematically shown in 
Figure I.2, the bioactive compounds within solid lipid nanoparticles can be 
either dispersed in the interstices of the fat crystals (bioactive-enriched core), 
or on the surface of the lipid nanoparticle protected by the emulsifier layer 





Bioactive-enriched core Bioactive-enriched shell  
Figure I.2 Possible localizations of a bioactive molecules into SLNs. 
 
Whether a bioactive enriched core or a bioactive enriched shell is formed 
depends on the solid lipid phase. A lipid phase consisting of fats of different 
types and with different properties as well as crystallization kinetics, will 
exhibit an inner core characterized by voids and defects of the crystalline 
structure, where the bioactive molecules can be preferentially hosted. In 
contrast, a lipid phase with a more ordered crystalline structure, for example 
consisting of a single type of fats, will offer less space for the bioactive 
molecules. In this case, during crystallization upon lipid cooling, the 
bioactive compounds are phase separated, either enriching the emulsifier 
shell or being expelled into the aqueous phase. 
SLNs with a bioactive-enriched core are able to keep the encapsulated 
bioactive compounds away from any hydrophilic reactive species dispersed 
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in the aqueous phase, as well as to promote a sustained release of the 
encapsulated active material upon oral administration (Muller et al., 2002). 
On the other side, SLNs with a bioactive-enriched shell are more 
indicated to provide a delayed release of the bioactive compounds. 
Typically, two or more lipids with different melting points, e.g., mixtures 
of purified triglycerides, waxes or fatty acids, are used rather than an 
individual lipid to increase the loading capacity and retention of 
encapsulated lipophilic components, which can fit better into the more 
imperfect crystalline structure formed (Schubert and Muller-Goymann, 
2005). 
Further development of the SLNs brought to the so-called nanostructure 
lipid carriers, consisting of a disperse phase made of a mix of solid and 
liquid lipids (Muller et al., 2002). The nanostructure lipid carriers, due to the 
decreased melting point of the lipid phase, can be produced at lower 
temperatures, reducing the extent of degradation of the thermolabile 
compounds. Moreover, they are also claimed to have smaller particle sizes 
than SLNs, as well as to exhibit a sustained release mechanism in the 
gastrointestinal tract (Zhuang et al., 2010). 
Table I.2 shows some examples of SLN-based delivery systems for 
applications in different fields, such as food, pharmaceutics and cosmetics. 
 
 
Table I.2 Examples of solid lipid nanoparticles-based delivery systems. 
Bioactives Formulation/ 
preparation 
Application Advantages Ref. 
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SLNs formulated with palm oil and soy lecithin were successfully used to 
increase the dispersibility and antimicrobial activity of essential oils, as well 
as to incorporate them into fruit juices, with minimal impact on the 
organoleptic properties of the product (Donsi et al., 2010c).  
However, SLNs are underused for food applications, because they require 
the formulation with solid lipids, such as saturated ones, which are not 
preferred in terms of nutrition and health (Sagalowicz and Leser, 2010). 
For pharmaceutical applications, SLNs are intensively studied in the field 
of controlled drug release.  
The therapeutic efficacy of curcumin encapsulated in transferring 
conjugated solid lipid nanoparticles was tested against breast cancer, with 
the results that the cellular uptake was increased and the sustained release of 
the encapsulated curcumin was favored (Mulik et al., 2010).  
In addition, SLNs were also used to control the penetration of several 
bioactive compounds into the skin, making them attractive for cosmetic 
applications and topical delivery. For example, skin permeation and release 
rate of vitamin A was increased when encapsulated into SLNs instead of 
nanoemulsions (Jenning et al., 2000). 
 
I.3 Production of nanometric delivery systems 
Nanometric size delivery systems can be produced by a top-down 
approach, by mechanical comminution of larger entities into homogeneously 
sized particles with desired functional properties (i.e. nanoemulsions and 
solid lipid nanoparticles), by bottom-up approach, assembling the molecular 
building blocks into structured systems (i.e. micelles, microemulsions, some 
biopolymeric nanoparticles), as well as by a mixed approach, where 
molecular assembly and nanonization are combined together (i.e. liposomes, 
cubosomes, hexosomes, some biopolymeric nanoparticles, multilayer 
emulsions). 
The bottom-up approach is based on self-assembling of molecules into 
nanometric structured systems exhibiting functional properties, in a process 
driven by the balance of attraction and repulsion forces tending to 
thermodynamic equilibrium. 
The forces between the building blocks can be controlled by 
environmental factors, such as temperature, concentration, pH and ionic 
strength of the system, as well as applying external stimuli, such as pressure, 
shear or electric and magnetic fields (Sanguansri and Augustin, 2006), with 
the input of mechanical energy being limited to keep the system perfectly 
mixed (Acosta, 2009). 
Since the nanostructures formed through bottom-up approach exist at the 
thermodynamic equilibrium, any environmental modification would bring to 
nanostructures disassembly, therefore limiting their use and incorporation in 
real food systems, which involves mixing with other ingredients and 
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thermal, pressure or shear stresses during product manufacturing. As a 
consequence, a stabilization step is required, to freeze the self-assembled 
nanostructures in the desired size and functional state. Such stabilization step 
can be conducted through physical or chemical changes, such as rapid 
quench cooling, sudden solvent dilution or evaporation, as well as chemical 
reactions, which are required to be more rapid than the system kinetics of 
attaining a novel equilibrium state. 
In the fabrication of nanostructured delivery systems via bottom-up 
approaches, the poorly water-soluble bioactive compound is first dissolved 
or dispersed in an organic solvent, and then precipitated through a non-
solvent addition, which is typically water for food applications, in the 
presence of stabilizers, such as surfactants or hydrocolloids (Acosta, 2009, 
Gao et al., 2011). Eventually, a polymer, which is soluble in the internal 
solvent but insoluble in the external one, may be added to the system 
(Acosta, 2009). 
The precipitation of the bioactive compound in nanoparticles may be 
induced by rapid solvent diffusion into the aqueous phase, such as in 
supercritical fluid technology, by evaporative precipitation into aqueous 
solution, spray-freezing into liquid process, and emulsion-solvent 
evaporation. 
On the other side, the top-down approaches for the production of 
nanometric particulate systems are mainly based on comminution by 
mechanical size reduction techniques without using chemical solvents.  
Figure I.3 reports a schematization of the different types of particle 
stressing exerted in comminution processes. 
At macroscopic level, comminution can be carried out by stressing the 
particles to be disrupted between two surfaces through the combination of 
compression and shear, in systems such as roller mills and media mills. 
Obviously in this case the minimum achievable particle size depends on the 
coupling of the mill surfaces that exert the stress, and, in general, it is 
> 1 mm. 
In order to obtain finer particles, comminution should be based on more 
focused particle stressing. For example, in impact mills the particles are 
accelerated towards a surface where they impact, with the stress intensity 
depending on the kinetic energy of the particles. 
An even more focused particle or droplet stressing is based on the 
transmission of the stress to the particles through a surrounding fluid, where 
intense fluid mechanical stresses occur. The energy is transferred from the 
sheared, elongated, or turbulent fluid to the particles, with a stress intensity 
significantly smaller than in the case of contact with solid surface, but of 
significantly higher efficiency. 
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Figure I.3 Particle stressing in comminution processes. 
 
 
In particular, the most used systems for nanonization processes in the 
food and nutraceutical industry, colloid or media milling and high pressure 
homogenization, are based mainly on stress transmission through a 
surrounding fluid, eventually in combination with the impact on solid 
surfaces. 
Particle stressing through non-mechanical energies, such as electrical or 
thermal, at the moment do not represent viable systems for the production of 
nanometric particles and droplets. 
Comminution processes are very energy-intensive, with the required 
energy exponentially increasing at decreasing the particle size. In fact, as the 
particle size decreases, the number of defects that allow crack propagation 
and particle disruption is reduced and the intermolecular forces significantly 
increase.  
On the other side, mechanical nanonization processes require minimal 
use of chemical additives in the formulation of nanometric systems, which 
represents the main advantage over chemical comminution processes 
(Acosta, 2009). 
Current challenges to the nanonization processes are the efficient use of 
shear or particle collision to break down larger entities in fine nanoscale 
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aggregates with minimal energy consumption, while preventing re-
aggregation and segregation of small and large particles (Acosta, 2009). At 
the same time, the issues of industrial scalability and cost-effectiveness 
attract increasing interest, in view of the transfer of the technology to the 
market. 
 
I.3.1 High pressure homogenization 
High pressure homogenization (HPH) is the most suitable currently 
available technique for the production of uniformly nanosized emulsions, 
suspensions and dispersions, when evaluated in terms of ease of operation, 
industrial scalability, reproducibility and high throughput (Schultz et al., 
2004). 
The high pressure homogenization process can be described as the 
production of a homogeneous size distribution of particles or droplets 
suspended in a liquid, by forcing the liquid under the effect of high pressure 
through a specifically designed disruption chamber. 
A typical HPH system consists therefore of a high-pressure generator, a 
disruption or homogenization chamber, as well as a temperature control 
system, as shown in the simplified schematics of Figure I.4. From the feed 
tank, the process liquid is pressurized in a set of pressure intensifiers, such as 
positive-displacement pumps coupled with piston-cylinder pressure 
intensifiers, whose phase-delayed movement guarantees an almost uniform 
flow at the desired pressure level.  
HPH working pressures are in the range of 100-300 MPa, with higher 
operating pressures requiring an increase in equipment costs, which is not 
balanced by a significant gain in size reduction of the processed emulsions 
and suspensions. 
The homogenization chamber, where the emulsion droplets are disrupted 
into finer droplets due to the fluid-mechanical stresses generated by the 
sudden pressure drop, can be realized in different geometries, ranging from a 
simple orifice plate to colliding jets and radial diffuser assemblies (Schultz et 
al., 2004). In Figure I.4, some examples of valve geometries are also given. 
The simplest valve geometry is represented by an orifice plate of 
appropriate size to generate the desired pressure level at the process flow 
rate. Because of their simplicity, orifice valves are widely used in hands-on 
experimental systems (Brosel and Schubert, 2000) as well as in commercial 
units (Bee International, Inc., USA). 
In the flat-bead valve assembly (Figure I.4-V1), typical of Manton–
Gaulin APV (USA), Emulsiflex Avestin (Canada) and GEA Niro Soavi 
(Italy) commercial models, the process fluid is radially and outwardly 
dispersed through a narrow gap between the valve piston and seat, with the 
resulting jet impinging on an impact ring. The flat-bead valve assembly is 
widely used in the preparation of nanosuspensions (Donsi et al., 2010d, 
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Moschwitzer et al., 2004), nanoemulsions (Donsi et al., 2010c) and solid-
lipid nanoparticles (Souto et al., 2005). 
Another valve assembly, which is a hybrid between a radial diffuser and a 
colliding jet assembly, is sketched in Figure I.4-V2. In such homogenization 
valve, equipping commercial models of Stansted Fluid Power Ltd (UK), the 
radial jet originating around the pressurized valve piston, converges to the 
inner core of the valve, where reciprocally colliding jet fringes contribute to 
increase the fluid dynamic stresses on the fluid. This geometry resulted more 
efficient in cell disruption (Donsi et al., 2009) than in nanoemulsion 
formation (Donsi et al., 2011c). 
 
 
Figure I.4 Schematics of a high pressure homogenization system. 
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The colliding jet assembly shown in Figure I.4-V3 shows the simplified 
schematics of the interaction chambers of Microfluidizer (Microfluidics 
Corp., USA) systems. The pressurized process fluid is divided into two 
microchannels and then recombined in a reacting chamber where the liquid 
jets collide, dissipating the energy input almost instantaneously at the point 
of impact. As the reaction chamber of the microfluidizer is static and 
contains no moving parts, a high level of reproducibility is ensured in 
nanoemulsion preparation (Paquin, 1999). On the other side, processing of 
dispersions and suspensions is limited by the impossibilities of unclogging 
by varying the gap opening (i.e. by moving the valve piston). 
An efficient heat exchanging system is required immediately downstream 
of the homogenization chamber to cool down the process fluid, whose 
temperature is increased proportionally to the pressure drop due to frictional 
heating (0.15-0.20 °C/MPa), in order to prevent the degradation of 
thermolabile compounds. In addition, temperature control of the process 
fluid upstream of the pressurization stage may be needed when multiple 
HPH passes are performed to reach the desired particle or droplet size 
distribution, as well as in the production of solid lipid nanoparticles, when 
the temperature should be consistently maintained above the melting 
temperature of the lipids to avoid their uncontrolled crystallization in the 
system and consequent clogging. 
Droplet or particle break-up occurs in the homogenization chamber 
thanks to droplet deformation, induced by the fluid-dynamic stresses arising 
from the combination of turbulence, elongational and shear stress, as well as 
cavitation within the homogenization chamber. 
In standard homogenization chambers, such as radial diffusers or 
Microfluidizer chambers, the inertial forces in the turbulent flow determined 
by the valve geometry are mainly responsible for droplet disruption, together 
with cavitation induced by pressure and velocity fluctuations (Shirgaonkar et 
al., 1998). In contrast, in orifice valves, where a laminar flow region is 
established due to the small size of the orifice gap (in some cases as low as 
100 µm), break-up can be ascribed to shear forces in elongational flow, as 
well as to the perturbation occurring in the region following the elongational 
flow. 
The severity of the HPH process and hence the intensity of the fluid-
mechanical stresses can be regulated by controlling the operating pressure, 
the number of passes through the disruption valve, the inlet temperature, as 
well as the homogenizer valve design, while the scale of operation does not 
appear to influence the extent of particle break-up, as shown in the case of 
microorganism cells (Donsi et al., 2009). 
In general, the flow regime established in the HPH valve and downstream 
controls the extent of mechanical disruption of suspended particles and 
microbial cells with break-up occurring when the fluid-dynamic stresses 
exceed the particle or cell wall resistance. 
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In contrast, the emulsification process by HPH consists of two 
phenomena: the deformation and disruption of the droplets and the 
consequent droplet stabilization due to the adsorption of the emulsifier 
molecules at the newly formed O/W interfaces (Brosel and Schubert, 2000). 
Consequently, product properties and, in particular, the rate of adsorption of 
emulsifier at the newly formed interfaces contribute to control the size 
distribution of the nanoemulsion droplets. 
Especially in the case of food applications, where the product formulation 
poses severe limits to the amount and type of emulsifiers to be used, 
recoalescence phenomena can be problematic. As a consequence, the 
advantage of a high-pressure homogenization chamber in comparison with 
another is not the more efficient droplet break-up, but rather droplet 
stabilization against coalescence after disruption (Schultz et al., 2004). 
In the comminution of solid particles into nanoparticles, high pressure 
homogenization results in lower polydispersity than media milling, which 
instead require a stage of removal of microparticles and of the residues of 
abrasion of the used beads or balls. 
High pressure homogenization can therefore be considered a highly-
recommended technique to reduce particle size efficiently with high 
reproducibility and to process highly concentrated systems. It can be widely 
applied to create stable nanoemulsions, as well as dispersions of solid 
nanoparticles. Moreover, HPH technique enjoys various advantages such as 
simplicity, high efficiency and needlessness of organic solvents. 
 
I.4 Protection of bioactive compounds by nanoencapsulation 
The protection of bioactive compounds against degradation and 
interaction with food ingredients occurs through the encapsulation in 
nanometric delivery systems. For this reason an efficient nanodelivery 
system must be stable in the food matrices over long periods of time. 
However, some of the conditions that a nanoemulsion encounters during 
processing (e.g. heating, high-shear mixing) are not conducive to stability. 
Therefore it is necessary to understand, and ideally to eliminate, the sources 
of instability in such nanometric delivery systems.  
A nanoemulsion may become unstable due to different types of physical 
and chemical processes. Physical instability, such as creaming, flocculation, 
coalescence, phase inversion, results in an alteration of the spatial 
distribution or structural organization of the molecules, whereas chemical 
instability, such as oxidation and hydrolysis, results in the alteration of the 
type of molecules present.  
Instability during nanoemulsion formation occurs if there is insufficient 
surfactant to cover the entire oil-water interface created by the homogenizer. 
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The surfactant has an important role to prevent immediate aggregation or 
coalescence and its properties largely determine the behaviour of the 
nanoemulsion.  
Sufficiently large droplets suspended in aqueous medium of low viscosity 
or yield stress will cream. The creaming rate depends on the square of the 
droplet diameter, emphasizing the need for efficient homogenization. 
Creaming itself does not destabilize an emulsion, but the high 
concentration of oil droplets in the creamed layer promotes interactions that 
lead to flocculation, aggregation or coalescence. For two droplets to 
coalescence, they must first approach to close proximity, then the film of 
water separating them must drain, and finally the resultant Newton black 
film must rupture and allow the two droplets’ contents to flow together 
(McClements, 2005). In many cases the repulsive forces between droplets is 
sufficient to limit droplet approach and film drainage while in other cases the 
mechanical strength of the film can resist rupture. Coarse emulsions are 
prone to coalescence as the lower internal pressure allows significant 
deformation of large droplets to form a polyhedral structure separated by 
large planar films vulnerable to rupture. On the other hand, fine emulsions 
act as hard spheres and to overcome the disjoining pressure and to force 
droplets into close proximity separated by a Newton black film an external 
pressure must be applied. 
Flocculation and aggregation of the oil droplets in an emulsion arise from 
the inability of the adsorbed surfactant layer to prevent the close approach of 
the droplets. Although the two terms are almost synonymous, flocculation is 
generally regarded as being weaker than aggregation, because even in the 
combined state the particles are further away from one another; flocculation 
is therefore more readily reversed, at least temporarily, by shaking or 
stirring. The particles tend to aggregate because of attractive inter-atomic 
forces, but aggregation is opposed by repulsive charge interactions, which 
arise from adsorbed emulsifier.  
Figure I.5 summarises the mechanisms of physical instability of 
emulsions highlighting that creaming and flocculation can often readily be 
reversed by gentle agitation, while coalescence is a irreversible phenomenon. 
The research has historically focused mainly on the physical aspects of 
emulsion stability in foods. Nevertheless, there are many types of chemical 
reactions that can have adverse effects on the quality of food emulsions: for 
example, lipid oxidation, hydrolysis, flavor or color degradation, bioactive 
degradation due to a chemical interaction of nutraceutical compound with 
food components.  
 







Figure I.5 Mechanisms of physical instability in nanoemulsions. 
 
Djordjevic et al. have studied the chemical and physical stability of 
O/W emulsions containing limonene, an important flavor component of 
citrus oils (Djordjevic et al., 2008). Since limonene is lipid soluble, it is often 
added to foods as an oil-in-water emulsion. However, o/w emulsions 
containing limonene are susceptible to both physical instability and oxidative 
degradation, leading to loss of aroma and formation of off-flavors. They 
showed that whey protein isolate could protect limonene in O/W°emulsion 
droplets more effectively than gum Arabic. The ability of whey protein 
isolate to decrease the oxidative deterioration of limonene could be due to 
the formation of a cationic emulsion droplet interface, which can repel 
prooxidative metals. Yuan et al. have investigated the influence of emulsifier 
type and concentration, homogenization pressure, temperature and number 
of cycles on the properties and stability of O/W nanoemulsions of β–
carotene (Yuan et al., 2008). They showed that the physical stability of the 
nanoemulsions decreased with an increase of temperature but increased with 
pressure and homogenization cycles. 
 
I.5 Increase of bioavailability of nanoencapsulated bioactives 
Many bioactive compounds are poorly absorbed and quickly metabolized 
once they have been ingested and, therefore, they are prevented from 
reaching the target organs in active form. Nanometric size delivery systems 
can contribute to increase the bioavailability of bioactive compounds 
through their protection during the digestive processes, as well as their 
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improved uptake in the gastrointestinal tract and enhanced transport to the 
target sites.  
First of all, “bioavailability” and “uptake” should be clearly 
distinguished, because they are often inappropriately used interchangeably. 
The term bioavailability indentifies the fraction of an ingested component 
that enters in the bloodstream (Holst and Williamson, 2008). On the other 
hand, the uptake defines the fraction of ingested component that is absorbed 
through the intestinal walls. Although these two phenomena can be related, a 
nutraceutical compound absorbed through the intestine may not be 
bioavailable, due to the complexity of the biological mechanisms involved in 
the digestion of nutrients (Acosta, 2009). 
The first stage of digestion occurs in the mouth once the ingested food is 
mixed with saliva and broken down in smaller pieces by mastication. 
Subsequently, the food is subjected in the stomach to a complex series of 
physical and chemical changes: it is exposed to a highly acidic environment 
(pH 1-3), then to enzyme hydrolysis (e.g., pepsin) and to a complex stress 
profile due to the various contractions of the stomach. Therefore, the 
resistance of the nanometric delivery system to the environment gastric 
digestion may be an important requisite, if the encapsulated bioactive 
compound is chemically unstable at acidic pH. Moreover, through the 
creation of physical barriers (i.e., coating a lipid droplet with multilayer 
emulsifiers or encapsulating droplets within a hydrogel) between the 
encapsulated compound and the surrounding aqueous phase, where the 
digestive enzymes are normally located, it is possible to control the enzyme 
accessibility to their specific substrates within the delivery systems (Mun et 
al., 2006). 
As the digested food leaves the stomach and enters in the small intestine, 
it is mixed with the digestive juices containing the bile salts, which emulsify 
the lipids and hydrophobic compounds present and transport them to the 
enterocyte cells, where they are absorbed, as sketched in Figure I.6. 
The absorption of bioactive compounds through the intestinal walls 
occurs by two main mechanisms, based on active and passive transport, 
respectively. Active transport is the movement of the active ingredient 
against its concentration gradient, due to specific channels on the surface of 
the epithelial cells. The cells use their own energy, such as adenosine 
triphosphate (ATP), to capture the active compounds. Passive transport is 
instead regulated by a simple diffusion across the epithelial membrane, 
which occurs along the concentration gradient. 
The ability to control the particle size of the encapsulation system is of 
primary importance for increasing the adsorption of encapsulated 
components, improving the passive transport through the intestinal walls 
thanks to the subcellular size of the nanoparticles. Moreover, particle size 
and surface moieties can control the retention time in the gastrointestinal 
tract, either favoring the particles entrapment in the mucous layer, or 
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promoting their direct uptake, as schematically shown in Figure I.6 (Hussain 
et al., 2001). In particular, several works on the determination of the 
correlation between uptake/bioavailability and particle size of the delivery 
system, clearly showed that when reducing the particle size below 500 nm 
higher nanoparticles uptake and higher absorption of the encapsulated active 



















Figure I.6 Schematic mechanism of uptake and bioavailability of 
nanoencapsulated bioactive compound. 
 
The delivery systems of nanometric scale provide a larger surface area for 
interaction with the biological substrates than the corresponding micrometric 
size carriers. Moreover, an efficient design of the interfacial properties of the 
nanocapsules can improve the controlled release of the encapsulated 
compound to its target site, while avoiding any undesired instantaneous 
release (Mozafari et al., 2008). Two mechanisms of controlled release are 
possible, as shown in Figure I.7: delayed release, with the bioactive 
compound being released after a certain lag time, and sustained release, with 
concentration of the bioactive compound being maintained constant over a 
prolonged release time (Fathi et al., 2011). In particular, delayed release is 
used for achieving the protection of nutrients during gastric digestion and the 
release in the intestinal tract. On the other hand, sustained release can be 
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employed for extending the release time of certain drugs, such as insulin, 























Figure I.7 Mechanisms of release of bioactive compounds. 
 
Different factors, such as ingredients, shape and dimensions of carrier, 
may influence the release of the encapsulated material. For example, 
McClements and coworkers have critically analyzed different delivery 
systems, such as nanoemulsions, multilayer emulsions, solid lipid 
nanoparticles and filled hydrogel particles, in terms of potential control of 
the digestion and release of bioactive lipophilic components within the 
gastro intestinal tract (McClements and Li, 2010).  
Another important aspect to take into account in the design and 
formulation of efficient delivery systems, is that lipid-based systems can 
improve the bioavailability of many poorly soluble bioactive compounds, 
being the absorption path of the bioactive ingredients affected by the co-
administration of fats (Porter et al., 2008). In contrast, although most orally 
administered compounds gain access to the systemic circulation via the 
portal vein, some highly lipophilic compounds are transported directly to the 
systemic circulation via the intestinal lymphatics, therefore requiring a 
different forlumation to improve their bioavailability. 
In summary, the ability to maintain the particle size of the delivery 
systems into the nanometric range is of primary importance not only for 
increasing the dispersibility of poorly soluble bioactive compounds in food 
matrices, as well as for preserving the organoleptic properties of the product, 
e.g., taste, aroma, texture, and appearance, but also for controlling the 
release of the encapsulated compounds, improving their absorption into the 










In recent years there was an intensive research focusing on the 
encapsulation of bioactive compounds in the pharmaceutical field, but just a 
few researches were specific to the food field. More specifically, no 
systematic study was conducted in terms of development, design and 
production of nanodelivery systems and of the interaction of 
nanoencapsulated bioactive compounds with food. Based on these 
considerations, the general objective of this thesis is the rational design of 
efficient nanometric delivery systems, above all nanoemulsions and solid 
lipid nanoparticles, made of natural food ingredients, to incorporate 
bioactive compounds. 
To achieve this goal the following specific objectives have been set:  
 
• Design of efficient formulations, in terms of lower emulsifier 
content, to improve the solubility of bioactive compounds, 
scarcely soluble in water and in aqueous systems, such as food 
matrices. 
• Improve the scalability of food-grade nanodelivery systems 
production through a deep understanding of high pressure 
homogenization process and a specific investigation of the 
interface interactions and the forces that regulate the formation 
and the thermodynamic and kinetics stabilization of a 
nanoemulsion. 
• Increase the physicochemical stability of nanoencapsulated 
bioactive compounds that can be easily degraded from 
environmental conditions. 
• Improve the bioavailability of functional ingredients, so that they 
can arrive in their most active form to the target sites, without 
being rapidly metabolized. 
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• Promote the incorporation in real foods, by an improved 
understanding of the interactions of nanoencapsulated bioactive 
compounds with food ingredients, as well as of the effect on the 
nutritional and organoleptic properties of their implementation in 
food matrices. 
 
The research activity will pursue the above objectives, specifically 
focusing on the encapsulation in food nanoemulsions of model bioactive 
compounds: polyphenols, such as resveratrol and curcumin, for the crescent 
interest on their beneficial effects on human health, especially an high 
antioxidant activity, and essential oils, in order to retain and possibly 
enhance the antimicrobial activity. 
 
II.2 Working plan 
The research was organized taking into account all the aspects related to 
the design and engineering of a delivery system for the nanoencapsulation of 
bioactive compounds, which are able to protect them against degradation and 
increase their bioavailability. In particular, to achieve the stated objectives, 
the research activity has been divided into the following steps, as shown 
schematically in Figure II.1: 
 
• Formulation procedures for high solubility: Definition of the criteria 
for the choice of a suitable formulation to increase the solubility of 
bioactive compounds in an aqueous system by means of the 
construction of the pseudo ternary phase diagram, which allows to 
evaluate, based on the composition of the emulsifiers and the lipid 
phase, the physically stable formulations. Curcumin, a polyphenolic 
compound which is insoluble in water and poor soluble in oil, will be 
chosen as model compound. 
• Investigation of HPH process parameters: The mechanisms of 
production of food nanoemulsions by high pressure homogenization 
(HPH) will be investigated, focusing on the effect on droplet 
nanonization of emulsifier type and concentration, as well as of the 
geometry of the homogenization chamber. Moreover, several food-
grade emulsifiers will be characterized, in comparison with artificial 
ones, in terms of their interfacial and dynamic properties, by pendant 
drop measurements. 
• Physical and chemical stability: Investigation of the 
physicochemical stability of encapsulated bioactive compounds into 
nanoemulsion-based delivery systems under accelerated ageing 
conditions (high temperature, UV light exposition and low/high pH).  
• Bioavailability of encapsulated compounds: Studying of the 
efficiency of nanometric delivery systems to increase the 
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bioavailability of bioactive compounds, using in vitro and ex vivo 
assays. In particular, the stability of the encapsulated compound 
during the digestion process will be evaluated, simulating in vitro 
gastric and intestinal digestion. The transport through the intestinal 
wall will be simulated, observing the transport through Caco-2 cell 
monolayers grown on permeable supports. The release profile of the 
bioactive compound from the nanocapsules will be performed by a 
dialysis bag method. For these experiments, resveratrol, having a 
very low bioavailability and a rapid metabolism, will be used as 
model. Furthermore, the effect of nanometric delivery systems on the 
antioxidant activity of the encapsulated compounds will be evaluated 
using a chemical and a biological-based approach. 
• Antimicrobial activity: Evaluation of the effect of the delivery 
systems on the antimicrobial activity of essential oils, such as a 
terpene mixture and D-limonene, encapsulated into food-grade 
nanoemulsions. The analysis will be performed by determining the 
minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) for three different classes of microorganisms 
(Lactobacillus delbrueckii, Saccharomyces cerevisiae, Escherichia 
coli). 
• Incorporation in real foods: The alteration of the organoleptic 
properties of fruit juices after the incorporation of nanoencapsulated 
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Figure II.1 Sketch of the research activities related to the 











This chapter explains the procedures used for the formulation of the 
delivery systems to be used for increasing the dispersability in aqueous 
systems of bioactive compounds, which are poorly soluble in water (i.e. 
curcumin). The approach adopted is based on the investigation of 
stability/instability regions of oil in water emulsion systems encapsulating 
curcumin at varying composition of the food nanoemulsions, in terms of 
content of emulsifiers and lipid phase, and the consequent construction of 





In the field of nutraceuticals and functional foods, there is a growing 
interest in exploiting the nanoemulsions to solve the problems of solubility 
and stability of nutraceuticals and food additives in aqueous solution. 
For example, curcumin, because of its polyphenolic structure, is not only 
water insoluble, but also scarcely dissolved by organic phases, thus requiring 
the encapsulation in suitable delivery systems to increase its solubility in 
aqueous systems, such as food matrices, and improve its bioavailability, 
which is solubility-limited. 
Knowledge of the equilibrium phase behaviour of emulsion systems, such 
as oil/water/emulsifier(s), has proven to be an interesting tool to study the 
emulsification process in terms of drop size and stability. However, the 
majority of the concepts developed to predict emulsion properties are 
focused on emulsifier’s characteristics. More specifically, the affinity of an 
emulsifier for oil or water depends on formulation parameters, which are 
taken into account through a concept called hydrophilic–lipophilic deviation 
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(HLD) (Salager, 1988). This number can be positive or negative, indicating 
the emulsifier’s affinity for oil or water phase respectively.  
When HLD is coupled with the composition (volume fraction of water in 
oil/water system), a two dimensional map is constructed called formulation–
composition map. On this 2D map the boundary which separates the 
morphology of one type of emulsion from another normally forms a stair-
like structure. A typical example of formulation–composition map of an 
emulsion system is shown in Figure III.1. The vertical line below and above 
the HLD = 0 is known as catastrophic inversion line, while the horizontal 
line (HLD = 0) is known as transitional inversion line. The knowledge of 
catastrophic inversion line appears in dynamic condition, i.e. during 
emulsion production, but transitional inversion line is the result of phase 
behavior of oil/water/emulsifier system at equilibrium (Salager, 1988). This 
map is advantageous for formulation protocol of an emulsion to get the 












Figure III.1 A generalized formulation–composition map on two-
dimensional plot (Salager, 1988). 
 
 
In food emulsion systems, such map is rare due to the complexities 
associated with (i) emulsifiers (i.e. phospholipids or proteins) and (ii) oil 
phase (mostly triglycerides). In particular, the phase behavior at equilibrium 
of even a simple food emulsion system is not easy to observe (Thakur et al., 
2007). 
For this reason, the region or composition of food nanoemulsions is 
usually defined or identified by constructing ternary-phase diagrams. 
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Ternary diagrams are employed to depict mixtures of three components. 
With the help of these diagrams, every state of the three-phase system for a 
specific temperature and specific pressure can be described. In case of 
nanoemulsion development, the diagrams are called pseudo-ternary phase 
diagrams, since a nanoemulsion is a complex system of oil, water and 
emulsifiers (surfactant and cosurfactant) and between these phases there is 
no thermodynamic equilibrium, but kinetic stabilization. Surfactant and 
cosurfactant is prepared in defined mixtures and is presented on one axis in 
the ternary phase diagram.  
 
III.2 Material and methods 
III.2.1 Materials 
Curcumin (85% pure, with 11% demethoxycurcumin and 4% 
bisdemethoxycurcumin as impurities) was obtained from Sabinsa 
Corporation (Piscataway, NJ) and used without further purification. 
Primary emulsion formulation was based on stearic acid (Sigma-Aldrich 
s.r.l., Milan, Italy), palm oil (Fluka, Germany) or hydrogenated palm oil (a 
kind gift from Prodotti Gianni, Milan, Italy) as organic phase, and the 
combination of lipophilic and hydrophilic emulsifiers. Lipophilic emulsifiers 
were soy lecithin Solec IP (a kind gift from Solae Italia s.r.l., Milan, Italy) 
and glycerol monooleate (Sigma-Aldrich s.r.l., Milan, Italy). Hydrophilic 
compounds were sugar ester P1670 (a kind gift from Prodotti Gianni, Milan, 
Italy) and defatted soy lecithin Solec FS-B (a kind gift from Solae Italia 
s.r.l., Milan, Italy). Bidistilled water was used as continuous phase. 
 
III.2.2 Screening of Emulsion Formulations 
The pseudo-ternary phase diagram of curcumin encapsulated into O/W 
emulsion system, using a lipophilic and hydrophilic emulsifier mole ratio of 
1:0.5, was constructed in order to identify stable formulations .  
The emulsions were prepared by mixing the separately prepared aqueous 
and oil phases. Curcumin (0.1 wt%) was first dissolved in the oil and mixed 
with the lipophilic emulsifier at a temperature above the lipid melting point 
(75 °C for stearic acid and 50 °C for palm oil). The aqueous phase 
containing the hydrophilic emulsifier was heated up to 75 °C under slight 
mixing. Nine different samples were initially prepared by mixing the 
aqueous phase with the lipid phase in different proportions (from 1:9 to 9:1).  
After high speed homogenization (HSH) using an Ultra Turrax T25 
blender (IKA Labortechnik, Jahnke und Kunkel, Germany) at 24000 rpm for 
4 min at a temperature above the lipid melting point to obtain a primary 
emulsion, part of the sample was collected in a tube for stability 
investigation, while the other part was serially diluted in water and treated 
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again by HSH to generate the other points of the phase diagram, which were 
all sampled and stored at room temperature. After 24 h from preparation the 
state of the emulsified systems was visually evaluated and classified in 
physically unstable or stable systems. 
Samples which resulted fluid enough to be sucked and pumped by the 
intensifier of the Nano DeBEE system, were further treated by HPH. 
 
III.3 Construction of a pseudo-ternary phase diagram for the 
evaluation of stable formulations 
The emulsion-based nanometric delivery systems are produced in two 
step: the formation of the primary emulsions prepared by high speed 
homogenization (HSH), followed by high pressure homogenization (HPH) 
for the formation of the secondary nanoscale emulsions. The limiting step to 
produce stable nanoemulsions for improving the solubility in an aqueous 
system of a compound poorly soluble in water, is the choice of the optimal 
composition, in terms of emulsifier and lipid contents, to obtain stable 
primary emulsions. The stability of the primary emulsions was evaluated 
thanks to the construction of a pseudo-ternary phase diagram. In particular, a 
pseudo-ternary phase diagram was used as a compositional map for the 
identification of the optimal conditions to obtain kinetically stable 
emulsions, through the reduction of the droplet size and minimization of the 
amount of emulsifier to be used.  
In the triangular phase diagram of Figure III.2, the first vertex 
corresponds to water, the second to curcumin (0.1 wt%) solubilized in stearic 
acid, and the third to a combination of a lipophilic and hydrophilic emulsifier 
in 1:0.5 ratios. In particular, glycerol monooleate and sugar ester (Figure 
III.2a), lipophilic soy lecithin and sugar ester (Figure III.2b), lipophilic and 
defatted soy lecithins (Figure III.2c) have been used as emulsifiers. 
As shown in Figure III.2, different regions of stability/instability can be 
identified. The unstable systems include: the “heterogeneous liquid” case, 
characterized by the physical separation of aqueous and oil phases and 
settling of curcumin, which precipitated to the bottom of the tube; the 
“heterogeneous cream” case, where two layers were observed with excess 
water at the bottom and the emulsion on top with settling of curcumin; the 
“heterogeneous solid” case, which consists of solid coarse particles in which 
the curcumin is completely insoluble.  
It was observed that the unstable zone of the diagram is confined to its 
lower part, while the stable conditions all exist above the imaginary water 
dilution line that starts from the middle of the right side of the phase diagram 
and reaches the water vertex.  
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Figure III.2 The pseudo-ternary phase diagrams of curcumin–encapsulated 
emulsion using stearic acid as lipid phase and a combination of (a) 
lipophilic soy lecithin, LSL, and sugar ester, SE, (b) lipophilic soy lecithin, 
LSL, and defatted soy lecithin, DSL, and (c) glycerol monooleate, GMO, and 
sugar ester, SE, as emulsifiers. 
 
Figure III.3 Samples collected for the evaluation of the stability/instability 
regions of the pseudo-ternary phase diagram. From left to right: 
homogeneous cream, heterogeneous cream, heterogeneous solid, 
heterogeneous and homogeneous liquid. 
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The stable systems that were obtained were divided into two large 
categories: the “homogeneous liquid” case, which included stable oil in 
water emulsions that exhibited a Newtonian flow behavior, and 
“homogeneous cream” case, which included the emulsion systems with a 
macroscopically non-Newtonian behavior. 
In Figure III.3 the pictures of some samples collected for the evaluation 
of the stability/instability regions of the pseudo-ternary phase diagram were 
reported to illustrate the different cases. 
The “homogeneous liquid” systems were considered to be the primary 
emulsions for further processing by HPH and comminution to nanometric 
size for the production of the secondary emulsions. 
In Table III.1 were reported the composition of the stable primary 
emulsions, that were further homogenized with high-pressure homogenizer 
at 200 MPa for 10 cycles of homogenization to reduce the sizes of the 
droplets and obtain curcumin-encapsulated O/W emulsions. After HPH 
processing, just a formulation, C/LSL-SE, remained stable without settling 




Table III.1 Composition of the “homogeneous liquid” systems that has been 
used as primary emulsions during the production by HPH of O/W emulsion 
for curcumin delivery. 
Homogeneous liquid Composition 
C/GMO-SE 
0.1% curcumin 
3.73% glycerol monooleate 
1.87% sugar ester 




3.73% lipophilic soy lecithin 
1.87% sugar ester 




3.73% lipophilic soy lecithin 
1.87% defatted soy lecithin 
2.4% stearic acid 
91.9% water 
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We also tried to increase the curcumin’s concentration from 0.05 to 
0.2 wt% and observe the stability of the emulsions to find the maximum 
concentration that can be encapsulated without precipitation.  
For curcumin concentration >0.1 wt%, there was a settling of curcumin 
on the bottom of the test tube. So we can conclude that 1000 mg/L is the 
maximum concentration of curcumin that can be encapsulated in stearic 
acid-based emulsions, resulting 1600 times higher than the solubility of 
curcumin in water, which is 0.6 mg/L (Donsi et al., 2010d). 
Moreover, in order to check the effect of the oil phase, palm oil and 
hydrogenated palm oil have been used as lipid phase instead of stearic acid. 
It has been observed that only the stearic acid gives stable submicron 
emulsions; on the contrary, in the formulations with palm oil and 
hydrogenated palm oil as lipid phase, the curcumin encapsulated has been 













In this chapter the production of food nanoemulsions by high pressure 
homogenization technique (HPH) was investigated, focusing on the effect of 
emulsifier type and concentration as well as of the geometry of the 
homogenization chamber on the mean droplet diameter obtained. The 
kinetics of the emulsification process was determined by dynamic light 
scattering measurements on the emulsions produced at different pressure 
levels and number of HPH passes, in four different homogenization chamber 
geometries.  
Moreover, several food-grade emulsifiers, such as soy lecithins, pea 
proteins, modified starch and sugar ester, were characterized in terms of their 
interfacial and dynamic properties, by pendant drop measurements and 
compared with synthetic compounds, such as Tween 80 and SDS. 
The results show that the kinetic parameters of the emulsification process 
can be primarily correlated with the interfacial and dynamic properties of the 
emulsifiers, while the fluid-dynamics regime establishing in the 
homogenization chamber contributes only to a lesser extent. Nevertheless, 
the correct design of the homogenization chamber may help in obtaining 






Emulsification at nanometric sizes can be conducted by means of energy 
intensive systems, such as colloid milling, ultrasonication and high pressure 
homogenization (Stang et al., 2001, Schultz et al., 2004). At the moment, 
high pressure homogenization (HPH) appears to be the most suitable 
technique for industrial applications, because of the ease of operation, 
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scalability, reproducibility and high throughput (Liedtke et al., 2000, Schultz 
et al., 2004). 
The emulsification process by HPH can be schematically represented by 
two stages, one consisting in the deformation and disruption of the droplets, 
with the consequent increase of the surface area of the emulsion, and the 
other in the droplet stabilization by means of the adsorption of the emulsifier 
molecules at the newly formed interfaces (Brosel and Schubert, 1999, 
Hakansson et al., 2009b, Hakansson et al., 2009a). 
Disruption occurs in the homogenization chamber when droplet 
deformation, induced by the fluid-dynamic stresses occurring partly in the 
discharge gap and mainly in the interaction chamber (Brosel and Schubert, 
1999), reaches a critical level. 
The fluid-dynamic stresses arise from the combination of different 
factors, such as turbulence, elongational and shear stress, as well as 
cavitation (Floury et al., 2004b, Floury et al., 2004a). Which of these factors 
is dominant depends on the equipment used, operating conditions, process 
fluid properties and droplet composition. 
For a given valve geometry, disruption is also influenced by product 
properties and operating conditions (Stang et al., 2001). While the viscosity 
of the continuous phase does not play a significant role on the disruption 
efficiency, the disperse phase viscosity or the viscosity ratio, defined as the 
ratio of the viscosity of the disperse phase to the viscosity of the emulsion 
phase (ηd/ηem) or of the continuous phase (ηd/ηc) (Stang et al., 2001, Qian and 
McClements, 2011), represents an important parameter.  
For example, the inertial forces generated in the highly turbulent region 
are identified as responsible of droplet disruption for disperse phases of low 
viscosity (Middelberg, 1995, Floury et al., 2004b). At higher disperse phase 
viscosities, the mechanisms of disruption due to the laminar elongational 
flow become instead predominant (Stang et al., 2001, Kleinig and 
Middelberg, 1998), because the lifetime of turbulent eddies is too short to 
critically deform highly viscous droplets (Stang et al., 2001). 
Another mechanism that contributes to droplet disruption is cavitation. 
Turbulent flow conditions favor cavitation due to fluid velocity and pressure 
fluctuations that can cause the formation and disruption of vapor cavities 
(Kleinig and Middelberg, 1998). 
Donsì and coworkers devoted numerous efforts to clarifying the 
mechanisms of inactivation by HPH of cells suspended in a liquid, which is 
a disruption-dominated process, using different valve geometries and scale 
of operation (Donsi et al., 2009), deriving the indications that the flow 
regime established in the HPH valve and downstream of it controls the 
extent of mechanical disruption (Donsi et al., 2009). 
Obviously, HPH emulsification is complicated by the recoalescence 
phenomena following disruption, which depends not only on the flow regime 
but also on emulsifier properties. For a very fast-adsorbing emulsifier, the 
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mean droplet diameter can be well correlated to the energy density delivered 
to the system by the HPH system by a power law (Stang et al., 2001, Schultz 
et al., 2004): 
b
Vem ECd
−⋅=  (IV.1) 
In eq. (IV.1), dem is the mean droplet diameter and EV is the energy 
density, which corresponds to the pressure drop in the homogenization valve 
times the number of HPH passes (Schultz et al., 2004), while C and b are 
kinetic constants, which depend on the efficiency of droplet disruption (C) 
and on the flow conditions in the interaction chamber (b). Typical values of 
b range from 1 for laminar elongational flow to about 0.6 for inertial forces 
in turbulent flow and 0.75 for shear forces in turbulent flow (Stang et al., 
2001). Values of C are instead affected by the emulsion properties and 
interfacial activity of the emulsifier. The lower interfacial tension induced by 
the emulsifier may in fact facilitate droplet deformation and disruption 
(Brosel and Schubert, 1999). 
For slow-adsorbing emulsifiers, the mean droplet diameter is instead 
controlled by interfacial adsorption velocity, which is the main determinant 
of the stabilization of the newly formed droplets, and hence of the minimum 
droplet size that can be obtained in the homogenizer.  
Despite considerations on droplet surface coverage suggest that the mean 
droplet diameter should be inversely proportional to emulsifier concentration 
(McClements, 1999), the theoretical minimum diameter is never achieved, 
because adsorption at the interface is a dynamic process, which is in 
competition with coalescence phenomena (Qian and McClements, 2011). In 
particular, the adsorption and coalescence phenomena, which can be both 
correlated to the collision of emulsifier molecules with oil droplets 
(adsorption) and to inter-droplet collisions (coalescence), are characterized 
by comparable time scales in the case of macromolecular emulsifiers 
(Nilsson and Bergenstahl, 2006). 
Recoalescence phenomena, being prevented by emulsifier adsorption at 
newly formed interfaces (Brosel and Schubert, 1999), are therefore affected 
by emulsifier type and concentration (Qian and McClements, 2011). 
Nevertheless, especially in food formulation, due to ingredient and taste 
constraints, it is not always possible choosing the optimal emulsifier or 
adding it at high concentration (Schultz et al., 2004). 
In general, small-molecule emulsifiers, such as Tween 20 and SDS, can 
lead, under similar processing conditions, to smaller droplet size than larger 
molecules, such as proteins (Qian and McClements, 2011), which can also 
undergo denaturation upon HPH, losing their interfacial and emulsifying 
properties (Qian and McClements, 2011, Floury et al., 2002b, Floury et al., 
2002a, Donsi et al., 2010b). 
The aim of this chapter is to contribute to the fundamental investigation 
of the HPH-assisted emulsification process at the nanometric size, using 
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food-grade ingredients. In particular, the effect of different food-grade 
emulsifiers, such as modified starch, vegetable proteins, sugar ester and soy 
lecithin, whose interfacial and dynamic properties are thoroughly 
characterized, are critically assessed in comparison with artificial 
emulsifiers, such as SDS and Tween 80. In addition, also the effect of 
different homogenization chamber geometries is investigated, in order to 
identify the key determinants of the emulsification process. 
 
IV.2 Material and methods 
IV.2.1 Materials 
All O/W emulsions tested in the present work were formulated using 
sunflower oil (Sagra, Lucca, Italy) as disperse phase and bidistilled water as 
continuous phase. Different hydrophilic compounds were tested as 
emulsifiers, which were dissolved in the aqueous medium prior to lipid 
mixing. Among small-molecule surfactants, polysorbate 80 (Tween 80) and 
sodium dodecyl sulphate (SDS), both acquired from Sigma-Aldrich s.r.l. 
(Milan, Italy), a sugar ester (sucrose palmitate P-1670), a kind gift from 
Prodotti Gianni (Milan, Italy), as well as a defatted soy lecithin (Solec FS-
B), a generous gift from Solae Italia s.r.l. (Milan, Italy), were tested. Among 
functional polysaccharides, a modified starch (Cleargum® CO01) and pea 
proteins isolates (Nutralys® F85M), both a generous gift from Roquette Italia 
S.p.A. (Alessandria, Italy), were used as emulsifying agents. 
 
IV.2.2 Experimental method 
IV.2.2.1 Interfacial tension measurements 
Interfacial tension at the water-oil interface, with different emulsifier 
loadings in the aqueous solution (from 0.01 g/L to 50 g/L), was measured by 
means of the pendant drop method. Measurements were conducted on a 
droplet of aqueous solution, of volume ranging between 5 and 10 µL, 
produced by means of a micrometric syringe in water-saturated sunflower oil 
contained in a transparent cuvette. This configuration was preferred for 
technical reasons to the reverse configuration (oil droplet in water), after it 
was experimentally verified that the same results were obtained in the two 
cases. 
A CAM200 apparatus (KSV Instruments, Finland), consisting of an 
experimental cell, an illuminating and viewing system to visualize the drop 
as well as a data acquisition system, was used to determine the interfacial 
tension from the pendant drop profile. Images of the drop were captured and 
digitalized, the drop contour was extracted for the determination of the 
radius of curvature at the apex necessary for the calculation of interfacial 
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tension. Interfacial tension was automatically determined via software by 
fitting the shape of the captured drop images to the Young-Laplace equation 
which relates interfacial tension to drop shape. 
Eq. (IV.2) reports the Young-Laplace equation, where ϕ is the angle 
made by the tangent at the point (X, Z), s is the linear distance along the 
drop profile and dϕ/ds corresponds to the radius of curvature at the point 
(X, Z) and β is the shape parameter, given by eq. (IV.3), where g is the 
gravitational constant, ρ is the effective density of the liquid drop, σ is the 
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The evolution of the interfacial tension over 104 s from the instant of drop 
formation was monitored by sequential acquisition of drop images at 
specified time intervals. 
The reported results are the average of 3 measurements. 
 
IV.2.2.2 Emulsion production by high pressure homogenization 
Primary emulsions were obtained by homogenizing water-emulsifier-oil 
mixtures (10% sunflower oil in water and emulsifier concentration in the 
emulsion ranging from 50 to 10 and 2.0 g/L) through high speed 
homogenization (HSH) using an Ultra Turrax T25 apparatus (IKA® Werke 
GmbH & Co., DE) equipped with a S25 N18 G rotor operated at 24000 rpm 
for 5 min at 4°C. Primary emulsions were then reduced into very fine 
secondary emulsions (nanoemulsions) by HPH either in a Nano DeBEE 
Electric Bench-top Laboratory Machine (Bee International, Inc., South 
Easton, MA) or in a bench-scale nm-GEN 7400 homogenizer (Stansted 
Power Fluids, Stansted, UK). 
The operating pressure ranged from 70 to 280 MPa, while the number of 
homogenization passes was varied from 1 to 10. The inlet temperature was 
set at 4°C and the outlet temperature, which increased because of frictional 
heating during pressure drop, was rapidly reduced back to 4 °C in a heat 
exchanger placed immediately downstream of the homogenization valve. 
Sampling was conducted on the primary emulsion (0 HPH passes) and 
after 1, 2, 3, 5, 7 and 10 HPH passes for mean droplet size measurements. 
Experiments were conducted in duplicate. 
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IV.2.2.3 Homogenization chamber geometry 
HPH-assisted emulsification process was conducted using two different 
HPH systems with four different configurations of the homogenization 
chamber, which are schematically depicted in Figure IV.1. 
The Nano DeBEE machine was characterized by an orifice valve fitted in 
a modular homogenization chamber, whose geometry could be simply 
regulated. In contrast, the Stansted homogenizer was characterized by a 
piston valve geometry of the homogenization valve, previously described 
(Donsi et al., 2009). 
Homogenization chamber configurations Z5, Z5-cf and Z8 (Figure IV.1) 
were all realized in the Nano DeBEE system, and differed in the orifice size 
and downstream flow pattern. The zirconia orifice nozzle mounted in the 
systems was available in two different sizes, 130 µm (Z5 and Z5-cf) and 
200 µm (Z8). In all cases the process fluid was forced under high pressure 
(70-280 MPa) through the orifice, generating an extremely high velocity jet. 
This was the first step in the droplet disruption process. Subsequently, the 
high velocity jet entered a series of 5 interaction chambers, where the 
disruption process was completed. The homogenization chamber geometry 
with different interaction chambers was designed to create a combination of 
fluid-mechanical stresses, in order to completely break apart the droplets, 












c) Nano DeBee with orefice Z8
b) Nano DeBee with orefice Z5-countercurrent flow






Figure IV.1 Simplified sketch of the different geometries of the 
homogenization chambers tested. 
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Z5 and Z8 configurations were operated in standard mode, with the outlet 
in the same direction of the fluid jet. In contrast, Z5-cf configuration was 
characterized by the outlet perpendicularly located immediately downstream 
of the orifice. The flow inversion induced either after the interaction 
chambers (as claimed by the manufacturer), or before them, theoretically 
improves turbulent fluid-fluid interactions and therefore droplet disruption. 
SFP configuration was realized in the Stansted Fluid Power machine and 
was characterized by a movable piston, whose position with respect to the 
valve seat determined the gap opening and hence the operating pressure 
(Figure IV.1). In the investigated pressure range (70-140 MPa), gap opening 
varied between 2 and 5 µm. More details on the relationship between gap 
opening, flow rate and operating pressure are given elsewhere (Donsi et al., 
2009, Floury et al., 2004a). In the SFP geometry, the pressurized flow is 
radially dispersed from the volume surrounding the piston to the inner 
interaction chamber through the annular gap formed by the piston and the 
valve seat. In the interaction chamber, the combination of shear and 
elongational stresses, turbulence and cavitation causes the droplet disruption 
(Donsi et al., 2009). 
 
IV.2.2.4 Photon Correlation Spectroscopy 
A photon correlation spectrometer (HPPS, Malvern Instruments, 
Malvern, UK) was used for the particle size measurement of the emulsion 
droplets, whose characteristic size was always comprised in the instrument 
sensitivity range (1–6000 nm). The droplet size distribution was 
characterized in terms of the mean droplet size (Z-diameter) and width of the 
distribution (polydispersity index, PDI) at 25 °C by measuring the 
backscattered (173°) light through samples diluted 1:100 with bidistilled 
water to avoid multiple scattering effects within polystyrene cuvettes. The 
intensity-intensity autocorrelation function, G(q,t), generated by the 
measurements was automatically analyzed through cumulant analysis 
coupled with the Stokes-Einstein equation (Stepanek, 1993) by the software 
provided by the manufacturer, with only refractive index and viscosity of the 
dispersant medium (water) required (1.332 and 0.895 mPa s respectively, at 
25 °C) as input parameters.  
 
IV.2.2.5 Viscosity measurement of the nanoemulsions 
Viscosity measurements of the emulsion samples treated at different 
pressures were conducted using a dynamic shear rheometer (TA Instruments, 
New Castle, DE) with a shear rate profile from 0.1 to 1000 s-1. All the 
measurements were performed at 25 °C. 
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IV.2.2.6 Density measurement of the nanoemulsions 
Density measurements of the emulsion samples treated at different 
pressures were conducted using a density-meter Densito 30PX (Mettler-
Toledo, Inc., Columbus, OH) at 25 °C. 
 
IV.2.3 Data fitting 
IV.2.3.1 Dynamic interfacial tension 
The dynamic interfacial tension σ(t) of the tested emulsifiers was 
measured as a function of time. The pronounced decrease of σ(t) with 
advancing time was attributed to the migration and reorganization of the 
emulsifier at water-oil interface (Shi et al., 2004). Accordingly, a kinetic 
model, eq. (IV.4), which enables the detailed description of the rate of 
transport of the different emulsifiers tested, was implemented by minor 
modifications of a literature model, validated for macromolecules (Shi et al., 
2004). 

























In eq. (IV.4), σf is the asymptotic interfacial tension for t → ∞, and σ1, σ2, 
τ1 and τ2 are the dynamic parameters that describe the decay kinetics of the 
interfacial tension over time until a stationary value is reached. More 
specifically, τ1 and τ2 represent the characteristic times of decay of σ(t) to the 
asymptotic value, with τ1 corresponding to the migration of the emulsifier to 
the water-oil interface, and τ2 to the reorganization of the emulsifier at 
water-oil interface and to the eventual configurational changes of 
macromolecules at interfaces (Nilsson and Bergenstahl, 2006). In general, τ1 
values are expected to be lower than τ2. 
 
IV.2.3.2 Emulsification process 
The effect on the mean droplet size (dem) of the emulsifier type and 
concentration, as well as of the geometry of the homogenization chamber 
was modeled as function of the energy density according to eq. (IV.1) (Stang 
et al., 2001). 
In eq. (IV.1) EV is the specific energy delivered to the emulsion by the 
HPH device, that is the mechanical energy input per unit volume of the zone 
where the droplets are disrupted (Stang et al., 2001), and that can be 
calculated as the homogenization pressure times the number of HPH passes. 
C and b are kinetic parameters, with a precise physical meaning. C is the 
mean droplet size of the primary emulsion for a unit specific energy, and 
therefore indicates the emulsifying ability of the used emulsifier upon mild 
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homogenization (prior to HPH). b represents the kinetic constant of 
reduction of the mean droplet size and therefore indicates how fast the 
droplets are disrupted. Better emulsification is attained for b → 1, while a 
worse performance is characterized by b → 0. 
In comparison with the model of eq. (IV.1), also the model reported in eq. 
(IV.5) was tested for fitting the experimental data, with the main difference 
consisting in a different exponent for operating pressure ∆Ph (b) and for 
number of passes n (f): 
fb
hem nPCd
−− ⋅∆⋅= ''  (IV.5) 
 
The polydispersity index, PDI, was instead fitted with eq. (IV.6): 
'' bVECPDI
−⋅=  (IV.6) 
 
IV.3 Results 
IV.3.1 Interfacial tension and adsorption kinetics 
The surface activity of several hydrophilic emulsifiers (modified starch, 
pea proteins, SDS, Tween 80, sugar ester, as well as soy lecithin) was 
characterized by measuring the dynamics of the interfacial tension at the 
O/W interface at different concentration in the aqueous phase, in comparison 
with the interfacial tension of a pure water-sunflower oil system. Results are 
reported in Figure IV.2. 
The interfacial tension of the pure water-sunflower oil system is about 
27.5 mN/m at t = 0, exhibiting a reduction of less than 3 mN/m over a period 
of 104 s, which must be ascribed to the presence of impurities in the oil 
phase. 
When a hydrophilic emulsifier is present in the aqueous phase, its 
adsorption at the O/W interface goes through three different stages affecting 
the interfacial tension: (a) the diffusion from the bulk to the boundary layer 
insisting at the interface, (b) the molecular adsorption at the interface and the 
penetration in the oil phase, and (c) the eventual molecular reorganization at 
the interface (Liu et al., 2011). 
In pendant drop experiments, the diffusional transport is the rate-
determining step only in the adsorption process of small molecules from 
dilute solutions. In the case of macromolecules, such as globular proteins, 
reorganization at the interface upon unfolding may become the rate-limiting 
factor (Liu et al., 2011). In addition, during high pressure homogenization, 
the turbulent regime that establishes immediately downstream of the 
disruption valve makes the diffusional transport of the emulsifier to the 
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interface less important, with faster turbulence-controlled convective 
transport instead dominating (Nilsson and Bergenstahl, 2006). 
In the experiments reported in Figure IV.2, the diffusion step is too fast to 
be detected with the experimental method used, with a few seconds elapsing 
between the droplet formation and the first recorded image. As a 
consequence, the value of the interfacial tension measured at t = 0 always 
exhibits a jump down with respect to the pure water-oil system, which is 
larger at higher emulsifier concentrations (Figure IV.2), and whose extent 
can be considered a qualitative measurement of the degree of diffusion of the 
emulsifier to the interface (Nino et al., 2005). 
From Figure IV.2 it is possible to identify two different characteristic 
times of exponential decay of σ as a function of t, with the shortest time 
being the inverse of a first-order constant of penetration into the oil phase 
and the longest time corresponding to the inverse of the rate constant of 
rearrangement at the interface (Liu et al., 2011). This is more evident for 
macromolecular emulsifiers, such as modified starch and pea proteins, 
whose conformational changes increase the number of interfacial contacts 
per protein molecule, thereby increasing the effective concentration of 
adsorbed segments and lowering the tension (Beverung et al., 1998). 
Moreover, the dynamics of the different stages of adsorption, and 
especially reorganization at the interface, can last even hours or days 
(Beverung et al., 1998), therefore preventing, in some cases, the attaining of 
an equilibrium interfacial tension, even after long equilibration times 
(10000 s). 
Figure IV.2 shows that the values of σ(t) exhibit a decreasing trend both 
with increasing time and concentration, because the adsorption of the 
emulsifier at the O/W interface is a dynamic process, driven by the 
concentration gradient and by the adsorption properties of the emulsifier. As 
a result, it is possible to classify the emulsifiers both in terms of the 
asymptotic interfacial tension, which would be attained for t → ∞ (σf) and by 
the characteristic times of adsorption at the interface (τ1, τ2). 
For example, modified starch, pea proteins and lecithin exhibited a very 
low surface activity at low concentration (from 10-2 to 1 g/L), with the 
interfacial tension being very slightly reduced, in contrast with SDS, Tween 
80 and sugar ester, whose surface activity was measurably higher already in 
the low concentration range. In particular, sugar ester resulted to be the 
emulsifier with the fastest adsorption kinetics and higher surface activity at 
the lowest concentrations, causing the detachment of the pendant drop after 
less than 20 s at 10-1 g/L, as well as the inability to stabilize a drop at higher 
concentrations. 
In order to derive some quantitative parameters for the characterization of 
the different emulsifiers, the experimental curves of Figure IV.2 were fitted 
with eq. (IV.4) (solid lines in Figure IV.2), with the corresponding 
parameters reported in Table IV.1.  
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Figure IV.2 Dynamic interfacial tension, σ, of different emulsifiers, 
modified starch (a), pea proteins (b), SDS (c), Tween 80 (d), sugar ester (e) 
and defatted soy lecithin (f), solubilized in water at the following 
concentrations: 10
-2
 g/L ( ), 10-1 g/L ( ), 1.0 g/L ( ), 10 g/L ( ) and 50 g/L 
( ) compared with the dynamic interfacial tension of water in sunflower oil 
(dashed line). Experimental data are fitted with eq. (IV.4) (solid lines). 
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In all cases, data fitting were extremely accurate, as shown by the values 
of the coefficient of determination R2, which are always close to 1. 
Some emulsifiers, such as sugar esters, Tween 80 and SDS, showed 
significantly shorter characteristic times for reaching the O/W interface (τ1) 
and being displaced on the same interface (τ2), with possible implications on 
the attainable mean droplet size during emulsification. In fact, fast 
adsorption kinetics of the emulsifier can significantly reduce recoalescence 
phenomena in the homogenization chamber (Brosel and Schubert, 1999, 
Stang et al., 1994, Stang et al., 2001). In contrast, pea proteins and modified 
starch exhibited the longer τ2 values, due to the slower reorganization of 
large biopolymeric molecules at the interface after adsorption. 
 
Table IV.1 Kinetic parameters from the fitting of the curves of Figure IV.2 



















10-2 22.3 23.4 170 25.5 10000 0.994 
10-1 20.6 21.4 170 22.4 5000 0.996 
1.0 18.4 20.0 190 21.3 5000 0.995 
10 14.3 16.0 100 16.2 1400 0.996 
50 10.2 11.8 66 11.0 910 0.993 
Pea 
proteins 
10-2 22.2 23.7 180 25.7 5000 0.995 
10-1 23.0 24.1 180 25.4 5000 0.995 
1.0 16.1 22.0 55 19.9 1000 0.997 
10 8.00 9.2 140 11.3 10000 0.997 
50 6.10 7.5 210 9.50 10000 0.999 
SDS 
10-2 23.7 24.6 150 25.7 3300 0.986 
10-1 22.2 23.4 140 24.5 5000 0.989 
1.0 9.20 10.7 88 10.7 2500 0.992 
10 3.40 3.7 44 4.10 290 0.971 
Tween 80 
10-2 15.0 20.3 120 20.7 1000 0.999 
10-1 11.2 19.9 52 15.5 710 0.996 
1.0 8.6 12.3 220 13.5 2500 0.995 
10 4.50 6.10 240 6.90 2500 0.999 
50 4.20 6.60 48 6.00 620 0.999 
Sugar ester 
10-2 10.8 11.6 31 23.9 560 1.000 
10-1 3.70 12.0 9.0 11.5 9.0 0.999 
Soy lecithin 
10-2 23.9 24.9 220 25.9 5000 0.997 
10-1 22.1 23.3 220 24.4 5000 0.991 
1.0 18.9 20.6 180 23.3 5000 0.997 
10 13.4 15.6 130 17.5 5000 0.994 
50 10.7 11.6 79 12.5 670 0.999 
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Among the kinetic parameters reported in Table IV.1, those expected to 
affect most the mean droplet size during HPH-emulsification are the 
asymptotic value of the interfacial tension σf, as well as the characteristic 
times of the interface adsorption and penetration into the oil phase τ1 and of 
reorganization at the interface τ2. On the other side, the values of parameters 
σ1 and σ2, obtained from the data fitting, can be considered to depend mainly 
on the diffusional transport to the interface, and hence are of less interest in 
the HPH process. In fact, downstream of gap of the homogenization chamber 
a turbulent regime is established, where emulsifier is transported to the O/W 
interface mainly by fast convective mechanisms. In addition, the trend of the 
values of σ1 and σ2 with emulsifier type and concentration, can be well 
correlated to σf, and therefore do not represent truly independent indicators 
of emulsifiers surface activity. 
The σf values of modified starch and soy lecithin exhibited the same 
trend, with significant activity becoming evident only above Cem > 1 g/L. Pea 
proteins were characterized by slightly better interfacial properties, with 
their σf values lower than for modified starch and lecithin in the high 
concentration range (1-50 g/L). SDS exhibited a remarkable decrease in σf 
only for Cem > 0.1 g/L. Tween 80 resulted to be very active already at very 
low concentration, while sugar ester was apparently required in extremely 
small quantities in order to explicate excellent surface activity. 
 
IV.3.2 Effect of emulsifier type and concentration on mean droplet 
diameter 
The effect of emulsifier concentration on the mean droplet size as a 
function of the specific energy of homogenization was studied in the Z5 
configuration, with the results being reported in Figure IV.3. In particular, 
the Z-diameter is plotted as a function of the energy density Ev, with the 
emulsifier concentration indicated by colors, the operating pressure ∆Ph by 
different symbols and the number of passes n that can be calculated from Ev 
and ∆Ph (Ev = n·∆Ph). 
For all the emulsifiers, the experimental data are grouped according to the 
emulsifier concentration, with a linear trend in the log-log diagram of Figure 
IV.3, which qualitatively appears to depend only on the energy density, 
rather than on the pressure level or number of passes separately. In fact, data 
points at the same Ev but different ∆Ph (and hence different n values) are 
always superimposed, suggesting that the mean droplet diameter is not 
strongly dependent on how the energy is delivered to the system. The 
suitability of the model of eq. (IV.1) to fit the experimental data of Figure 
IV.3 was quantitatively assessed in comparison with the model reported in 
eq. (IV.5), where the disrupting effects of operating pressure and number of 
passes are uncoupled by allowing for different exponent parameters. 
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Figure IV.3 Effect of emulsifier concentration on the mean droplet size, Z-
diameter, as a function of the energy density, EV, for modified starch (a), pea 
proteins (b), SDS (c), Tween 80 (d), sugar ester (e) and soy lecithin (f). 
Experimental data: emulsifier concentration of 2.0 g/L (green symbols), 
10 g/L (red symbols) and 50 g/L (black symbols); pressure of 70 MPa ( ), 
140 MPa ( ), 210 MPa ( ) and 280 MPa ( ); the number of passes can be 
calculated as Ev divided pressure. 
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The parity plots of Figure IV.4 show that both models can fit the 
experimental data quite accurately, with R2 values ranging from 0.961 for 
the model of eq. (IV.5) to 0.933 for the model of eq. (IV.1). Being the 
improvement in fitting accuracy deriving from the introduction of an 
additional parameter in eq. (IV.5) only marginal, the energy density-based 
model of eq. (IV.1) was applied to fitting all the experimental data. 
Experimental

















Figure IV.4 Parity plots reporting fitted values, according to the models of 
eqs. (IV.1) and (IV.5), vs. experimental values of Figure IV.3. 
 
Figure IV.3 shows that for all the emulsifiers, at the highest concentration 
investigated (50 g/L), the efficiency of droplet disruption increased with the 
energy density. Therefore, at the most severe conditions (10 HPH passes at 
280 MPa, corresponding to 2800 MJ/m3) the smallest mean droplet diameter 
was achieved, which depended on emulsifier surface and dynamic 
properties. 
Based on the smallest achievable Z-diameter, the best emulsifying 
efficiency was observed for sugar ester (90 nm), followed by Tween 80 
(95 nm), SDS (110 nm), modified starch (150 nm), pea protein (180 nm) and 
soy lecithin (190 nm). Interestingly, the emulsifying efficiency could be well 
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correlated with the parameters σf, τ1 and τ2, reported in Table IV.1, as 
described in the Discussion section. 
For some emulsifiers, such as SDS, a very modest difference was 
observed among the Z-diameter vs. Ev curves at 2.0, 10 and 50 g/L, while in 
the other cases the differences were quite significant. In fact, if the 
emulsifier concentration is too low, its contribution against recoalescence is 
negligible, and increasing the energy density does not contribute to decrease 
the mean droplet size. This was observed for sugar ester, modified starch and 
pea proteins at 2.0 g/L, and for Tween 80 and soy lecithin also at 10 g/L. In 
addition, for Tween 80 and soy lecithin, a low emulsifier concentration had a 
detrimental effect on HPH-assisted droplet disruption, with an observed 
increase in mean droplet diameter, which can be attributed to increased 
coalescence at higher pressures and for multiple HPH passes when 
emulsifier surface coverage is insufficient. 
In summary, production of emulsions at the nanometric size, which for 
food application can be considered to be below 200 nm, where, due to the 
subcellular size, emulsion droplets exhibit improved properties in delivering 
active biomolecules (Huang et al., 2010), significantly depends on emulsifier 
type and concentration. For a 10% oil phase, it is required a concentration 
higher than 10 g/L of modified starch, pea proteins, Tween 80 and soy 
lecithin, to obtain a mean droplet size below 200 nm. In contrast, emulsions 
with a mean droplet size below 200 nm were obtained with SDS and sugar 
ester concentration of 10 g/L, thanks to the lower O/W interfacial tension 
and faster kinetics of adsorption at the O/W interfaces than other emulsifiers 
(Figure IV.2). 
 
IV.3.3 Effect of homogenization chamber geometry on mean droplet 
size 
Figure IV.5 comparatively reports the emulsification curves (Z-diameter 
vs. energy density) obtained in the four homogenization chamber geometries 
tested for different emulsifiers (modified starch, pea proteins, Tween 80 and 
SDS) at the concentration of 10 g/L. 
Very small differences were observed among the different chamber 
geometries, with the emulsification process being primarily ruled by the 
energy density and by the emulsifier properties. The geometry of the 
homogenization chamber contributed to the efficiency of the emulsification 
process in a less significant but still measurable way.  
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Figure IV.5 Dependence of the mean droplet size, Z-diameter, of the 
emulsion on the energy density, EV, for different geometries of the 
homogenization chamber: Z5 (a), Z5-cf (b), Z8 (c) and SFP (d). 
Experimental data: pea proteins ( ), modified starch ( ), SDS ( ) and 
Tween 80 ( ) and Cem = 10 g/L. Experimental data are fitted with eq. (IV.1) 
(solid lines). 
 
From Figure IV.5 it is evident that the SFP geometry performed worse, 
while Z8 geometry exhibited a slightly better performance than the other 
geometries for all the tested emulsifiers. In addition, no significant 
difference could be observed between the standard flow and counterflow 
configuration (Z5 and Z5-cf). 
This is even more evident when considering the polydispersity index, 
PDI, of the produced nanoemulsions (Figure IV.6).The performance of the 
Z8 geometry is without any doubt better, followed by the Z5 and Z5-cf. In 
contrast, the performance of the SFP configuration was the poorest, with all 
the produced emulsions exhibiting a PDI always higher than 0.2, and above 
0.3 at lower energy density, for all the tested emulsifiers. 
These results suggest that in the interaction chamber of the SFP 
configurations the fluid-dynamic stresses are highly inhomogeneous, with 
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regions dominated by highly turbulent regimes alternating to regions 
characterized by milder conditions, where droplets are not efficiently 
disrupted. 
It is also interesting to highlight that, when considering the mean droplet 
diameter, SDS performed better than Tween 80. Nevertheless, in terms of 
polydispersity index, SDS was less efficient than Tween 80 and exhibited a 
performance comparable to that of modified starch. Probably, the minimum 
Z-diameter significantly depends on the emulsifier effect on interfacial 
tension (σf), while the polydispersity index is affected mainly by the kinetics 
of surface adsorption of the emulsifier. 
 






























Figure IV.6 Dependence of the polydispersity index, PDI, of the emulsion 
on the energy density, EV, for different geometries of the homogenization 
chamber: Z5 (a), Z5-cf (b), Z8 (c) and SFP (d). Experimental data: pea 
proteins ( ), modified starch ( ), SDS ( ) and Tween 80 ( ) and 
Cem = 10 g/L. Experimental data are fitted with eq. (IV.6) (solid lines). 
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IV.4 Discussion 
According to the results reported in Figures IV.3-6, several factors 
contribute to regulate the efficiency of the HPH-based emulsification 
process. Therefore, a sensitivity analysis was conducted, based on a 
statistical approach previously tested on different problems (Cimino et al., 
2008, Donsi et al., 2009), in order to define the dependence of the kinetic 
parameters of the emulsification process (C and b, according to eq. (IV.1)) 
on the emulsifier properties and concentration, as well as on the fluid-
dynamic conditions. 
The values of C and b, determined by the fitting of the data of Figures 
IV.3-5, are reported in Table IV.2, with the exception of those cases where a 
negative value of b was obtained, corresponding to the increase of the mean 
droplet size with the energy density (i.e. pea proteins, Tween 80 and soy 
lecithin at low concentration). 
The emulsifier interfacial and dynamic properties were instead expressed 
through σf, τ1 and τ2, which resulted, from a preliminary analysis, to be the 
key determinants of the efficiency of the emulsification process (Table 
IV.1). 
The fluid-dynamic parameters that are more likely to contribute to droplet 
disruption are the shear and elongational stresses, turbulence and cavitation 
(Stang et al., 2001, Floury et al., 2004b, Kleinig and Middelberg, 1998, 
Donsi et al., 2009). 
At the entrance of the homogenization valve gap, emulsion droplets are 
subjected to a very intense elongational flow. The consequent extensional 
stresses may exceed the mechanical resistance of the droplet (Floury et al., 
2002a), inducing a critical deformation, followed by droplet disruption in the 
turbulent region immediately downstream of the elongational flow (Stang et 
al., 2001), where a fluid jet is formed. 
The balance between the elongational stresses and the droplet resistance 








Fluid acceleration α (s−1) is calculated from average fluid velocity in the 
gap ugap, divided by the length over which acceleration occurs (Floury et al., 
2004a), which was considered to be 10 times the orifice/gap size.  
Turbulence is an important mechanism of droplet disruption especially 
for low-viscosity process media, due to the inertial forces generated in the 
highly turbulent region, located just at the exit of the gap (Floury et al., 
2004b).  
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Turbulence in such region can be expressed through the Reynolds 








For the SFP geometry, dor is substituted by the gap opening h in eq. 
(IV.8). 
In the case of viscous media, the primary disruption mechanisms is 
represented by shear stress in laminar flow (Kleinig and Middelberg, 1998, 
Middelberg, 1995, Stang et al., 2001, Floury et al., 2004b). 
The importance of the shear stresses is expressed through the capillary 
number (Ca), as the ratio of the shear stress and the droplet resistance 
(Floury et al., 2004b), as shown in eq. (IV.9). 
σ
αη emem dCa =
 
(IV.9) 
Another mechanism of droplet disruption may be represented by 
cavitation, which occurs in turbulence regions, due to fluid velocity and 
pressure fluctuations favoring the formation and collapse of vapor bubbles. 
The cavitation number (K) can be expressed as the ratio between the 
difference of a local absolute pressure downstream of the homogenizing 
valve (P2) from the vapor pressure (Pv) at the local temperature (Th = 4 °C + 
0.18·∆Ph) (Donsi et al., 2009), and the specific kinetic energy, which 
















Preliminary data analysis showed that in the cases considered in the 
present study, shear stresses and cavitation do not significantly affect the 
emulsification process.  
Therefore, the sensitivity analysis was set to take into account only the 
We and Re numbers as fluid-dynamic parameters, together with the 
emulsifier interfacial and dynamic properties σf, τ1 and τ2, as well as the 
emulsifier concentration Cem. 
Table IV.2 collects all the dependent and independent variables used in 
the sensitivity study, together with the measured values of viscosity (ηem) and 
density (ρem) of the homogenized samples, as well as the mean droplet size 
of the primary emulsion dem,0 (produced by high speed homogenization), 
used in the calculations of We and Re. The We and Re reported for each 
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emulsifier type and concentration are the average of the values calculated at 
the different pressure levels. 
 
Table IV.2 Dependent and independent variables used in the sensitivity 
analysis. 













10 Z5 720 988 3.08 1.66·10-5 2880 412 0.080 
10 Z8 720 988 3.33 1.62·10-6 1940 404 0.090 
2.0 Z5 1700 988 2.63 1.59·10-4 3340 455 0.010 
50 Z5 560 988 5.39 1.07·10-5 1740 476 0.130 
Pea 
proteins 
10 Z5 2600 988 3.09 1.29·10-3 2880 1890 0.265 
10 Z5-cf 2600 988 3.09 1.25·10-3 2880 1740 0.249 
10 Z8 2600 988 3.31 1.20·10-4 1940 1919 0.285 
10 SFP 2600 988 3.31 4.48·10-4 107 1954 0.245 
50 Z5 1170 988 5.40 1.41·10-4 1740 954 0.202 
SDS 
2.0 Z5 12500 984 2.54 2.54·10-1 3450 433 0.122 
10 Z5 8990 984 2.66 1.36·10-1 3310 383 0.119 
10 Z5-cf 8990 984 2.66 1.37·10-1 3310 380 0.113 
10 Z8 8990 984 2.83 1.31·10-2 2250 365 0.116 
10 SFP 8990 984 2.83 4.91·10-2 124 602 0.188 
50 Z5 5380 984 3.23 2.92·10-2 2770 357 0.140 
Tween 80 
10 Z5 550 986 2.91 2.13·10-5 3230 231 0.016 
10 Z5-cf 550 986 2.73 2.13·10-5 3230 262 0.034 
10 Z8 550 986 2.91 2.05·10-6 2190 255 0.048 
10 SFP 550 986 2.91 7.65·10-6 121 360 0.068 
50 Z5 0.999 984 3.23 3.00·10-3 2770 336 0.142 
Sugar 
ester 
2.0 Z5 540 986 2.63 2.75·10-5 3350 444 0.014 
10 Z5 260 986 2.73 3.07·10-6 3230 357 0.155 
50 Z5 315 986 3.23 5.45·10-6 2770 436 0.129 
Soy 
lecithin 
50 Z5 330 988 3.78 1.58·10-6 1950 427 0.092 
Mean 
value 
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The statistical approach used to critically analyze the data was a simple 





















































































In the multilinear model of eqs. (IV.11) and (IV.12), the differential 
values of the kinetic parameters ∆C and ∆b with respect to their mean values 
( C , b ) were calculated as an incremental variation of the selected 
independent variables ∆xi with respect to their mean values x , which are 
reported in the last row of Table IV.2. By fitting the data reported in Table 
IV.2, the regression coefficients mi and ni were calculated. 
The coefficients mi and ni, reported in Figure IV.7a for each 
corresponding independent variable, represent the percentage gain or loss in 
C and b with respect to their own averages as a consequence of the variation 
of each independent variable.  
The parity plot and the specific coefficients obtained by the linear 
regression are reported in Figure IV.7b. The linearized expressions of 
eqs. (IV.11) and (IV.12) are able to satisfactorily reproduce all the 
experimental data with regard to both C (R2 = 0.943) and b (R2 = 0.847). 
Experimental












































Cem τ1 τ2 We Reσf
 
Figure IV.7 Values of the regression coefficients of the different parameters 
from linearization of experimental data of HPH-emulsification (eqs. (IV.11) 
and (IV.12)) (a), and corresponding parity plot, reporting fitted vs. 
experimental values (b). 
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The results of Figure IV.7a should be analyzed keeping in mind that a 
faster disruption kinetics is characterized by a low C value and a b value 
tending to 1 (Stang et al., 2001). 
Figure IV.7a shows that the increase in the concentration of emulsifier is 
highly beneficial to the process of emulsification, with increasing Cem 
causing the decrease of C and the increase of b. Despite previous results 
showed that a small but measurable effect on disruption kinetics was caused 
by a viscosity increase due to large macromolecules (with molecular mass 
>> 100 kDa) (Stang et al., 2001), the increased viscosity of the emulsion, 
deriving from the increase of concentration of pea proteins and modified 
starch (Table IV.2), apparently did not affect the disruption kinetics. This is 
especially remarkable for pea proteins, whose molecular mass was 
previously shown to be in the range 49-80 kDa. 
The interfacial properties of the emulsifier, which are lumped in the 
asymptotic value of the interfacial tension σf, exhibit a contrasting effect on 
the disruption kinetics: both regression coefficients are in fact negative. 
Nevertheless, it must be pointed out that the impact of a variation of σf on C 
is less significant than on b, meaning that the net impact of a good emulsifier 
(low σf) is a faster disruption kinetics. 
The effect of the dynamic properties of the emulsifier was evaluated 
through the characteristic times τ1 and τ2 of adsorption at the O/W interface 
measured during the pendant drop experiments, adimensionalized by their 
respective mean values. Despite the kinetics of adsorption at the O/W 
interface in the pendant drop experiments can be significantly different from 
the kinetics of adsorption on the smaller emulsion droplets formed in the 
fluid dynamic field occurring in the homogenization chambers, a clear 
dependence of C and b values on adimensional τ1 and τ2 was observed. The 
decrease of the characteristic time of molecular adsorption and penetration in 
the oil phase (τ1) causes the increase of both C and b, while the reduction of 
the characteristic time of reorganization at the interface (τ2) determines the 
decrease of both C and b. Despite the values of the regression coefficients 
corresponding to τ1 are comparable, a fractional variation of b has a 
significantly higher impact on the kinetics of disruption than a fractional 
variation of C of similar amplitude. On the other side, τ2 has a lower impact, 
due to the main effect on C (lower τ2 values contributes to reduce C) and a 
contrasting effect on b. Moreover, the regression coefficients corresponding 
to τ1 and τ2 are significantly higher than the regression coefficients of the 
other parameters considered, suggesting that the dynamic properties of the 
emulsifiers are the key determinants of the HPH-assisted disruption for the 
production of food nanoemulsions. 
The results of Figure IV.7a also show that more intense elongational 
stresses contributes to accelerate the disruption kinetics, with lower C values 
and higher b values corresponding to higher We numbers. Nevertheless, the 
values of the corresponding regression coefficients are very small in 
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comparison to the other parameters, implying that the recoalescence stage is 
probably the limiting factor of the emulsification process. 
The effect of Re number is contrasting, with increasing Re causing the 
decrease of C, as well as the decrease of b. Probably, a high Re number may 
contribute to the disruption efficiency, but is also responsible of a higher 
recoalescence degree in the homogenization chamber, due to the increased 
frequency of inter-droplet collisions. 
From the sensitivity analysis it is possible to conclude that emulsifier 
interfacial and dynamic properties rules the disruption process when food 
emulsifiers are used and the emulsification process is carried out at the 
nanometric scale. 
These results are quite different from the conclusions reached by Stang 
and coworkers, who showed that in a disruption-dominated HPH 
emulsification process, conducted with fast-adsorbing emulsifiers, the 
kinetics of disruption can be described by the power law of eq. (IV.1), with b 
values of about 0.6 for low-viscosity disperse phase (such as the case of 
sunflower oil) (Stang et al., 2001). 
In contrast, in a stabilization/coalescence-dominated process, b values are 
always << 0.6 (Table IV.2), because the food-grade emulsifiers are not as 
fast as required to prevent completely recoalescence of newly formed 
droplets, as well as because in the reported experiments, nanometric size 
emulsions were obtained by multiple HPH passes at different pressure levels. 
In particular, recoalescence phenomena become more and more dominating 
when the emulsion droplet size is below 1 µm, such as for all the data 
reported in Figures IV.3-5. 
In general, the production of food nanoemulsions by HPH requires the 
use of food-grade emulsifiers at a concentration as high as possible, 
compatibly with the product quality requirements and cost restrictions. 
Moreover, the homogenization chamber geometry should be able to ensure 
efficient droplet disruption, with high elongational stresses coupled with 
elevated turbulence, as well as a homogeneous volume of interaction 
downstream of the valve gap, where emulsifier adsorption at the droplet 
interface can occur uniformly to guarantee a low polydispersity index of the 
emulsion size distribution. 
 
IV.5 Conclusions 
High pressure homogenization processing for production of O/W 
nanometric emulsion is a process controlled by disruption efficiency 
achieved in the homogenization valve and by capability of the emulsifiers 
used to prevent recoalescence phenomena of newly formed droplets. For 
food application, the limiting stage is represented by the emulsifiers, whose 
requisites of food compatibility and use in limited amounts to minimize the 
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product quality, pose some limitations to their interfacial and dynamic 
properties.  
The reported results showed that different emulsifiers, ranging from small 
molecules to biopolymeric macromolecules, can be characterized, by simple 
pendant drop measurements, in terms of interfacial properties and 
characteristic times of adsorption. These characteristics can be well 
correlated to the efficiency of the emulsification process.  
Moreover, the geometry of the homogenization chamber plays a 
significant role, not that much in controlling the minimum mean droplet size 
achievable for a defined energy density delivered to the product, but 
especially in minimizing the width of the droplet size distributions. 
Homogenization chambers, where non-uniform flow regimes are established, 
are likely to produce wide particle size distributions that, as well as mean 
droplet diameters exceeding the nanometric size, are not acceptable for 












In this chapter the physicochemical stability of some bioactive 
compounds, such as resveratrol, grape marc polyphenols and curcumin, 
encapsulated in O/W food-grade nanoemulsions of subcellular size, 
produced by high pressure homogenization, was evaluated under accelerated 




V.1 Nanoencapsulation of resveratrol 
Resveratrol, a polyphenolic compound that can be found in red grapes, 
peanuts, as well as a variety of other plant sources, is one of the natural 
compounds that have been intensively investigated in recent years for its 
health-beneficial properties, and for potential applications in the fields of 
pharmaceutics, nutraceuticals and functional foods. 
Resveratrol is well known for its high antioxidant activity and is considered 
as a key component for the health benefits of red wine. Chemically, 
resveratrol can be one of the two geometrical isomers, trans-resveratrol and 
cis-resveratrol, however, trans-resveratrol is the natural form of isomer and 
the more stable and the most active form (Filip et al., 2003). 
Resveratrol is highly soluble in alcohols, whereas only soluble in trace 
amounts in aqueous or lipid phase. Its solubility was reported to be 
0.023 mg/ml in drinking water (Asensi et al., 2002) and about 0.18 mg/ml in 
coconut oil (Hung et al., 2006). In addition, resveratrol is a very reactive 
molecule, very susceptible to react with dissolved oxygen, producing 
different degradation products, as well as very easily degraded by sunlight 
(Vian et al., 2005). The physicochemical properties of resveratrol, 
particularly its high reactivity and low solubility in aqueous and lipid phases, 
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have been limiting factors for its bioavailability and efficacies of the desired 
health-beneficial effects. 
Therefore, exploitation of resveratrol as a functional food and nutraceutical 
ingredient or pharmaceutical compound is only feasible when encapsulated 
in a delivery system, which is capable of stabilizing and protecting it from 
degradation, while preserving its biological activities and enhancing its 
bioavailability. However, until now, only few studies have addressed the 
suitability of delivering encapsulated resveratrol to the site of action and the 
main research focus has been its biological activity, especially in synergy 
with the consumption of other diet/beverage components (Narayanan et al., 
2009). 
Encapsulation of resveratrol in delivery systems of micrometric size has 
been studied as a means to improve resveratrol stability and to control its 
release. In particular, polymeric microspheres have been used to improve 
resveratrol stability during long-term storage (Nam et al., 2005), and to 
improve the efficacies of a topical delivery (Hung et al., 2008) and a 
controlled-release formulation during oral application (Peng et al., 2010). 
Encapsulation in Saccharomyces cerevisiae cells has also been reported as 
an alternative strategy to significantly improve the release and stability of 
resveratrol (Shi et al., 2008). 
On the contrary, encapsulation of resveratrol in delivery systems of 
nanometric size has been found to contribute even more significantly to the 
improvement of its cell uptake. For examples, nanometric carriers for 
pharmaceutical applications were designed using lipospheres to efficiently 
transport resveratrol into the cardiovascular system (Fang et al., 2007), while 
biodegradable polymeric nanoparticles (Shao et al., 2009) and liposomes 
were developed to enhance resveratrol chemopreventive efficacy (Narayanan 
et al., 2009). More recently, polymeric micelles have been used to enhance 
the ability of resveratrol to protect cells from oxidative stress and apoptosis 
(Lu et al., 2009), and solid lipid nanoparticles to increase the uptake of 
resveratrol in keratinocytes cells (Teskac and Kristl, 2010). In addition, 
cyclodextrins have been used as a carrier molecule to increase both 
bioavailability and stability of resveratrol through the formation of inclusion 
complexes (Lucas-Abellan et al., 2007). 
Most of the above nanoparticulate carriers are based on hydrophobic 
interactions of resveratrol either with functional groups of specific 
molecules, such as biopolymers or cyclodextrins, or with amphiphilic 
molecular assemblies, such as liposomes or polymeric micelles. In all this 
cases, the ratio of the encapsulating functional molecules to resveratrol is 
very high, on one side strongly promoting its solubilisation in aqueous 
phase, but on the other side severely limiting the application in food, due to 
taste, regulations or cost constraints. Among the cited nanometric carriers, 
only solid lipid nanoparticles are suitable for food application, due to the 
high loading capacity and low emulsifier content. Nevertheless, the high cost 
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of production, related to the high processing temperature and pressure 
required, is still a limit to their full exploitation. 
In food applications, an optimal delivery system of resveratrol would include 
a formulation containing all natural ingredients, which has minimal impact 
on the organoleptic properties of the food product, and is able to preserve 
resveratrol in its most active form during the different phases of food 
transformation and storage and to ensure high bioavailability upon ingestion. 
Oil in water (O/W) nanoemulsions are ideal candidates for encapsulation of 
resveratrol, because of the easy fabrication by high-throughput processes 
(i.e. high pressure homogenization), the possibility of using all natural 
ingredients with low concentrations of emulsifiers (Donsi et al., 2010a, 
Donsi et al., 2011c, Donsi et al., 2011a), and the easy dispersibility in 
aqueous-based food matrices.  
Since nanoemulsions have never been reported for the encapsulation of 
resveratrol because of the issues of formulation, stability and cell absorption, 
in this section is presented the contribution for the development of efficient 
nanoemulsion-based delivery systems for resveratrol. In particular, the main 
goal of the investigation activity is the fabrication of delivery systems, with 
requisites of (a) formulation with natural ingredients, (b) high physical 
stability of the emulsions and chemical stability of the most active form of 
resveratrol (trans-resveratrol) under conditions simulating the transformation 
and storage of the final product. 
 
V.1.1 Materials and methods 
V.1.1.1 Chemicals 
Resveratrol, extracted from grape skin (purity > 98%), was a kind gift 
from Organic Herb Inc, China. Emulsion formulation was based on peanut 
oil (Sagra, Lucca, Italy) as organic phase, and the combination of lipophilic 
and hydrophilic emulsifiers. Lipophilic emulsifiers were soy lecithin Solec 
IP (a kind gift from Solae Italia s.r.l., Milan, Italy), soy lecithin Lecinova 
(Nutrition & Santè, Varese, Italy) and glycerol monooleate (Sigma-Aldrich 
s.r.l., Milan, Italy). Hydrophilic compounds were sugar ester P1670 (a kind 
gift from Prodotti Gianni, Milan, Italy), defatted soy lecithin Solec FS-B (a 
kind gift from Solae Italia s.r.l., Milan, Italy) and polysorbate Tween 20 
(Sigma-Aldrich s.r.l., Milan, Italy). Bidistilled water was used as continuous 
phase. 
 
V.1.1.2 Fabrication of nanoemulsions loaded with resveratrol 
Resveratrol (0.01 wt%) was encapsulated in peanut oil-based 
nanoemulsions, produced by high pressure homogenization. A preliminary 
study was carried out to optimize the formulation by constructing a pseudo-
ternary phase diagram of kinetic stability, which was used to determine the 
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optimal fractions of the different emulsion ingredients, as previously 
described chapter III.  
The tested formulations had the following composition: 0.01°wt% 
resveratrol, 0.2°wt% ethanol, 1°wt% lipophilic soy lecithin Solec IP, 
0.5°wt% defatted soy lecithin Solec FS-B, 6°wt% peanut oil, 92.29°wt% 
water (R/LSL-DSL); 0.01°wt% resveratrol, 0.2°wt% ethanol, 2.1°wt% soy 
lecithin Lecinova, 27.9°wt% peanut oil, 69.79°wt% water (R/LEC); 
0.01°wt% resveratrol, 0.2°wt% ethanol, 1°wt% lipophilic soy lecithin Solec 
IP, 0.3°wt% sugar ester, 9°wt% peanut oil, 89.49°wt% water (R/LSL-SE); 
0.01°wt% resveratrol, 0.2°wt% ethanol, 1.5°wt% polysorbate Tween 20, 
1.5°wt% glycerol monooleate, 7°wt% peanut oil, 89.79°wt% water (R/T20-
GMO). 
Since the oil phase alone did not increase sufficiently the solubility of 
resveratrol, a small amount of ethanol (ethanol: resveratrol weight ratio was 
20) was used to dissolve resveratrol crystals prior to mixing at room 
temperature with peanut oil and the eventual lipophilic emulsifier. The 
concentration of ethanol in oil was kept at 0.024 g/g, which is significantly 
lower than the equilibrium solubility of ethanol in different oils, which was 
reported to range at 25 °C from 0.125 g/g for canola oil to 0.147 g/g for corn 
oil (da Silva et al., 2010). 
The lipid phase containing resveratrol was subsequently dispersed in the 
aqueous phase containing the hydrophilic emulsifier by high speed 
homogenization using an Ultra Turrax T25 blender (IKA Labortechnik, 
Jahnke und Kunkel, Germany) at 24000 rpm for 4 min, to obtain a primary 
emulsion.  The primary emulsion was then disrupted to the nanometric size 
in a Nano DeBEE Electric Bench-top laboratory high pressure homogenizer 
(BEE International, USA), by means of 10 passes at 300 MPa. The operating 
temperature was maintained at 10 °C, by initial conditioning of the primary 
emulsion in a thermostatic bath and by rapidly cooling the heat generated by 
friction with a heat exchanger, fitted immediately downstream of the 
homogenization valve. All formulations tested were prepared in triplicate. 
 
V.1.1.3 Fluorescence spectrum of nanoencapsulated resveratrol 
The fluorescence emission spectra of resveratrol water solution and 
nanoencaspsulated resveratrol were determined using a Jasco FP-8200 
fluorescence spectrofluorometer (Jasco Europe, Milano). The excitation 
wavelength was set at 280 nm and the corresponding emission spectra were 
recorded in the range of 320-500 nm. The slit widths for excitation and 
emission were set both at 5 nm. 
 
V.1.1.4 Physical stability 
The physical stability of nanoencapsulated resveratrol was evaluated in 
terms of evolution of the mean droplet size of the nanoemulsions and of the 
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creaming volume over time under accelerated ageing conditions. For each 
formulation, three independent samples (15 ml) were stored vertically in 
plastic tubes at different temperatures (4, 30 and 55 °C) in dark condition, 
with observations being carried out for 4 weeks. 
The droplet size distribution was determined by photon correlation 
spectroscopy (PCS) at 25 °C (HPPS, Malvern Instruments, UK). The mean 
droplet size (Z-diameter) was determined by Cumulant analysis of the 
intensity-intensity autocorrelation function, G(q,t) (Stepanek, 1993). Prior to 
measurements, the samples were diluted with bidistilled water to a suitable 
concentration.  
The value of the creaming volume percentage C was computed for each 











where Vt (ml) is the total volume of the sample and Vs (ml) is the volume of 
the lower phase layer (serum). According to eq. (V.1), the value of C tending 
to 100 is an indication of a stable emulsion. Physical stability tests were 
conducted in triplicates. 
 
V.1.1.5 Chemical stability 
The chemical stability of nanoencapsulated resveratrol was also evaluated 
under accelerated ageing conditions, by determining the kinetics of 
degradation upon UV light exposure and at three different storage 
temperatures (4, 30 and 55 °C). 
For UV light stability, samples (20 ml) of each nanoemulsion containing 
resveratrol were exposed to a laboratory UV-C lamp (280-100 nm) at room 
temperature for 2 h. Aliquots were sampled at predetermined time points 
(10, 30, 60 and 120 min) for quantitative analysis.  
For thermal stability, samples (15 ml) of resveratrol nanoemulsion were 
stored vertically in open test tubes in dark condition and aliquots were 
sampled each week for 4 weeks for quantitative analysis. 
Quantitative analysis was conducted by extracting resveratrol from the 
emulsion and by using HPLC. One ml of resveratrol nanoemulsion was 
mixed in a test-tube with 400 µl of carbon tetrachloride and 400 µl of 
ethanol, by agitation on a vortex mixer for 15 s. The separation of the phases 
was improved by centrifugation at 6500 rpm for 5 min at 10 °C. The lighter 
phase, which contains resveratrol, was recovered with a Pasteur pipette and 
the heavier phase was then extracted twice with 500 µl of ethanol. 
Anhydrous sodium sulphate was added to the organic phase to remove any 
traces of water, prior to concentration under reduced pressure (Rotavapor) at 
36 °C and the residue was redissolved in 1 ml of ethanol. The resveratrol 
extract was then injected in the HPLC system, consisting of a Waters 1525 
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Binary HPLC pump and a UV-Vis 2487 Waters Dual Absorbance Detector. 
A RP C18 Spherisorb® (Waters, 5 µm, 4.6 x 250 mm) column was used, 
and the separation was done using an isocratic mobile phase of 45% 
methanol in water (v/v) which was adjusted to pH 2.6 with acetic acid. The 
flow rate was 0.8 ml/min and the injection volume was 10 µl. The 
UV/visible detector was set at 306 nm for trans-resveratrol and at 280 nm 
for cis-resveratrol. 
Quantification of trans-resveratrol was based on a calibration curve 
generated with serial dilutions (0.1 and 100 mg/l) of the stock solution of 
200 mg/l in ethanol. The calibration curve of cis-resveratrol was obtained 
using the standard solutions of trans-resveratrol exposed to daylight for 1 h, 
because of the unavailability of commercial standard. According to a 
previously reported method (Vian et al., 2005), the concentrations of cis-
resveratrol were assigned on the basis of the decreased levels of intensity of 
the trans-resveratrol peak which were proportional to the area of the cis-
resveratrol peak. 
The effect of encapsulation on the kinetics of degradation under UV light 
and at different temperatures was evaluated in terms of retention percentage, 
θtrans, shown in eq. (V.2), and of yield of cis-resveratrol with respect to the 

















The chemical stability of encapsulated resveratrol was compared with 
unencapsulated resveratrol, which was dissolved in ethanol (ethanol: 
resveratrol weight ratio was 20) and then in water until the same resveratrol 
concentration of nanoemulsions was reached. Chemical stability tests were 
conducted in triplicates. 
 
V.1.2 Results 
V.1.2.1 Formulation of stable nanoemulsions 
Resveratrol was encapsulated in peanut oil-based nanoemulsions at a 
final concentration of 0.01% by weight. The resveratrol concentration used 
was preliminary chosen to be 10 times higher than the therapeutic blood 
concentration, which is at least 10 mg/l (Yu et al., 2003).  
The percentage of each ingredient and the formulation of the 
nanoemulsion-based delivery systems were largely determined according to 
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the use of the lipophilic and hydrophilic emulsifiers with the ultimate goal of 
improving resveratrol entrapment in the lipid phase by hydrophobic 
interactions, thus reducing the extent of localization of resveratrol at the 
O/W interface, where it can be easily degraded (Fang et al., 2007).  
Resveratrol localization can be determined by investigating the extent of 
hydrophobic interactions between resveratrol and emulsion constituents 
(lipid phase and emulsifiers) through fluorescence spectroscopy. 
Considering that resveratrol itself is a fluorescent compound, and the fact 
that the fluorescence spectrum of a compound is usually affected by its 
microenvironment (Hailong and Qingrong, 2010), the comparison of the 
fluorescent emission spectrum of resveratrol in pure water with that of 
resveratrol in nanoemulsion shows that the characteristic emission peak of 
resveratrol is shifted from 400 nm in water to 386 nm when resveratrol was 
encapsulated in peanut oil-based nanoemulsion (Figure V.1). This result 
confirms that microenvironment of resveratrol is changed after 
encapsulation, supporting the hypotheses of its entrapment in the 




Figure V.1 Fluorescence emission spectra of resveratrol dissolved in water 
and encapsulated resveratrol into peanut oil-based nanoemulsion. 
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V.1.2.2 Physical stability 
The physical stability of the resveratrol-encapsulating nanoemulsions was 
evaluated in terms of the evolution of their mean droplet diameter under 
accelerated ageing conditions at different storage temperatures (4, 30 and 55 
°C) for 30 days. Both lecithins-based nanoemulsions, R/LEC and R/LSL-
DSL, characterized by an initial mean droplet diameter of 270 and 230 nm, 
respectively, and sugar ester-based nanoemulsion R/LSL-SE, with an initial 
mean droplet diameter of 160 nm, exhibited no significant variations of the 
Z-diameters at all storage temperatures (Figure V.2b, d and f). On the 
contrary, the nanoemulsion R/T20-GMO, which exhibited smaller initial 
mean droplet diameter (90 nm), was stable only at low temperatures (4 and 
30 °C), while at 55 °C underwent significant instability phenomena, 
highlighted by a drastic increase of Z-diameter already at day 14 (Figure 
V.2f). 
The different physical stability of the nanoemulsions tested could be 
related to the different emulsifiers used, with the respective interfacial 
properties depending on the kinetics of adsorption at the O/W interface as 
well as on the subsequent molecular reorganization at the interface (Donsi et 
al., 2011b). Molecules with high mobility and fast adsorption kinetics, such 
as polysorbate, significantly contribute to reduce recoalescence phenomena 
during high pressure homogenization, because of the extremely short times 
of coverage of the newly formed droplet surfaces. On the other side, at 
increasing temperature, the muted thermodynamic conditions may induce the 
displacement of emulsifier molecules from the O/W interface. Emulsifiers 
with higher molecular mobility will therefore exhibit higher instability and 
coalescence phenomena, as observed for polysorbate-based nanoemulsions 
(R/T20-GMO). 
The evolution of the creaming volume percentage C over time was 
coherent with the droplet size measurements. C remained constant at about 
100% for all nanoemulsions at 4 °C (Figure V.2a), decreased by 10% at most 
after 30 days for all the formulations at 30 °C, except for R/T20-GMO which 
remained completely stable (Figure V.2c). This parameter was reduced by 
30% for R/LEC and R/LSL-DSL and by 10% for R/T20-GMO and R/LSL-
SE after 30 days at 55 °C (Figure V.2e). 






























































































Figure V.2 Evolution of the creaming volume percentage, C, (a, c and e) 
and of the mean droplet diameter, Z-diameter, (b, d and f) of the resveratrol-
encapsulated nanoemulsions stored at 4 °C (a, b), 30 °C (c, d) and 55 °C (e, 
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V.1.2.3 Chemical stability 
The chemical stability of the encapsulated resveratrol was evaluated for 
the retention percentage of trans-resveratrol, θtrans, and the formation yield of 
cis-resveratrol, θcis, under different storage conditions. 
Preliminary studies showed that trans-resveratrol, which is extremely 
photosensitive and susceptible to oxidative degradation, remained stable 
during the nanoencapsulation process. In fact, the typical HPLC 
chromatograms of unencapsulated and nanoencapsulated resveratrol had the 
same retention time at about 8 min under the same chromatographic 
conditions used in this study. In addition, the UV-Vis spectra of the 
unencapsulated and nanoencapsulated resveratrol exhibited the same pattern, 
with the absorption maximum at 306 nm, in agreement with previous results 
(Vian et al., 2005). The same HPLC retention time and UV-Vis spectrum 
suggested that no chemical changes occurred during the nanoencapsulation 
process. 
The exposure of unencapsulated resveratrol to UV-C light showed the 
formation of the cis- form of resveratrol. In fact, the area of trans-resveratrol 
decreased and a new peak appeared, with its area increasing with the 
exposure time. More specifically, the UV-Vis spectrum of the new peak was 
consistent with that of cis-resveratrol, with the absorption maximum at 
280 nm (Vian et al., 2005). Therefore, the new peak can be ascribed to cis-
resveratrol, formed from trans-resveratrol due to UV light exposure, as 
previously reported (Shi et al., 2008). It must be pointed out that in this study 
the formation of cis-resveratrol was used as a qualitative instead of a 
quantitative indicator of trans-resveratrol oxidation. 
Figure V.3 reports the evolution of θtrans (Figure V.3a) and of θcis (Figure 
V.3b) of unencapsulated and nanoencapsulated systems. The trans-
resveratrol was significantly degraded (θtrans ≈ 45%) after a 2 h exposure to 
UV-C light. Concurrently θcis increased up to 0.04%, with trace amounts of 
cis-resveratrol appearing already after 10 min of UV-C light exposition. 
Nanoencapsulated resveratrol was more stable under the UV-C light 
compared to the unencapsulated compound, with a slower rate of 
degradation of trans-resveratrol and less formation of cis-resveratrol (Figure 
V.3a and b). In particular, for R/LSL-SE and R/LEC only a limited 
degradation of trans-resveratrol was observed, with θtrans being reduced to 
83% and 92% respectively, and no formation of cis-resveratrol being 
detected over the exposure time. R/T20-GMO system exhibited a 
comparable trans-resveratrol degradation (≈ 82%), but detectable cis-
resveratrol (θcis ≈ 0.03%) after 2 h of light exposure. R/LSL-DSL was the 
least stable system which exhibited a reduction of the θtrans value ≈ 65% and 
a sustained increase of θcis value, which was however slower than that of the 
unencapsulated resveratrol. 
 








































Figure V.3 The retention percentage of trans-resveratrol, θtrans , (a) and cis-
resveratrol yield, θcis , (b) under UV-C light exposure. 
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Figure V.4 shows the kinetics of degradation of unencapsulated and 
nanoencapsulated resveratrol at three different storage temperatures (4, 30 
and 55 °C). In all cases cis-resveratrol was never detected.  
Under refrigerated conditions (4 °C) and at 30 °C nanoencapsulated 
resveratrol remained extremely stable for all the formulations, with a 
reduction of θtrans value ≈ 70% being observed only for R/LSL-DSL after 30 
days (Figure V.4a and b).  
On the contrary, the unencapsulated resveratrol exhibited a different 
behaviour, with active resveratrol being better preserved at higher 
temperatures. In particular, a severe chemical degradation occurred at 4°C, 
which reduced the θtrans value to ≈ 50% after 30 days (Figure V.4a), while 
θtrans value was substantially stable at 30 °C (Figure V.4b) and at 55 °C 
(Figure V.4c). This can be explained by increased oxidative degradation due 
to the higher solubility of oxygen in water at lower temperatures. Therefore, 
the observed stable behaviour of the encapsulated compound at lower 
temperature means that the nanoencapsulation process prevented the 
chemical degradation of resveratrol, effectively protecting it from contact 
with oxygen molecules dissolved in the water.  
Trans-resveratrol in all nanoemulsion formulations degraded significantly 
after 30 days at 55°C (Figure V.4c), which can be explained by its 
interaction with the emulsion ingredients and the destabilization of the 
nanoemulsion as shown in Figure V.2f.  
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Figure V.4 The retention percentage of trans-resveratrol, θtrans, at 4 °C (a), 
30 °C (b) and 55 °C (c) for 30 days. Different letters in the same day 
indicate statistically (Student t-test) significant differences (p<0.05). 
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V.2 Nanoencapsulation of grape marc polyphenols 
The increase in demand for processed crop products has substantially 
increased the amount of waste produced during food processing, giving 
consequently impulse to the search of possible solutions for waste recovery. 
For example, in the wine industry, vast amounts of grape marc is produced 
as a waste: every 100 kilograms of grape-vine generates approximately 20-
25 kilograms of grape marc. Grape marc has a heavy environmental impact 
for the high content of phenols that considerably increase chemical and 
biochemical oxygen demands (Spigno and De Faveri, 2007), making its 
disposal an increasing environmental problem. The industrial exploitation of 
this by-product was oriented to its use as animal feed (Vaccarino et al., 
1992), as organic fertilizer (Ferrer et al., 2001), or in harvesting yeast cells 
(Lo Curto and Tripodo, 2001). More attractive are instead those options with 
higher added value, involving the extraction and recovery of bioactive plant 
constituents from grape seeds and skins (Bonilla et al., 1999, Negro et al., 
2003, Amendola et al., 2010), such as anthocyanins to be used as natural 
dyes (Vatai et al., 2009), as well as polyphenols to be used as a low-cost 
natural source of antioxidants for the pharmaceutical, nutraceutical and food 
industries. The exploitation of grape marc wastes as a source of antioxidant 
compounds can also greatly contribute to reduce their production costs while 
increasing the margin profit (Spigno and De Faveri, 2007). 
Recovery of antioxidant compounds from grape marc is mainly carried 
out by organic solvent extraction, with the extraction yield being increased 
by non-conventional techniques, such as ultrasound-assisted extraction 
(UAE) (Ghafoor et al., 2009, Palma and Barroso, 2002), microwave-assisted 
extraction (MAE) (Li et al., 2011), as well as high pressure and temperature 
extraction (HPTE) (Casazza et al., 2010b). 
The polyphenols are generally characterized by scarce solubility in water, 
which severely limit their use in pure form as bioactive compounds in 
functional foods, because of insufficient solubility in the GI tract and low 
permeability to pass through the intestinal wall (Haslam, 1996).  
Consequently, their effective oral delivery requires the encapsulation in 
nanometric size carriers, such as O/W nanoemulsions or solid lipid 
nanoparticles. 
The aim of this section is to show how polyphenolic compounds, 
recovered from grape marc, can be exploited as natural antioxidants for 
possible use in functional foods and nutraceutical products, by means of 
their encapsulation into nanoemulsion based delivery systems. Based on 
these premises, the polyphenols nanoencapsulation will be carried out using 
solely food-grade solvents and ingredients. The delivery systems will be 
validated by evaluating the stability of the extracts under accelerated storage. 
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V.2.1 Materials and methods 
V.2.1.1 Chemicals 
Skins and seeds of Pinot Noir cultivar from white-vinification (a kind gift 
from a company located in Trentino region, Italy) were used for the 
extraction of polyphenols. 
Emulsion formulations were based on sunflower oil (Sagra, Italy) or palm 
oil (Fluka, Germany) as organic phase, and the combination of lipophilic and 
hydrophilic emulsifiers. Defatted soy lecithin Solec FS-B (a kind gift from 
Solae Italia s.r.l., Italy) was used as hydrophilic emulsifier, while soy 
lecithin Solec IP (a kind gift from Solae Italia s.r.l., Italy) and glycerol 
monooleate (Sigma-Aldrich, Germany) as lipophilic emulsifiers. Bidistilled 
water was used as continuous phase. 
 
V.2.1.2 Extraction of grape marc polyphenols 
Grape marc (skins and seeds) were separated from stalks manually and 
then by means of sieves. After that, the samples were washed in order to 
eliminate the possible rest of the pomace. The samples were oven-dried at 
65 °C to a constant moisture of about 4-5 % (D-82152, MMM Medcenter, 
München, Germany) (Fiori et al., 2009). Samples were then ground with the 
help of a laboratory mixer to obtain a homogeneous powder for extraction 
with a particle size of 0.80 ± 0.05 mm. 
Dried and ground samples were extracted by methanol with a constant 
solid liquid ratio of 1:5. Extraction tests were performed in a high pressure 
high temperature reactor (HPTE) model 4560 (PARR Instrument Company, 
Moline, IL, USA). Grape marc was extracted at 150 °C for 150 min of 
contact time following the method previously described (Casazza et al., 
2011). 
After the reaction, the alcoholic extracts were centrifuged by a PK 131 
centrifuge (ALC, Alberta, Canada) at 6000 xg for 10 min and the 
supernatant was subjected to quantitative analysis. 
The supernatants were then subject to total polyphenol analysis, using the 
Folin-Ciocalteau assay as described previously (Casazza et al., 2010a). 
The single phenolic compound analysis was carried out using a HPLC 
(1100 Series, Hewlett Packard, Palo Alto, CA, USA) equipped with a C18 
reverse-phase column (201TP54, Vydac, Hesperia, CA, USA) coupled with 
a UV-Vis detector. The mobile phase was water/acetic acid (99:1 %, v/v) 
and methanol/acetonitrile (50:50 %, v/v), following a previously described 
method (Aliakbarian et al., 2011). 
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V.2.1.3 Encapsulation of grape marc polyphenols at the nanoscale 
Grape marc polyphenols were encapsulated in nanoemulsion-based 
delivery systems by high pressure homogenization (HPH) technique. First of 
all the grape marc polyphenols in methanol were dispersed in the lipid and 
lipophilic emulsifier phase on a hot plate at a temperature of 60 °C to obtain 
the melting of the lipid (in the case of palm oil), as well as the evaporation of 
the methanol. Subsequently, the primary emulsions were prepared mixing 
the lipid and water phases by high shear homogenization (HSH) using an 
Ultra Turrax T25 (IKA Labortechnik, Jahnke und Kunkel, Germany) at 
16800 rpm for 3 min at 60 °C. The emulsion droplets embedding the 
polyphenolic compounds were finally reduced to nanometric size by high 
pressure homogenization in a Nano DeBEE Electric Bench-top Laboratory 
homogenizer (BEE International, USA) at 200 MPa for 10 passes, 
maintaining the temperature during processing always at about 60 °C 
through heat exchange downstream of the homogenization valve and thermal 
conditioning of the inlet tank. All formulations were prepared in duplicate. 
 
V.2.1.4 Physical stability 
The physical stability of nanoencapsulated grape marc polyphenols was 
evaluated in terms of evolution of the mean droplet size of the 
nanoemulsions and of the creaming volume over time under accelerated 
ageing conditions according to the method described in the section V.1.1.4. 
 
V.2.1.5 Chemical stability 
The chemical stability of nanoencapsulated grape marc polyphenols was 
evaluated by recording the evolution of the ultraviolet–visible (UV–Vis) 
absorption spectra of the encapsulated polyphenols, at three different storage 
temperatures (4, 30 and 55 °C) for 14 days. The UV-Vis measurements were 
performed in the range of 250-450 nm using a V-650 UV-Vis 
spectrophotometer (Jasco Instruments, USA). Prior to measurements, the 
samples were diluted with bidistilled water to a suitable concentration. 
Chemical stability tests were conducted in duplicates. 
 
V.2.3 Results 
V.2.3.1 Composition of the polyphenols in the grape marc extracts 
The poliphenolic compounds were extracted from grape marc using high 
pressure and temperature extraction (HPTE) with methanol as solvent to 
obtain improved extraction yield and antioxidant power of the extracts in 
comparison to conventional methods, as previously discussed (Casazza et 
al., 2010a). 
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The polyphenol concentration in the extract was 51.2 mg of gallic acid 
equivalent per g of dried marc, while the concentration in the methanolic 
extract was 12.29 mg/mlmethanol.  
The content of the main phenolic compounds contained in the extracts is 
reported in Table V.1 per gram of dry extracts and per milliliter of extracting 
solvent. The most abundant phenolic compound is syringic acid 
(3.09 mg/gDW), followed by catechin, gallic acid and quercetin. Trans-
resveratrol was detected only in trace amounts (0.39 mg/gDW). 
 
 
Table V.1 Total polyphenols and main phenolic compounds content 
(mg/gDW) and concentration (mg/mlmethanol) in skin extract obtained by HPTE 
and analyzed with Folin-Ciocalteau and HPLC. 
1 Total polyphenols; 2 gallic acid; 3 5-hydroxymethylfurfural; 4 protocatecuic acid; 5 catechin; 




The total amounts of individual phenolic compounds quantified by HPLC 
(9.76 mg/gDW) was significantly lower than the value of total polyphenols 
measured by the Folin–Ciocalteau colorimetric method (51.2 mgGAE/gDW), 
because of the low selectivity of the Folin–Ciocalteu reagent, that reacts 
positively with different antioxidant compounds (phenolic and non-phenolic 
substances) (Que et al., 2006). 
 
V.2.3.2 Physicochemical stability of the nanoencapsulated 
polyphenolic extracts 
Grape marc polyphenols were encapsulated at a final concentration of 
0.1% (w/w) in sunflower oil and palm oil-based nanoemulsions.  
The polyphenolic compounds were encapsulated in the core of the tested 
nanoemulsion by using a dual-emulsifier formulation, which was previously 
tested in the nanoencapsulation of resveratrol (Sessa et al., 2011). In 
particular, the addition of a lipophilic emulsifier such as glycerol monooleate 































12.29 0.35 0.04 0.11 0.64 0.04 0.74 0.04 0.09 0.29 
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hydrogen bonding with the polyphenolic compounds, which are scarcely 
soluble both in lipid and in aqueous phase. The hydrophilic emulsifier 
(defatted soy lecithin) contributed not only to the stabilization of the lipid 
droplets in the continuous aqueous phase, but also to limit the localization of 
polyphenols at the oil/water interface, thus improving the encapsulation in 
the lipid phase by hydrophobic interactions. 
Table V.2 reports the compositions of those formulations that resulted to 
be stable. The total lipid phase, consisting of the oil and of the lipophilic 
emulsifier, was always kept at a fixed concentration of 10% (w/w), varying 
the type of oils and emulsifiers used.  
 
 
Table V.2 Composition, mean droplet size (Z-diameter) and polidispersity 








0.1% grape marc 
polyphenols 
1% glycerol monooleate 
0.5% defatted soy lecithin 
9% sunflower oil 
89.4% water 
176 ± 2 0.130 ± 0.07 
SO/LSL-DSL 
0.1% grape marc 
polyphenols 
1% lipophilic soy lecithin 
0.5% defatted soy lecithin 
9% sunflower oil 
89.4% water 
219 ± 4 0.190 ± 0.03 
PO/GMO-DSL 
0.1% grape marc 
polyphenols 
1% glycerol monooleate 
0.5% defatted soy lecithin 
9% palm oil 
89.4% water 
1330 ± 124 0.980 ± 0.09 
PO/LSL-DSL 
0.1% grape marc 
polyphenols 
1% lipophilic soy lecithin 
0.5% defatted soy lecithin 
9% palm oil 
89.4% water 
178 ± 2 0.140 ± 0.03 
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The physical stability of encapsulated grape marc polyphenols was 
evaluated in terms of the evolution over time of the mean droplet diameter, 
Z-diameter, and the creaming volume percentage, C, under accelerated 
ageing conditions.  
The sunflower oil-based nanoemulsions, SO/GMO-DSL and SO/LSL-
DSL, characterized by an initial mean droplet diameter of 175 and 220 nm 
respectively, showed no significant (p < 0.05) variation of Z-diameter at all 
storage temperatures (Table V.3). The good physical stability of these 
formulations was confirmed by the evolution of the creaming volume 
percentage, which exhibited at all tested temperatures a decrease below 5% 
(Figure V.5a and b). 
Unlike the sunflower oil-based nanoemulsions, the palm oil-based 
systems, PO/LSL-DSL and PO/GMO-DSL, exhibited different trends of 
physical stability under accelerated ageing. PO/LSL-DSL, characterized by 
an initial mean droplet size of 180 nm, showed a slight increase of the Z-
diameter until 250 nm over the 14 days of storage at all the tested 
temperatures (Table V.3). In contrast, PO/GMO-DSL, formulated with 
glycerol monooleate as lipophilic emulsifier, was characterized by an initial 
mean droplet diameter, as measured immediately after HPH treatment, in the 
micrometric range (1300 nm), probably due to the formation of aggregates 
of the solid fat droplets. This hypothesis is confirmed by the evolution of the 
Z-diameter over storage time: while at lower temperatures a micrometric 
mean droplet size is always observed, when the temperature is increased 
above the melting temperature of the palm oil (i.e. for storage temperature of 
55 °C), the mean droplet size decreases to values similar to the other tested 
systems (around 200 nm), as shown in Table V.3.  
This phenomenon can be attributed to the break-down of the droplet 
aggregates when the storage temperature is higher than the melting point of 
the lipid phase. The evolution of the creaming volume percentage, C, over 
time was coherent with the droplet size measurements. For PO/LSL-DSL, C 
remained constant at about 100% at 4 and 30 °C and decreased slightly at 
about 88% at 55 °C (Figure V.5d). On the contrary, for PO/GMO-DSL C 
was constant only at 4 °C, while a decrease of C by 20 and 25% was 
measured at 30 and 55 °C respectively (Figure V.5c), in accordance with an 
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Table V.3 Evolution of the mean droplet diameter (Z-diameter) of the 
encapsulated grape marc polyphenols in sunflower oil-based (SO/GMO-DSL 
and SO/LSL-DSL) and palm oil-based (PO/GMO-DSL and PO/LSL-DSL) 
delivery systems, stored at 4, 30 and 55 °C for 14 days. Different lowercase 
letters in the same day indicate statistically (Student t test) significant 
differences (p<0.05). Different capital letters at a fixed storage temperature 





4 °C 30 °C 55 °C 
SO/GMO-DSL 
0 176 ± 2 a, A 176 ± 2 a, D 176 ± 2 a, G 
1 183 ± 3 b, B 185 ± 10 b, E 180 ± 1 b, H 
3 184 ± 4 c, B 178 ± 1 d, D F 189 ± 8 c, I L 
6 183 ± 5 e, B C 182 ± 5 e, E F 192 ± 11 f, I 
10 178 ± 1 g, A C 175 ± 1 h, D 185 ± 1 i, L 
14 181 ± 2 l, B C 181 ± 1 l, E 192 ± 2 m, I 
SO/LSL-DSL 
0 219 ± 4 a, A 219 ± 4 a, F 219 ± 4 a, L 
1 231 ± 11 b, B C 326 ± 6 c, G 256 ± 21 d, M 
3 254 ± 19 e, D 227 ± 2 f, H 248 ± 15 e, M N 
6 239 ± 9 g, B E 225 ± 2 h, H 238 ± 20 g, N P 
10 247 ± 31 i, D E 216 ± 1 l, F 273 ± 7 m, O 
14 225 ± 2 n, C 232 ± 2 o, I 229 ± 2 o, P 
PO/GMO-DSL 
0 1330 ± 124 a, A 1330 ± 124 a, G 1330 ± 124 a, O 
1 19400 ± 8000 b, B 1530 ± 523 c, H 1670 ± 85 d, P 
3 13600 ± 976 e, C 1120 ±199 f, I 220 ± 34 g, Q 
6 13900 ± 3010 h, D 971 ± 175 i, L 199 ± 2 l, R 
10 18300 ± 2480 m, E 2610 ± 1030 n, M 208 ± 4 o, Q 
14 17800 ± 1630 p, F 5720 ± 3800 q, N 190 ± 3 r, S 
PO/LSL-DSL 
0 178 ± 2 a, A 178 ± 2 a, F 178 ± 2 a, L 
1 188 ± 7 b, B 187 ± 7 b, G 213 ± 20 c, M 
3 184 ± 2 d, B 207 ± 33 e, H 248 ± 42 f, N 
6 226 ± 28 g, C 243 ± 23 h, I 215 ± 34 g, M 
10 241 ± 3 i, D 180 ± 1 l, F 296 ± 8 m, O 
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Figure V.5 Evolution of the creaming volume percentage, C, of the 
encapsulated grape marc polyphenols into different delivery systems: (a) 
SO/GMO-DSL, (b) SO/LSL-DSL, (c) PO/GMO-DSL and (d) PO/LSL-DSL. 
Storage temperatures were 4 °C ( ), 30 °C ( ) and 55 °C ( ). 
 
The chemical stability of the nanoencapsulated grape marc polyphenols 
was evaluated monitoring the evolution of their UV-Vis absorption spectra 
over 14 days of storage at different temperatures (4, 30 and 55 °C), with the 
results being reported in Figure V.6. It must be highlighted that the chemical 
stability of the different systems reproduced the same trends observed for the 
physical stability. The SO/GMO-DSL and SO/LSL-DSL systems were able 
to efficiently protect the grape marc polyphenols from degradation over 14 
days at all the storage temperatures (Figure V.6.1a, 2a, 3a and Figure V.6.1b, 
2b, 3b). In contrast, the palm oil-based systems were less efficient, with a 
slight decrease of the absorbance peak being measured after 14 days for 
PO/LSL-DSL and a much more significant decrease already after 3 days for 
PO/GMO-DSL, suggesting the release of the encapsulated compounds and 
subsequent degradation (Figure V.6.1d, 2d, 3d and Figure V.6.1c, 2c, 3c). 
The unstable behaviour of grape marc polyphenols nanoencapsulated in the 
formulation PO/GMO-DSL is in agreement with the observed physical 
instability of the system. 
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Figure V.6 The UV-Vis absorption of the encapsulated grape marc 
polyphenols into different nanoemulsions: a) SO/GMO-DSL, b) SO/LSL-
DSL, c) PO/GMO-DSL and d) PO/LSL-DSL, after storage at 1) 4 °C, 2) 
30 °C and 3) 55 °C for 14 days. 
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V.3 Encapsulation of curcumin 
Curcumin (diferuloylmethane), the yellow pigment in turmeric and curry, 
is extensively used in the food and chemical industry as a colouring, 
flavouring and preservative agents. It has also been found to exhibit anti-
oxidative (Sharma et al., 1994) and anti-inflammatory properties in clinical 
trials (Lin et al., 1997). During the past decades, many research reports 
indicated that curcumin can induce apoptosis and suppress the formation of 
procarcinogens through various mechanisms (Chauhan, 2002). Curcumin 
possesses not only chemopreventive but also anti-cancer activities (Huang et 
al., 1994, Huang et al., 1997). Curcumin has been considered by the National 
Cancer Institute (NCI) as the third generation of cancer chemopreventive 
agent in America. 
Curcumin with its polyphenolic structure is water insoluble and scarcely 
dissolved in the organic phase. Previous studies addressing the absorption 
and metabolism of curcumin after oral administration showed its poor 
bioavailability in vivo (Ravindranath and Chandrasekhara, 1981). Curcumin, 
however, is unstable at neutral-basic pH values and in serum-free medium, 
and is degraded to vanillin, ferulic acid, feruloyl methane and trans-6-(40-
hydroxy-30-methoxy-phenyl)-2,4-dioxo-5-hexenal (Huang et al., 1994). 
Lin and coworkers have investigated the stability and characterization of 
a curcumin-encapsulated O/W microemulsion system using food-acceptable 
components, lecithin and Tween 80 as the surfactants and ethyl oleate as the 
oil phase (Lin et al., 2009). The formulations tested resulted stable for 2 
months with an average diameter of 72 nm. 
Tiyaboonchai and co-workers have investigated the stability of curcumin 
in microemulsion and solid lipid nanoparticles (SLNs) (Tiyaboonchai et al., 
2007). However, the high dose of ethanol used in the formulation and the 
submicron size of SLNs (about 450 nm) calls for the improvement of the 
procedure.  
Solid lipid nanoparticles have attracted much interest over the past years 
as potential drug delivery systems because of their ease of preparation and 
long-term stability. Furthermore, the choice of the surfactant is critical for 
the formulation of the curcumin-based delivery systems. Lecithin, which has 
two long hydrocarbon chains, is a major component of lipid bilayers of cell 
membranes and a natural, biological amphiphilic compound. Moreover, it is 
in many respects regarded as an ideal biological surfactant because it is 
biodegradable.  
The main aim of this study was to find stable O/W emulsions containing 
curcumin encapsulated with food-acceptable ingredients, such as soy lecithin 
and sugar ester, to protect curcumin from chemical degradation.  
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V.3.1 Materials and methods 
V.3.1.1 Chemicals 
Curcumin (85% pure, with 11% demethoxycurcumin and 4% 
bisdemethoxycurcumin as impurities) was obtained from Sabinsa 
Corporation (Piscataway, NJ) and used without further purification. 
The submicron emulsion were prepared using stearic acid (Sigma-Aldrich 
s.r.l., Milan, Italy) as lipid phase and soy lecithin Solec IP (a kind gift from 
Solae Italia s.r.l., Milan, Italy) and sugar ester P1670 (a kind gift from 
Prodotti Gianni, Milan, Italy as lipophilic and hydrophilic emulsifiers. 
 
V.3.1.2 Fabrication of encapsulated curcumin into emulsion 
Curcumin (0.1% w/w) was dispersed in the lipid and lipophilic emulsifier 
phase on a hot plate at a temperature of 70 °C to obtain the melting of the 
lipid. Subsequently, the primary emulsion was prepared mixing the lipid and 
water phases by high shear homogenization (HSH) using an Ultra Turrax 
T25 (IKA Labortechnik, Jahnke und Kunkel, Germany) at 16800 rpm for 2 
min at 70°C. The emulsion droplets embedding curcumin were finally 
reduced to micrometric size by high pressure homogenization in a high 
pressure bench-scale homogenizer (nm-GEN 7400 series by Stansted Fluid 
Power, UK) at 200 MPa for 10 passes, maintaining the process temperature 
above the lipid melting temperature (70 °C), in order to produce a hot 
emulsion, whose rapid cooling will generate solid lipid particles.  
It was tested the formulation which proved to be the most stable by the 
construction of the pseudo ternary phase diagram, described in detail in 
Chapter III, and having the following composition: 0.1% (w/w) curcumin, 
2.4% (w/w) stearic acid, 3.73% (w/w) lipophilic soy lecithin, 1.87% (w/w) 
sugar ester and 91.9% (w/w) water. 
 
V.3.1.3 Physicochemical stability of encapsulated curcumin 
The physical stability was evaluated by measuring the variation of the 
mean droplet diameter over time under accelerated ageing conditions. The 
particle size distributions (PSD) were measured by wet laser diffraction 
(Mastersizer 2000, Malvern Instruments, Malvern, UK).  
Moreover the chemical stability of encapsulated curcumin was measured 
recording the evolution of the UV–Vis absorption spectra at three different 
storage temperatures (4, 30 and 55 °C) and pH (3, 7 and 10) for 20 days. The 
UV-Vis spectra were obtained in the range of 360-460 nm using a V-650 
UV-Vis spectrophotometer (Jasco Instruments, USA). (high temperature and 
high-low pH). 
Each measurement was replicated three times. 
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V.3.3 Results 
V.3.3.1 Physicochemical stability of curcumin emulsions 
In this section, the physical and chemical stability of the encapsulated 
curcumin into submicron emulsion was examined in terms of the evolution 
of the mean droplet diameter and curcumin degradation over time under 
accelerated ageing conditions (high temperature and high-low pH).  
The results, reported in Figure V.7, show that the emulsion, after a slight 
initial increase of the mean droplet diameter, probably due to the formation 
of aggregates of the solid fat crystals, was very stable when kept at 
refrigerated conditions (4 °C) and at room temperature (30 °C) for 20 days 
with averaged diameter of about 7 µm; on the contrary at high storage 
temperature (55 °C) the particle diameters gradually increased with the 
storage time. Moreover, after 10 days for the samples stored at 55 °C it has 
been observed the settling of curcumin at the bottom of the test-tube. When 
the temperature is increased around the melting temperature of the stearic 
acid (i.e. for storage temperature of 55 °C), coalescence and aggregation 
phenomena were favoured by the melting and subsequent break-down of 
solid lipid particles, causing an increase of the mean droplet diameter and 
also the release of curcumin from the capsules.  
time (day)






















Figure V.7 The evolution of the mean droplet diameter, d(0.5), of the 
curcumin-encapsulated emulsion under accelerated ageing conditions. 
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An analogous behaviour was confirmed by the analysis of the chemical 
stability of the encapsulated curcumin. Figure V.8 shows the UV-Vis 
absorption curves of encapsulated curcumin into solid lipid particles, stored 
at different temperatures and pH. The results demonstrate that emulsions 
stored at 4 and 30 °C were more stable than emulsion at 55 °C with no 
degradation and release of the curcumin from the delivery system after 20 
days. Moreover, the peaks of the absorbance at 420 nm remain quite 
constant at pH 3 and 7 over the storage time. At pH 10 the peak of the 
absorbance at 420 nm disappeared after only 4 days (Figure V.8f) and 













































































Figure V.8 The evolution of the UV–Vis absorption curves of the curcumin-
encapsulated emulsion after storage at different temperatures, (a) 4 °C, (c) 
30 °C and (e) 55 °C) and different pH, (b) 3, (d) 7 and (f) 10, for 20 days. 
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V.4 Conclusions 
The design of nanoemulsion-based delivery systems with the use of a 
combination of hydrophilic (sugar ester, defatted soy lecithin, polysorbate 
20) and lipophilic emulsifiers (defatted soy lecithin, glycerol monooleate) 
was able to encapsulate polyphenols, such as resveratrol and grape marc 
extracts, and disperse them in aqueous systems at a concentration at least 10 
times higher than their therapeutic concentration. 
Fluorescence spectroscopy studies have confirmed the hypothesis that the 
combined use of a hydrophilic and a hydrophobic emulsifier can better 
retain, through hydrophobic interactions, the scarcely water- and lipid-
soluble polyphenols in the droplet core. 
For the first time, a nanoencapsulation system based on nanoemulsions 
was developed for the delivery of resveratrol, while measurably increasing 
its physical and chemical stability in comparison with the unencapsulated 
compound. Accelerated ageing tests, conducted at different storage 
temperatures (from 4 to 55 °C) and under UV-C light showed that the 
formulation based on the combination of soy lecithin and sugar esters was 
the most physically and chemically stable, with the mean droplet size always 
lower than 180 nm under the different conditions tested. 
Furthermore, the exploitation of polyphenols extracted from grape marc 
was evaluated by means of their encapsulation in nanoemulsions, formulated 
with only natural ingredients, using either a liquid (sunflower oil) or a solid 
(palm oil) lipid phase. Sunflower oil-based nanoemulsions resulted to be the 
most physically and chemically stable, with no significant variation of the 
mean droplet size and no degradation of the encapsulated compounds under 
the different conditions tested.  
Finally, curcumin was encapsulated in stearic acid-based solid lipid 
particles, increasing solubility in aqueous systems more than 1600 times in 
comparison to its solubility in water. It was observed that the solid lipid core 
protects curcumin from chemical degradation at high temperatures and 
neutral pH. Further studies are needed to prevent the aggregation of solid 
lipid particles during the rapid cooling treatment after hot HPH in order to 
further reduce the mean droplet diameters. 
The present study serves as a useful model for developing delivery 
systems of bioactive compounds, poorly water soluble and chemically 
unstable once extracted from plant tissues, for the nutraceutical and 











In this chapter the demonstration is given of how the nanoencapsulation 
of bioactive compounds, and in particular resveratrol, which is studied as 
model compound, can improve their bioavailability, protecting them from 
chemical degradation and avoiding a rapid metabolism. To this purpose, the 
gastric-intestinal digestion process was simulated in vitro. Furthermore, the 
transport of nanoencapsulated resveratrol through the intestinal wall was 
investigated through the ex vivo measurement of its transport rate through 
Caco-2 cell monolayers grown on permeable supports. These in vitro and ex 
vivo experiments were conducted in the laboratories of the Guelph Food 
Research Centre, Agriculture and AgriFood Canada. 
Finally, the in vitro release of nanoencapsulated resveratrol was studied 
evaluating the possibility to use O/W nanoemulsions as delivery systems for 




VI.1 Resveratrol and its beneficial effects 
Starting in 1990s and continuing to date, clinical studies have 
demonstrated several health-promoting activities of trans-resveratrol, such 
as anti-oxidizing (Orallo, 2006) and anti-atherosclerotic effects, inhibition of 
platelet aggregation (Olas and Wachowicz, 2005), beneficial effects on the 
cardiovascular system, reducing lipid peroxidation, improving vasodilatation 
and lowering blood pressure (Bradamante et al., 2004) and chemoprotective 
advantages against cancer proliferation (Jang et al., 1997).  
The biological properties of resveratrol are attributed to its ability to 
inhibit the oxidation of human low-density lipoprotein and its suppression of 
cyclooxygenase-2 contribute to its anti-inflammatory and antioxidant effects 
(King et al., 2005). On the other hand, the chemopreventive effect of 
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resveratrol is due to the inhibition of quinone reductase 2 activity, which 
regulates the expression of cellular antioxidant and detoxification enzymes 
to improve cellular resistance to oxidative stress (Buryanovskyy et al., 
2004). Furthermore, resveratrol increases the activity of SIRT (a member of 
the sirtuin family of nicotinamide adenine dinucleotide-dependent 
deacetylases), resulting in improved cellular stress resistance and longevity 
(Holme and Pervaiz, 2007). 
However, the physicochemical properties of resveratrol, particularly its 
high reactivity and low solubility in aqueous and lipid phases, constituted 
also the limiting factors for its bioavailability and for the explication of the 
desired health-beneficial effects. 
In a biological system, resveratrol is rapidly and extensively metabolized, 
probably due to its low water solubility, which reduces the dissolution-rate 
limited cell absorption (Wenzel and Somoza, 2005), thus reducing its oral 
bioavailability. In order for resveratrol to exert its beneficial effects, it must 
reach a concentration in the blood of at least 10 mg/l (Yu et al., 2003), 
which, for an average weight person, translates in the absorption of 50 mg of 
resveratrol. 
The development of the therapeutic potential of resveratrol can only be 
applied in vivo if the limitations tied to its bioavailability can be overcome. 
Research is currently exploring different methods for enhancing resveratrol 
bioavailablility, including a) co-administration with inhibitors of resveratrol 
metabolism in order to prolong its presence in vivo, b) the use of resveratrol 
analogs possessing a better bioavailability, c) investigation of the potential 
activity of resveratrol metabolites, and d) design of drug delivery systems 
exploiting the advantages of nanotechnology (Amri et al., 2011).  
Concerning the first approach, some authors have evaluated the 
opportunities for enhancing the pharmacokinetic parameters of resveratrol 
by partially inhibiting its glucuronidation via a co-administration with 
inhibitors, thereby slowing its elimination. For example, Johnson et al. 
(Johnson et al., 2011) used piperine, an alkaloid derived from black pepper, 
to inhibit glucuronidation and observed in vivo an increase in the serum 
resveratrol concentration. 
There is also increasing interest in the second strategy, consisting in 
evaluating novel naturally-occurring and/or synthetic analogs of resveratrol 
possessing the same structural backbone but with chemical modifications 
resulting in superior efficacy. Kapetanovic and coworkers studied the 
naturally-occurring dimethylether analog of resveratrol, pterostilbene, and 
compared its bioavailability to that of resveratrol in healthy rats, which was 
resulted 3-4 fold higher (Kapetanovic et al., 2011). 
There is speculation that resveratrol metabolites may retain some activity, 
making it necessary to lead further studies on the their beneficial effects. 
Among the numerous resveratrol metabolites, piceatannol significantly 
decreased dextran sulfate sodium which induces inflammatory injury and 
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regulated iNOS expression in the same way as resveratrol did in mouse 
colitis (Youn et al., 2009). 
Finally, the design of drug delivery systems able to enhance resveratrol 
bioavailability is particularly promising. While conventional forms, such as 
tablets or capsules, are only mentioned in clinical studies evaluating 
resveratrol bioavailability in humans (Boocock et al., 2007), research is 
currently focused on exploring delivery systems in micrometric to 
nanometric range, as described in section V.1. 
The aim of this chapter is to demonstrate how the O/W nanoemulsions, 
being able to protect bioactive compounds from chemical degradation, as 
demonstrated in chapter V, can be also efficient delivery systems for the oral 
administration of resveratrol, preserving it during the digestion process, 
favoring a sustained release and hence enhancing its bioavailability. 
 
 
VI.2 Materials and methods 
VI.2.1 Chemicals 
Pepsin from porcine gastric mucosa, pancreatin from porcine pancreas, 
bile salts and phenylmethanesulfonyl fluoride (PMSF), were all purchased 
from Sigma-Aldrich (Oakville, ON, Canada). 
Dulbecco’s Modified Eagle Medium (DMEM), Hanks’ Balanced Salt 
Solution (HBSS) and antibiotic-antimycotic (100x) were purchased from 
Gibco Life Technologies (Grand Island, NY). Fetal bovine serum (FBS) was 
obtained from Thermo Scientific HyClone (Logan, UT). 
All other solvents were of HPLC grade and were purchased from Sigma-
Aldrich (Oakville, ON, Canada). 
 
VI.2.2 Production of nanoemulsions for resveratrol delivery 
Resveratrol (0.01 wt%) was encapsulated in peanut oil-based 
nanoemulsions by high pressure homogenization, as described in section 
V.1.1.2.  
The O/W nanoemulsions were produced using a combination of 
hydrophilic and lipophilic emulsifiers to enhance the entrapment of 
resveratrol into the lipid phase. Natural products, such as defatted soy 
lecithin, lipophilic soy lecithin and sugar ester, or synthetic compounds, such 
Tween 20 and glycerol monooleate, were used as emulsifiers. 
The composition and the mean droplet diameter (Z-diameter) of the 
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0.01% resveratrol  
0.2% ethanol 
1% lipophilic soy lecithin 
0.5% defatted soy lecithin 
6% peanut oil 
92.29% water 
212 ± 4.9 
R/LEC 
0.01% resveratrol  
0.2% ethanol 
2.1% soy lecithin Lecinova 
27.9% peanut oil 
69.79% water 
235 ± 1.5 
R/T20-GMO 
0.01% resveratrol  
0.2% ethanol 
1.5% Tween 20 
1.5% glycerol monooleate 
7% peanut oil 
89.79% water 
128 ± 2.3 
R/LSL-SE 
0.01% resveratrol  
0.2% ethanol 
1% lipophilic soy lecithin 
0.3% sugar ester 
9% peanut oil 
89.49% water 
138 ± 0.4 
 
 
VI.2.3 In vitro gastrointestinal digestion 
The digestion process was conducted according to the method proposed 
by Boyer and coworkers (Boyer et al., 2005) with some modifications. 
Briefly, for simulated gastric digestion, a sample of 6 ml of each 
nanoemulsion containing resveratrol was placed in a test tube with 3 ml of 
saliva and incubated in a water bath at 37 °C for 15 min. Saliva was 
collected in a sanitary manner to sterile tube 5 min after a volunteer had 
consumed 250 ml of milk. A sample of 3 ml of phosphate buffer saline was 
then added, the pH was adjusted to 2.0 by drop-wise addition of 1 M HCl 
and porcine pepsin was then added to a final concentration of 1.3 mg/ml. 
The sample was incubated in a water bath at 37 °C for 30 min. Aliquots of 
the digestion mixture were collected for HPLC analysis. 
Then the pH was increased to 5.8 by drop-wise addition of 1 M NaHCO3, 
to prepare for the simulated intestinal digestion. Pancreatin and bile salts 
were added to a final concentration of 0.175 and 1.1 mg/ml, respectively. 
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The pH was adjusted to 6.5 by drop-wise addition of 1 M NaHCO3 and the 
digestate was incubated in a water bath at 37 °C for 2 h, before sample 
collection. The two different stages of digestion (gastric and intestinal) were 
stopped by adding PMSF to a final concentration of 0.174 mg/ml. 
 
VI.2.4 Cell cultures 
Caco-2 cells were obtained from the American Type Culture Collection 
(ATCC) (Rockville, MD). The cells were maintained at 37 °C in Dulbecco’s 
Modified Eagle’s Medium (DMEM), supplemented with 10% fetal bovine 
serum (FBS) and 1% antibiotic-antimycotic solution, in an atmosphere of 
5% CO2. The cells were seeded on PTFE filter inserts (0.4 µm, 6.5 mm 
diameter) of Transwell cell culture chambers (Corning Incorporated - Life 
Sciences, Lowell, MA, USA). Cells used were at passage 25-30. The cells 
were allowed to grow and differentiate to confluent monolayers for 14-21 
days.  
 
VI.2.5 Transport across filter-grown Caco-2 cell monolayers 
Transport at 37 °C was determined across Caco-2 cell monolayers in the 
apical-to-basolateral direction according to Nature Protocols (Hubatsch et 
al., 2007). For cell culture experiments, Transwell-grown cell monolayers at 
days 19-21 after plating were used. Donor solutions containing 100 µl of 
encapsulated resveratrol in nanoemulsion-based delivery systems in 150 µl 
of medium were prepared. In the receiving compartment were added 750 µl 
of cell culture medium. Samples (30 µl) were taken from the receiver side at 
specified time intervals. The transport experiments were carried out over a 
time period of 6 h. The amount of the transported compound was determined 
by HPLC. At beginning and at the end of the transport experiments the 
integrity of the monolayer was checked by measurement of the 
transepithelial electrical resistance, TEER, using Millicell-ERS (Millipore 
Corporation, Billerica, MA, USA). The transport experiments were 
performed in triplicate at 37 °C in an incubator. 
The cumulative amount, Q, transported at any time point is the sum of the 
amount of the transported compound in the receiver side and the amount of 
the compound contained in the samples removed at previous time points. 











where Q is the cumulative amount of the resveratrol transported; cn is the 
concentration of resveratrol determined at nth sampling interval; Vr is the 
volume of the solution on the receiver side (750 µl) and Vs is the sampling 
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volume (30 µl); ci was the resveratrol concentration determined at n-1 
sampling interval. Plotting the cumulative amount transported (Q) versus 
time, the linear appearance rate (slope = ∆Q/∆t) of resveratrol on the 
receiver side was determined. Then, the apparent permeability coefficient, 
Papp (cm/s), was calculated according to the following equation: 
)/1)(/( 0AcdtdQPapp =  (VI.2) 
where ∆Q/∆t is the linear appearance rate of the compound on the 
receiver side (in mmol/sec); A is the surface area of the cell monolayers (in 
cm2; 4.71 cm2 for Transwells 24 mm in diameter); and c0 is the initial 
concentration of the compound on the donor side (in mmol/cm3). 
 
VI.2.6 Cellular uptake 
To check mass balance, the uptake of the compound in Caco-2 cells was 
determined. Immediately after performing transport studies, the transport 
medium was removed and the cells were washed with HBSS to stop further 
uptake and to remove unbound compound. Subsequently, the cells were 
scraped from the polycarbonate filters into 1 ml of 0.01 M HCl:methanol 
solution (50:50% v/v – pH:2.4). After sonication in water bath sonicator for 
5 min, the samples were centrifuged at 8600 xg for 5min at 4°C. Samples 
were then analyzed by HPLC. 
 
VI.2.7 In vitro release 
Release profile of resveratrol from nanoemulsions was performed by a 
dialysis bag method using water as dissolution medium. A sample of 2 ml of 
resveratrol nanoencapsulated was placed into a pre-swelled 12 kDa 
molecular weight cutoff dialysis bags (20/32’’ Visking tubing, Scientific 
Instument Centre Ltd, London, UK) with the two ends fixed by clamps. The 
bags were immersed in 200 ml of water and stirred at 100 rpm at 37°C. At 
predetermined time, samples of 5 ml were withdrawn from the release media 
and replaced with an equal volume of the corresponding fresh media to 
maintain a constant volume. The test solution was analyzed by HPLC and 
the cumulated amounts of resveratrol released from the nanoemulsions were 


















where Q was the cumulative amount of resveratrol released (%); cn was 
the concentration of resveratrol (mg/l) determined at nth sampling interval; ci 
was the resveratrol concentration (mg/l) determined at n-1 sampling interval; 
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Vt and Vs were the volumes of the acceptor phase (200 ml) and of the sample 
withdrawn from the acceptor phase (5 ml) respectively; c0 was the initial 
concentration of resveratrol in dialysis bag and Vb was the volume of the 
sample in dialysis bag (2 ml). 
Experiments were performed at least three times. 
 
VI.2.8 HPLC analysis 
An HPLC system (Agilent Technology 1100 series, Palo Alto, CA) 
equipped with a quaternary pump, an inline degasser, a thermostatic 
autosampler, and a diode array detector (DAD) was used for the 
identification and quantification of resveratrol in the samples. A 
Phenomenex Luna C18(2) analytical column (250 × 4.6 mm i.d.; particle 
size, 5 µm) with a C18 guard column (Phenomenex, Torrance, CA) was used 
for the separation. The binary mobile phase consisted of methanol:acetic 
acid:water (45:5:50 v/v %) (solvent A) and 1.2 v/v % of acetic acid in 
methanol (solvent B), and the gradient program was as follows: 0% B to 
10% B in 10 min, 10% B to 100% B in 2.5 min, 100% B for 2.5 min, 100%B 
to 100% A in 2.5 min and 100% A for 5 min.  
The flow rate was 0.8 ml/min for a total run time of 22.5 min. The 
injection volume was 10 µl for all samples. The standard curve was 
constructed diluting resveratrol in methanol. The detector was set at 310 nm 
for trans-resveratrol and at 280 nm for cis-resveratrol. The excitation 




VI.3.1 In vitro digestion of nanoencapsulated resveratrol 
The polyphenols are generally characterized by scarce solubility in water, 
which severely limits their use in pure form as bioactive compounds in 
functional foods, because of insufficient solubility in the GI tract and low 
permeability to pass through the intestinal wall (Haslam, 1996).  
Although the biochemical changes in the digestive tract by enzymes and 
intestinal microflora makes them more soluble in water and suitable to be 
metabolized, this process is likely to affect their therapeutic properties 
(Scalbert and Williamson, 2000). For this reason, the use of a delivery 
system is necessary to protect the encapsulated bioactive compound during 
the digestion process by allowing to keep intact its health-beneficial 
properties up to the intestinal wall where it must be adsorbed. 
In this section the chemical and physical stability of encapsulated 
resveratrol into different nanoemulsion-based delivery systems was 
evaluated during the digestion process conducted under conditions 
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simulating cumulatively the digestion activities of the stomach and the small 
intestine. 
During the gastric and intestinal digestions, resveratrol remained 
chemically stable, with no significant changes in the quantity and quality of 
the encapsulated resveratrol. The HPLC analysis has confirmed the stability 
of the nanoencapsulated resveratrol with no additional peaks detected after 
digestion. It can be then speculated that resveratrol remains encapsulated in 
the lipid phase, is not metabolized in the gastrointestinal tract, and can 
therefore reach the colon in active form to be absorbed through the intestinal 
wall. Nevertheless, final proof of resveratrol being still encapsulated requires 
further experimental investigations. 
However, several studies based on animal and human models have 
demonstrated that for unencapsulated resveratrol, only traces of its active 
form actually circulate in the plasma; resveratrol was found to be extensively 
glucuronidated and sulfated in gut and liver (Walle et al., 2004). Biliary 
excretion has been found to be an important elimination pathway for 
resveratrol and previous studies have shown that in rats at least 30% of the 
administered dose was eliminated via feces in the form of conjugated 
metabolites (Wenzel et al., 2005). 
The integrity of the nanocapsules during digestion was assessed by 
measuring the variation of the mean droplet diameters after the different 
digestion phases (Figure VI.1).  
 




















Figure VI.1 Mean droplet diameter, Z-diameter, of the nanoemulsions 
encapsulating resveratrol before and after the in vitro digestion process. 
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The R/T20-GMO and R/LSL-SE nanoemulsions were physically stable 
during gastric and intestinal digestion, without any variation of the Z-
diameter being observed. The lecithins-based nanoemulsions, R/LEC and 
R/LSL-DSL, characterized by a higher initial mean droplet diameter in 
comparison to the previous formulations, appeared to be not as stable during 
gastric digestion, with a significant increase of the Z-diameter. Nevertheless, 
the following step of intestinal digestion determined the reduction of the 
mean droplet size due to the action of the bile salts, which emulsified the fat 
aggregates produced during gastric digestion. 
 
 
VI.3.2 Transport through Caco-2 cell monolayers 
Figure VI.2 shows the cumulative amount transported from the apical to 
the basolateral side across Caco-2 cell monolayers for encapsulated 
resveratrol into nanoemulsion-based delivery systems in comparison with 
the unencapsulated compound diluted in DMSO. The formulations R/T20-
GMO and R/LSL-SE, with smaller particle size (128 and 138 nm 
respectively), show higher cumulative amount transported in comparison to 
the other formulations, confirming the importance of nanometric size to 
improve the passive transport mechanisms through the cell membrane. 
Furthermore, although these two formulations show a slight difference in the 
mean droplet diameters, R/LSL-SE shows an higher permeability due to the 
presence of soy lecithin, which, being a mixture of phospholipids similar to 
the phospholipid bilayer structure of the cellular membrane, favours the 
absorption and the entrapment of the oil droplets in the microvilli and their 
consequent transport through the cell membrane. 
From the HPLC analysis of the samples in the basolateral side no new 
peaks were detected in addition to the peak of resveratrol, confirming the 
fact that resveratrol is not metabolized by the cells, not being detected its 
metabolites, because it was entrapped in the lipid phase and protected by the 
double layer of hydrophilic and lipophilic emulsifiers during transport 
through the Caco-2 cell monolayers. In fact, the analysis of the mean droplet 
diameters confirmed the hypothesis that resveratrol has been transported 
through the cell monolayers into the oil droplets, due to the fact that no 
variation of Z-diameter was observed after transport experiments, as showed 
in Figure VI.3. 
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Figure VI.2 Cumulative amount (Q) versus time (t) of unencapsulated 
resveratrol (R/DMSO) and nanoencapsulated resveratrol transported from 
the apical to the basolateral side across Caco-2 cell monolayers. 
 

















Figure VI.3 Mean droplet diameter (Z-diameter) of the nanoemulsions 
encapsulating resveratrol before and after transport across Caco-2 cell 
monolayers. 
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The transepithelial electrical resistance, TEER, was measured before and 
after the transport experiments to check the integrity of the monolayer. 
Generally, TEER values obtained are in the range of 1000-4000 Ohms for a 
21 day culture and 1000-3000 Ohms for a 10 day culture. It is considered a 
failing well below 1000 Ohms. Table VI.2 shows that for all the samples 
tested the TEER values were higher than 1000 Ohm and remained constant 
after the transport experiments, confirming that the cell monolayers were not 
damaged during the tests. 
 
Table VI.2 Transepithelial electrical resistance measurements (TEER) of 
Caco-2 cell monolayers grown on permeable supports before and after 
transport experiments. 
Delivery systems  
applied to the cells 
TEER (Ohm) 
Befor transport After transport 
R/DMSO 1250 ± 130 1310 ± 170 
R/LSL-SE 1293 ± 20 1297 ± 20 
R/T20-GMO 1150 ± 14 1073 ± 50 
R/LSL-DSL 1030 ± 40 1013 ± 10 
R/LEC 1153 ± 30 1037 ± 70 
 
 
The apparent permeability of nanoencapsulated resveratrol has been 
calculated plotting the cumulative amount transported (Q) versus time and 
extrapolating the linear appearance rate (∆Q/∆t) of resveratrol on the 
receiver side. It must be used the linear part of the graph to determine ∆Q/∆t 
and ignore any possible lag time and plateau regions that may exist. A lag 
phase in the beginning of the experiment may be caused by loading of the 
compound into the cells. This phenomenon may be significant for a 
compound that has high cellular uptake. A late plateau region may be caused 
by a significant decrease in the donor concentration of the compound, due to 
the fact that a large amount has been transported to the receiver side (Gao et 
al., 2001). 
The apparent permeability of most compounds falls in a range of 1×10-7 
to 1×10-5 cm/sec. A poorly transported compound, such as mannitol, usually 
exhibits a low Papp value of 1×10
-7 cm/sec. In contrast, a well-transported 
compound, such as testosterone, has a Papp value of 1×10
-5 cm/sec. An 
“average” compound will have a Papp value of 1×10
-6 cm/sec (Gao et al., 
2001). Figure VI.4 shows that for all the formulations tested the Papp value 
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falls in the range indicated. In particular, R/LSL-SE shows the higher Papp 
value and can be considered a very good formulation to increase the 
transport of resveratrol. In particular, it has been observed as expected that 
the apparent permeability decreases with the increase of the mean droplet 
diameters. On the other side, the unencapsulated resveratrol shows a Papp 
value higher than that of the nanoencapsulated resveratrol. This behaviour 
can be explained in terms of the different matrices used: the unencapsulated 
resveratrol was dissolved in a organic solvent (DMSO) and the 
nanoencapsulated resveratrol was entrapped in a aqueous system (O/W 
nanoemulsions). For the permeability test across Caco-2 cell monolayers it 
has not been used an aqueous system to dissolve the unencapsulated 
resveratrol because the solubility of resveratrol in water is very low. 
 
















128 nm 212 nm
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Figure VI.4 The Apparent permeability coefficient, Papp, of unencapsulated 
resveratrol (R/DMSO) and encapsulated resveratrol into different 
nanoemulsion-based delivery systems. 
 
The low Papp values obtained for the nanoemulsions with bigger particle 
sizes (R/LSL-DSL and R/LEC) can be explained in terms of cellular uptake 
(Figure VI.5). While smaller particle sizes can favour the permeability, 
bigger droplets can be entrapped into the Caco-2 cells increasing the cellular 
uptake and reducing the permeability. 
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Figure VI.5 The cellular uptake of unencapsulated resveratrol (R/DMSO) 




VI.3.3 In vitro release of nanoencapsulated resveratrol 
Nanometric size delivery systems offer considerable advantages 
especially in the control of the release rate of resveratrol, as shown in Figure 
VI.6, where the in vitro release of resveratrol encapsulated in the different 
nanoemulsions is reported in comparison with unencapsulated resveratrol. 
For the unencapsulated resveratrol the release occurs rapidly, reaching the 
maximum concentration of 45% after 3 h. When resveratrol is encapsulated 
in nanoemulsions a more sustained release was obtained, with different 
maximum concentrations of resveratrol being released. In particular, the 
nanoemulsions R/LSL-SE and R/LSL-DSL seem to be the best delivery 
systems for a sustained release, reaching a maximum concentration of 80% 
of the bioactive released after 24 h, in comparison with the other two 
formulations, which show a maximum concentration of resveratrol released 
only of 60% after 24 h.  


































Figure VI.6 Comparison of cumulative release into aqueous medium from 




At the end of the in vitro release test, the mass balance between the 
resveratrol released and the compound still present in the dialysis bag was 
closed considering the aliquot of resveratrol chemical degraded during the 
test (Figure VI.7). On one side, when resveratrol was diluted in a water 
solution, 47% of compound was quickly released and the remaining 52% 
was degraded, being not protected from the interaction with external agent 
(O2, temperature and light). On the other side, the nanoencapsulation 
improves the release and also protects resveratrol from degradation, reducing 
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Figure VI.7 The concentration of resveratrol released, in dialysis bag and 




Resveratrol, such as other bioactive compounds, has different therapeutic 
properties, whose exploitation is severely limited by its low bioavailability 
and rapid metabolism, because of poor solubility in water. For this reason, 
the use of nanoemulsion-based delivery systems seems to be ideal for 
increasing the bioavailability, protecting the bioactive compound during 
digestion and favouring a sustained release to reach in its active form the 
target sites. 
In particular, in this section has been demonstrated that resveratrol 
encapsulated into O/W nanoemulsions, produced only with natural and food-
grade ingredients, was not metabolized during in vitro gastric and intestinal 
digestion. Moreover, the formulations with smaller mean droplet diameters 
(below 200 nm) remain physically stable during the digestion process, 
allowing the resveratrol to reach the intestinal wall entrapped in the lipid 
droplets. These formulations, having subcellular diameters, show also higher 
apparent permeability coefficients in comparison with the other formulations 
(R/LSL-DSL and R/LEC), which, having bigger mean droplet diameters, 
remain uptaken into the cells.  
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Furthermore, lecithin-based nanoemulsions improve the transport through 
the cell monolayer, enhancing the passive transport mechanism due to their 
structure similar to the phospholipid bilayers of the cellular membrane. 
Finally, the nanoencapsulation favors the sustained release of the 
bioactive compound, avoiding an undesired instantaneous drug release 











This chapter reports the results related to the antioxidant activity of 
encapsulated bioactive compounds, measured with two different chemical 
assays (FRAP and ORAC) and a cellular antioxidant assay (CAA). The 
research was conducted at the Guelph Food Research Centre, Agriculture 





Reactive oxygen species (ROS) are an entire class of highly reactive 
molecules derived from the metabolism of oxygen, which are often 
generated as by-products of biological reactions. In vivo, these species can 
play a positive role in cell physiology, but also damage the cell membranes 
and DNA, inducing the oxidation that causes membrane lipid peroxidation, 
decreased membrane fluidity and other DNA mutations, that may lead to 
cancer and degenerative diseases (Finkel and Holbrook, 2000). 
Antioxidants are chemical substances that reduce or prevent oxidation. 
Many studies have shown that phenolic compounds display antioxidant 
activity as a result of their capacity to scavenge free radicals (Seyoum et al., 
2006) or to chelate metal ions, preventing radical formation (Al-Azzawie 
and Alhamdani, 2006). Recently, polyphenols are receiving increasing 
interest as functional food ingredients or nutraceutical compounds because 
of their health beneficial properties, such as the antioxidant and reducing 
activity, as well as the capability of protecting cell constituents against 
oxidative damage and, therefore, limiting the risk of various degenerative 
diseases associated to oxidative stress (D'Archivio et al., 2007, Scalbert and 
Williamson, 2000).  
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The growing interest in the physiological benefits of natural antioxidants 
has been matched by acceleration in the development of analytical and 
biological methodologies for measurement of the antioxidant potential of 
these compounds. Several in vitro studies have been conducted to evaluate 
the total antioxidant capacity of food products. So far, however, there is no 
official standardized method, and therefore it is recommended that each 
evaluation should be made with various oxidation conditions and different 
methods of measurement (Frankel and Meyer, 2000). 
The methods most commonly used to determine the total antioxidant 
capacity differ in terms of their assay principles and experimental 
conditions: assays based on a single electron transfer reaction, monitored 
through a change in colour as the oxidant is reduced, and assays based on a 
hydrogen atom transfer reaction, where the antioxidant and the substrate 
(probe) compete for free radicals (Huang et al., 2005).  
Electron transfer reaction assays include the Trolox equivalent 
antioxidant capacity (TEAC or ABTS) assay, the ferric reducing ability of 
plasma (FRAP) assay, and the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical 
scavenging capacity assay. On the other side, hydrogen atom transfer 
reaction assays include the total peroxyl radical-trapping antioxidant 
parameter (TRAP) assay, and the oxygen radical absorbance capacity 
(ORAC) assay (Huang et al., 2005, Prior et al., 2005).  
Among all these assays, ABTS, DPPH and ORAC are the most widely 
used. However, the ORAC assay is considered more relevant because it uses 
a biologically relevant radical source (Prior et al., 2003). Moreover, a major 
advantage of ORAC is that the method is automated and largely 
standardized; hence, values can be easily compared across laboratories.  
Despite wide usage of these chemical antioxidant activity assays, their 
ability to predict in vivo activity is limited, because none of them take into 
account the bioavailability, uptake, and metabolism of the antioxidant 
compounds (Wolfe and Liu, 2007). Biological systems are much more 
complex than the simple chemical mixtures employed. The best antioxidant 
activity measurements are from animal models and human studies; however, 
these are expensive and time-consuming and not suitable for initial 
antioxidant screening of foods and dietary supplements (Liu and Finley, 
2005). Cell culture models provide an approach that is cost-effective, 
relatively fast, and address some issues of uptake and metabolism. 
Therefore, Wolfe and Liu developed a cell-based antioxidant activity 
assay to screen foods, phytochemicals and dietary supplements for potential 
biological activity (Wolfe and Liu, 2007). 
The aim of this section was to evaluate the effect of nanometric delivery 
systems on the antioxidant activity of encapsulated polyphenols, comparing 
two chemical assays, FRAP and ORAC, with a cellular antioxidant activity 
assay. 
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VII.2 Materials and methods 
VII.2.1 Chemicals 
Ascorbic acid, 2,4,6-tripyridyl-s-triazine (TPTZ), fluorescein, dimethyl 
sulfoxide (DMSO) and 2’,7’-dichlorofluorescein diacetate (DCFH-DA) were 
from Sigma Chemical Co. (St. Louis, MO), iron(III) chloride hexahydrate 
and hydrogen peroxide solution at 30% w/w were obtained from Sigma-
Aldrich (Oakville, ON, Canada), 6-hydroxy-2,5,7,8-tetramethylchromane-2-
carboxylic acid (Trolox) and 2,2’-azobis (2-methylpropionamidine) 
dihydrochloride (AAPH) were purchased from Aldrich Chemical Co. 
(Milwaukee, WI). 
Caco-2 cells were obtained from the American Type Culture Collection 
(ATCC) (Rockville, MD). Dulbecco’s Modified Eagle Medium (DMEM), 
Hanks’ Balanced Salt Solution (HBSS) and antibiotic-antimycotic (100x) 
were purchased from Gibco Life Technologies (Grand Island, NY). Fetal 
bovine serum (FBS) was obtained from Thermo Scientific HyClone (Logan, 
UT). 
 
VII.2.2 Chemical antioxidant activity 
The antioxidant activity of encapsulated compounds was determined in 
comparison with unencapsulated compound diluted in DMSO or in methanol 
by using the Ferric Reducing Antioxidant Power assay (FRAP) and the 
Oxygen Radical Absorbance Capacity assay (ORAC). 
The FRAP assay was conducted according to a previously reported 
procedure (Tsao et al., 2005) with minor modifications. Reagents included 
300 mM acetate buffer, pH 3.6 (3.1 g C2H3NaO2·3H2O and 16 ml C2H4O2), 
10 mM TPTZ in 40 mM HCl and 20 mM FeCl3·6H2O. Working FRAP 
reagent was prepared by mixing the reagents in a ratio 10:1:1 (acetate 
buffer:TPTZ solution:FeCl3·6H2O solution). Aqueous solutions of known L-
(+)-ascorbic acid concentration, in the range of 10-1000 µM, were used for 
generating the calibration curve. FRAP values were expressed as µM 
ascorbic acid equivalent by using the standard curve calculated for each 
assay. 
Nanoencapsulated compound (30 µl) was allowed to react with 900 µl of 
the working FRAP reagent for 30 min at room temperature. The sample was 
then centrifuged at 20000 xg for 3 min at 25 °C and 300 µl of the 
supernatant was used for analysis. Absorbance readings were taken using a 
visible-UV microplate reader (Power Wave XS2, Bio-Tek Instruments Inc., 
Winooski, VT, USA) set at 593 nm. A blank control was included at each 
time the assay also conducted for the samples and the standard. The blanks 
of the different delivery systems were the corresponding nanoemulsions 
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without the bioactive compound. All the reaction mixtures were prepared in 
triplicate. 
The ORAC assay was conducted according to a previously reported 
method (Davalos et al., 2004) with some modifications. Analyses were 
conducted in 75 mM phosphate buffer (pH 7.4) and the final reaction 
mixture was 200 µl. Nanoemulsions (25 µl) containing the bioactive and 
fluorescein (150 µl; 86.8 nM, final concentration) solutions were placed in 
96-well plate and preincubated for 30 min at 37 °C in a fluorescence 
microplate reader (FLx800, Bio-Tek Instruments Inc., Winooski, VT, USA). 
The reaction was initiated by the addition of 25 µl of AAPH (153 mM final 
concentration) reagent followed by shaking at maximum intensity for 10 s. 
The fluorescence was then monitored kinetically with data taken every 
minute for 1 h. The 96-well plate was also loaded with the blank controls 
including phosphate buffer with DMSO and different nanoemulsions without 
the bioactive compound, as well as the standard solutions of Trolox (6.25, 
12.5, 25, 50, 100 µM). All the reaction mixtures were prepared in triplicate. 
The area under the fluorescence decay curve corresponding to a sample (net 
AUC) was calculated by subtracting the AUC corresponding to a blank. 
ORAC values were expressed as Trolox equivalents by using the standard 
curve calculated for each assay. 
 
VII.2.3 Cellular antioxidant activity 
Caco-2 cells were grown in growth medium (DMEM supplemented with 
10% FBS, 1% antibiotic-antimycotic) and were maintained at 37 °C in an 
incubator with 5% CO2. The medium was changed every 2 days. Cells used 
in this study were at passage 25-30. 
Caco-2 cells were seeded at a density of 4 x 104/well on a 96-well 
microplate (collagen treated black plate) in 100 µL of growth medium/well 
and incubated for 15 days at 37 °C and 5% CO2. The growth medium was 
then removed and the cells were washed with 100 µl of treatment medium 
(HBSS+10% FBS). Triplicate wells were treated with 100 µl of encapsulated 
bioactive compound suspended in 100 µl of treatment medium and incubated 
for 1 h at 37 °C. The wells were washed with 100 µl of treatment medium. 
Then the cells were treated with 200 µl of 100 µM DCFH-DA in treatment 
medium and incubated for 30 min at 37 °C. The wells were washed with 
100 µl of treatment medium. Then 50 µM H2O2 was applied to the cells in 
100 µl of treatment medium and the 96-well microplate was placed into a 
fluorescence microplate reader (FLx800, Bio-Tek Instruments Inc., 
Winooski, VT, USA) at 37 °C. Emission at 528 nm was measured with 
excitation at 485 nm every minute for 1 h. Each plate included triplicate 
control, blank and sample background wells: control wells contained cells 
treated with DCFH-DA and oxidant, blank wells contained cells treated with 
DCFH-DA without oxidant, sample background wells contained cells treated 
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with nanoemulsions and DCFH-DA without oxidant. The area under the 
curve of fluorescence versus time was integrated to calculate the CAA value, 




















where ∫ SA  is the integrated area from the sample curve; ∫ BA  is the 
integrated area from the blank curve or sample background curve and ∫CA  is 
the integrated area from the control curve. 
 
VII.3 Results 
VII.3.1 Antioxidant activity of nanoencapsulated resveratrol 
Resveratrol was encapsulated into different peanut oil-based 
nanoemulsions, whose composition and mean droplet diameter is reported in 
Table VI.1, using a combination of hydrophilic and lipophilic emulsifiers. 
Moreover, the physicochemical stability of encapsulated resveratrol during 
in vitro digestion has been evaluated and described in section VI.3.1.  
The retention of the antioxidant activity of nanoencapsulated resveratrol 
during in vitro digestion was preliminary assessed by two chemical assays, 
namely FRAP and ORAC, in comparison with the unencapsulated 
resveratrol diluted in DMSO (Figure VII.1).  
It is important to investigate the antioxidant activity of resveratrol also in 
non-digested delivery systems, because one of the advantages of the 
nanometric delivery systems is the acceleration of the transport to the 
intestinal epithelial cells, due to the high dispersibility and hence diffusivity 
through the intestinal aqueous boundary layer (Acosta, 2009), making 
unnecessary the stage of bile emulsification. 
The results of both FRAP and ORAC analyses, which were very 
consistent with each other, showed that the nanoencapsulated resveratrol 
controls retained an antioxidant activity comparable to the unencapsulated 
form, with higher values being observed for R/T20-GMO and R/LSL-SE. 
In vitro digestion caused for all formulations a reduction of the 
antioxidant activity, which was particularly evident in the gastric step for 
R/LSL-DSL and R/LEC formulations. This result can be explained with the 
increase of the mean droplet sizes observed after gastric digestion (Figure 
VI.1), which was responsible for a significant reduction of the surface area 
(of two orders of magnitude), and consequently making resveratrol 
unavailable through the oil/water interfaces. 
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Figure VII.1 Antioxidant activity of nanoemulsions containing resveratrol 
by FRAP assay (a) and ORAC assay (b) before and after the in vitro 
digestion process, in comparison with resveratrol dissolved in DMSO 
(R/DMSO). 
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The antioxidant activity of the control (undigested nanocapsules) and 
digested samples was also assessed using a cell-based antioxidant assay 
system. Caco-2 cells were seeded on a 96-well microplate and the CAA 
assay was performed 15 days after seeding, in order to measure the 
antioxidant activity on mature differentiated intestinal cells with fully 
developed brush border enzymes and transporters.  
Caco-2 cells were pre-treated with nanoencapsulated resveratrol, which 
due to the nanometric size of the capsules passed through the membrane to 
enter the cell. In this study Caco-2 cells were first pre-treated with the 
nanoencapsulated resveratrol, followed by DCFH-DA treatment, rather than 
pretreating the cells with the DCFH-DA and the antioxidant together, as 
suggested in a previous work (Wolfe and Liu, 2007). Preliminary results (not 
reported) showed that this modification eliminates the possibility of having 
the antioxidant effect outside the cells in the medium, and restricts the 
measured CAA solely to the interaction of intracellular resveratrol with 
DCFH. The cells were subsequently treated with H2O2, instead of a synthetic 
radical (Wolfe and Liu, 2007). H2O2 is a biologically relevant reactive 
oxygen species and is readily diffused into the cells. Once inside the cells, 
H2O2 oxidizes the intracellular DCFH to the fluorescent DCF. The 
nanoencapsulated resveratrol exerts its cellular antioxidant activity by 
preventing the oxidation of DCFH and reduce the formation of DCF. 
Figure VII.2 shows the cellular antioxidant activity of the nanoemulsions 
containing resveratrol in comparison with the unencapsulated compound and 
the variation of the CAA during the in vitro digestion process. All 
formulations exhibited excellent antioxidant activity on Caco-2 cells, which, 
for R/LSL-SE, R/LEC and R/LSL-DSL was greater than 80% and 
comparable to the CAA of resveratrol dissolved in DMSO, suggesting that 
the nanometric size of the nanocapsules may improve the uptake of the 
antioxidant compound into the cells. Moreover, R/LEC and R/LSL-DSL 
showed a cellular antioxidant activity higher than expected considering the 
FRAP and ORAC results (Figure VII.1), which reported lower antioxidant 
activity for these formulations in comparison to the others due to a better 
resveratrol entrapment in the lipid phase and consequent reduction of the 
extent of its localization at the oil/water interface, as well as of the 
interaction with the oxidant reagents. The better entrapment of resveratrol 
can be likely attributed to the formation of reversed micelles of the more 
lipophilic emulsifier (i.e. glycerol monooleate, soy lecithin) within the lipid 
droplets stabilized by the more hydrophilic emulsifier (i.e. Tween 20, 
defatted soy lecithin, sugar ester). 
The digestion process did not significantly affect the cellular antioxidant 
activity of encapsulated resveratrol, suggesting it being stable after gastric 
and intestinal digestion, and available to be absorbed by the cells in its active 
antioxidant form. 
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Figure VII.2 Cellular antioxidant activity, CAA unit, of resveratrol-
encapsulated nanoemulsions before and after in vitro digestion. 
It must be highlighted that, despite very surface active bile salts may have 
displaced some emulsifier molecules at the O/W interface, no significant 
changes were observed in the efficiency in delivering resveratrol to the cells 
in antioxidant activity measurements conducted before and after the gastric 
and intestinal digestion processes, probably thanks to the dual-emulsifier 
formulation that improved protection of resveratrol and its transport through 
the biological membranes. 
Moreover, the most physically and chemically stable formulations also 
exhibited the highest chemical and cellular antioxidant activity, which was 
comparable to the undigested and unencapsulated resveratrol dissolved in 
DMSO.  
 
VII.3.2 Antioxidant activity of encapsulated grape marc polyphenols 
The antioxidant activity of grape marc polyphenols encapsulated in the 
O/W nanoemulsion-based delivery systems, whose compositions and mean 
droplet diameters have been reported in Table V.2, was measured in 
comparison to the unencapsulated grape marc extracts using both a 
chemical-based and a biological-based approach, in order to evaluate the 
capability of the delivery systems to efficiently protect the bioactive 
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compounds against degradation and to transport them to the intestinal 
epithelium in active form. 
Figure VII.3 reports the chemical antioxidant activity of the encapsulated 
grape marc polyphenols in comparison with the unencapsulated compounds, 
according to two chemical assays, based on different mechanisms of 
antioxidant activity against free radicals: by single electron transfer reaction 
(FRAP assay) or by hydrogen atom transfer reaction (ORAC assay).  
In fact, not always the ORAC and FRAP measurements of antioxidant 
activity correlate well with each other, with the observed discrepancies 
mainly depending on the nature of the bioactive compounds, as observed in 
the characterization of more than 900 vegetable extracts (Ou et al., 2002). 
The combined use of ORAC and FRAP assays can therefore provide more 
complete details on the dominant mechanisms of antioxidant activity of the 
tested extracts, both in encapsulated and unencapsulated form. 
The results of the FRAP assay always showed a lower antioxidant 
activity of the encapsulated extracts in comparison with the unencapsulated 
compounds (Figure VII.3a). In contrast, the antioxidant activity of the 
encapsulated grape marc polyphenols measured with ORAC assay resulted 
comparable or higher than the antioxidant activity of unencapsulated 
compounds, except when the polyphenols were encapsulated in PO/GMO-
DSL (Figure VII.3b), because of the already discussed issues of 
physicochemical stability of this formulation (Table V.3, Figure V.5c, Figure 
V.6c).  
In the FRAP assay, the measure of antioxidant activity corresponds to a 
measure the capability of reducing the complex Fe(TPTZ)2(III) to 
Fe(TPTZ)2(II) (Benzie and Strain, 1996). In order to obtain an accurate 
measurement, the following conditions must be satisfied: 1) under the 
reaction conditions, Fe(TPTZ)2(III) should only interact with and hence be 
reduced by the antioxidant compounds object of measurement (other 
compounds with reducing activity might interfere with the measurement); 2) 
the reaction should be fast enough to get to completion within the assay time 
(30 min); 3) the oxidized antioxidant should have no absorption at 593 nm, 
where the absorption of Fe(TPTZ)2(II) is located (Ou et al., 2002). 
Probably, the reaction rate of reduction of a ferric tripyridyltriazine 
complex, Fe(TPTZ)2(III), to the ferrous tripyridyltriazine, Fe(TPTZ)2(II), is 
faster for unencapsulated compounds (higher FRAP values) than for the 
encapsulated ones, which are embedded by the lipid phase and prevented 
from an optimal contact with Fe(III) complex. 
The ORAC assay reflects instead the peroxyl radical scavenging activity, 
which is more relevant to the biological antioxidant activity. In fact, it was 
clearly demonstrated that hydrogen atom transfer reaction concurs with 
electron transfer reaction and plays a dominant role in biological redox 
reactions (Wright et al., 2001), with the consequence that the ORAC 
Chapter VII   
112 
principle is closely related to biological functions of chain-breaking 
antioxidants. 
The comparable ORAC values for the antioxidant activity of 
encapsulated and unencapsulated polyphenols suggest their being similarly 
available for the peroxyl radical scavenging activity, which is apparently not 
affected by their inclusion in the lipid phases. 
The total measured antioxidant activity resulting from FRAP assay is of 
about 3800 µM of ascorbic acid equivalents in the methanolic solution and 
3000 µM in the prepared nanoemulsions (Figure VII.3a), corresponding to 
about 0.5 gascorbic acid equivalents/L. This antioxidant activity is comparable to that 
of a commercial orange juice, where the average concentration of ascorbic 
acid is about 0.3 g/L (Pisoschi et al., 2008). The equivalent concentration of 



























































Figure VII.3 Chemical antioxidant activity using (a) FRAP assay and (b) 
ORAC assay of grape marc polyphenols nanoencapsulated into: ( ) 
SO/GMO-DSL, ( ) SO/LSL-DSL, ( ) PO/GMO-DSL and ( ) PO/LSL-
DSL, in comparison with ( ) unencapsulated grape marc polyphenols 
dissolved in methanol. Different letters indicate statistically (Student t test) 
significant differences (p<0.05). 
 
To overcome the limitations of biological significance of the FRAP and 
ORAC chemical assays, such as the redox reaction of a ferric/ferrous 
complex, and the use of pH values quite far from the physiological pH 
(FRAP), or the measurement of the antioxidant activity against peroxyl 
radicals, not considering other biologically relevant reactive oxygen species 
(ORAC), a biological-based approach was used to take into account also the 
bioavailability, uptake, and metabolism of the antioxidant compounds. 
Remarkably, all the tested formulations exhibited a CAA value 
significantly higher than the unencapsulated grape marc polyphenols (Figure 
VII.4). This can be explained in terms of an increased transport through the 
Caco-2 cell membrane thanks to the nanometric size of the delivery systems, 
comprised between 176 and 220 nm. The PO/GMO-DSL system, despite its 
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large mean droplet size (1330 nm), also showed very high CAA value, 
comparable to the other nanometric delivery systems, probably due to its 
being composed of aggregated nanoparticles, which are able to adhere to the 
cell walls and possibly facilitate the penetration of the active compounds 
inside the cells. 
The formulation of the delivery systems based with soy lecithin, which is 
a mixture of phospholipids similar to the phospholipid bilayer structure of 
the cellular membrane, seems to significantly contribute to their absorption 
into the cells, favouring the entrapment in the microvilli and the consequent 





















Figure VII.4 Cellular antioxidant activity (CAA unit) of grape marc 
polyphenols nanoencapsulated into: ( ) SO/GMO-DSL, ( ) SO/LSL-DSL, 
( ) PO/GMO-DSL and ( ) PO/LSL-DSL, in comparison with ( ) 
unencapsulated grape marc polyphenols dissolved in methanol. Different 
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VII.3.3 Antioxidant activity of encapsulated curcumin 
Curcumin was encapsulated in solid lipid particles of micrometric sizes, 
using stearic acid as lipid phase and a combination of soy lecithin and sugar 
esters (C/LSL-SE) or lipophilic and defatted soy lecithins (C/LSL-DSL) as 
emulsifiers, as described in section V.3. 
The influence of the delivery system on the antioxidant activity of 
curcumin was evaluated using a chemical-based approach (FRAP and 
ORAC assays) and a biological-based approach, based on the measurement 
of the cellular antioxidant activity on Caco-2 cells, to overcome the 
limitations of the chemical assays as previously described.  
Figure VII.5a shows a very low antioxidant activity of encapsulated 
curcumin in comparison with unencapsulated form using FRAP assay, 
probably due to the presence of a solid lipid matrix which avoids the 
interaction of the encapsulated curcumin with FRAP reagents. On the 
contrary, when an ORAC assay is used, an higher antioxidant activity for the 
encapsulated curcumin was measured (Figure VII.5b). Moreover, the 
lecithin/sugar ester-based formulation shows an antioxidant activity 
comparable to the unencapsulated curcumin. 
As already shown for the other nanoencapsulated polyphenols, the trend 
of the antioxidant activity using ORAC assay is similar to that obtained from 
the results of a cellular antioxidant activity assay, confirming that ORAC 
assay better simulates the biological processes. 
In particular, a cellular antioxidant activity (> 60%) of curcumin 
encapsulated in lecithin/sugar°ester-based emulsion and comparable with the 
unencapsulated compound was observed using a biological approach. This 
latter behaviour is explained by the ability of the delivery system to improve 
the cellular uptake of the encapsulated bioactive compound. 
 Antioxidant activity of encapsulated compounds 
 115



































































Figure VII.5 Comparison of the antioxidant activity of encapsulated 
curcumin into solid lipid particles, produced by HPH using as emulsifiers 
lipophilic soy lecithin and sugar ester (C/LSL-SE) or lipophilic and defatted 
soy lecithin (C/LSL-DSL), with unencapsulated curcumin diluted in DMSO, 
using (a) FRAP assay, (b) ORAC assay and (c) Cellular Antioxidant Activity 
assay. 
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VII.4 Conclusions 
For the first time, the effect of nanoemulsion-based delivery systems on 
the antioxidant activity of encapsulated bioactive has been investigated.  
The antioxidant activity of nanoencapsulated compounds has been 
measured using two chemical assays, FRAP and ORAC, based on different 
mechanisms. Moreover, an ex vivo antioxidant assay has been used to 
overcome the limitations of the chemical assays. 
For this purpose, a novel method was proposed and tested for measuring 
the cellular antioxidant activity (CAA) exclusively due to the bioactive 
absorbed into the cells. In our modified method Caco-2 cells are pre-treated 
with the nanoencapsulated polyphenols first, followed by probe treatment. 
This modification eliminates the possibility of measuring any antioxidant 
effect outside the cells in the medium, and restricts the measured cellular 
antioxidant activity solely to the interaction of intracellular polyphenols with 
fluorescent probe.  
The FRAP and ORAC assays showed that the antioxidant compounds, 
when encapsulated, are as available as unencapsulated polyphenols in 
scavenging the peroxyl radicals (ORAC), but are less available in reducing 
the ferric tripyridyltriazine complexes (FRAP). Remarkably, the cellular 
antioxidant activity was significantly higher for the encapsulated bioactive 
compounds than for the unencapsulated ones, suggesting the fundamental 







Antimicrobial activity of 





In this chapter is highlighted how the encapsulation on nanometric scale 
of essential oils (terpene mixture and D-limonene) represents a viable 
method to enhance the antimicrobial activity and minimize the alteration of 
the quality attributes of the product where the antimicrobials are 
incorporated.  
The effect of the nanodelivery systems on the antimicrobial activity of 
essential oils was evaluated by determining the minimum inhibitory 
concentration (MIC) and minimum bactericidal concentration (MBC) for 
three different classes of microorganisms (Lactobacillus delbrueckii, 
Saccharomyces cerevisiae, Escherichia coli). Moreover, the different 
mechanisms of inactivation of encapsulated antimicrobials were investigated 
by fluorescence microscopy. 
Finally, the incorporation of the most efficient antimicrobial 
nanocapsules was tested in real systems, such as fruit juices, inoculated with 




VIII.1 Essential oils as natural antimicrobials 
Nowadays, the approaches that can be adopted in food preservation 
include: a) handling and aseptic packaging, to prevent the penetration of 
microorganisms in the food, b) the mechanical removal of microorganisms 
by washing or filtration, c) destruction of microorganisms by heat, pressure, 
radiation, electric or magnetic fields as well as by chemical sanitization, and 
finally d) the inhibition of pathogens through environmental control.  
The latter approach has benefited most from the recent developments in 
nanotechnology. Inhibition of microbial growth through environmental 
control is achieved through the addition of chemical compounds 
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(antimicrobial preservatives) with an inhibitory or bactericidal/fungicide 
activity. In the last years, natural antimicrobials have attracted considerable 
attention due to the increased consumer awareness on the aspects of food 
quality and safety. 
Similar to most bioactive compounds (aromas, antioxidants and 
nutraceuticals, etc.), antimicrobial agents are chemically reactive species, 
which can cause considerable problems when they are embedded into a 
complex food system. For antimicrobial compounds, this translates into the 
need to use concentrations which are high enough to inhibit microbial 
growth within the limits imposed by food regulations, but at the same time 
minimally alter the qualitative properties of the product (Weiss et al., 2009).  
Nanoencapsulation of antimicrobial compounds represents a viable and 
efficient approach to increasing the concentration of the bioactive 
compounds in food areas where microorganisms are preferably located, for 
example water-rich phases or liquid-solid interfaces (Weiss et al., 2009). 
A significantly large part of current literature on the encapsulation of 
essential oils deals with micrometric size capsules, which are used for the 
protection of the active compounds against those environmental factors, 
which contribute to their deterioration (e.g. oxygen, light, moisture, pH), as 
well as enhance their antimicrobial activity by increasing the mass transfer 
efficiency. 
For example, solid lipid microparticles (delivery systems where the lipid 
phase is in a solid state) have been proposed for the encapsulation of juniper 
oil, in order to reduce the volatility of the antimicrobial agent, loaded inside 
the lipidic structure (Gavini et al., 2005).  
Several authors have proposed the use of biopolymers for the formulation 
of microparticles in the encapsulation of essential oils, such as chitosan, 
whose use for oral cavity care was recently reviewed (Pedro et al., 2009), as 
well as Ca-alginate hydrogels (Wang et al., 2009). In particular, the 
entrapment of carvacrol in microcapsules made of Ca-alginate hydrogel, 
tested for oral administration to pigs, resulted in the reduced absorption of 
carvacrol in the upper gastrointestinal tract, therefore retaining its potential 
antibacterial activity for the small intestine in controlling enteric diseases 
(Wang et al., 2009).  
In food applications, spray drying has been frequently investigated for the 
microencaspulation of antimicrobial agents. For example, milk protein-based 
matrices exhibited excellent properties for coating the essential oils of 
oregano as well as the aroma extracts of citronella and sweet marjoram 
(Baranauskiene et al., 2006). The use of a blend of Arabic gum, maltodextrin 
and modified starch as wall materials offered a good protection in 
encapsulating cardamom oleoresin against degradation (Krishnan et al., 
2005). 
While microcapsules may guarantee excellent protection of essential oils 
against degradation or evaporation, they in general do not affect 
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antimicrobial activity. In contrast, nanometric size delivery systems, due to 
the subcellular size, may increase the passive cellular absorption 
mechanisms, thus reducing mass transfer resistances and increasing 
antimicrobial activity. 
Proof of this concept was given by the incorporation into liposomal 
delivery systems of Origanum dictamnus L. (Liolios et al., 2009), Citrus 
limon extracts (Gortzi et al., 2007) and Artemisia arborescens L. essential oil 
(Sinico et al., 2005): all these systems resulted in the improvement of the 
antimicrobial activity of encapsulated compounds. 
The encapsulation of eugenol and carvacrol into nanometric surfactant 
micelles (microemulsions), also resulted in enhanced antimicrobial activity, 
which has been attributed to the increased solubility of essential oil 
components in the aqueous phase due to the presence of surfactants as well 
as to the improved interactions of antimicrobials with microorganisms 
(Gaysinsky et al., 2005). Nevertheless, when the encapsulated eugenol was 
added to milk, it resulted to be less or as inhibitory as unencapsulated 
eugenol against target pathogens (Gaysinsky et al., 2007). Moreover, the 
appreciable water solubility of eugenol appeared to promote a rapid 
diffusional mass transport of the essential oil molecules from 
microemulsions to the milk macroemulsions, especially for systems 
composed of phytophenols above a critical loading ratio (Gaysinsky et al., 
2007).  
In spite of the fact that nanoemulsions are potentially very promising 
antimicrobial carrier systems, thanks to the easy industrial scalability of the 
production process by high pressure homogenization, up to now very little 
systematic research has been carried out to evaluate their use in 
encapsulating antimicrobial essential oils (Weiss et al., 2009).  
The results of current literature highlight that very often antimicrobial 
activity is reduced by nanoencapsulation. For example, the antimicrobial 
activity of chitosan in soybean lecithin or Polaxamer-based nanoemulsions 
resulted to be slightly lower than the activity of free chitosan (Jumaa et al., 
2002), with it being most likely due to the adsorption of positively charged 
chitosan onto the surface of the emulsion droplets, thereby decreasing the 
concentration of chitosan in the aqueous phase as well as its overall activity. 
Similarly, the encapsulation of different preservatives (such as 
benzalkonium chloride, methyl and propyl parabens as well as chlorocresol) 
into submicron emulsions induced instability phenomena and in some cases 
insufficient antimicrobial activity (Sznitowska et al., 2002). 
In comparison with unencapsulated active compounds, corn-oil-in-water 
emulsions loaded with eugenol exhibited lower activity, inhibiting E. coli 
strains, but failed to inhibit the growth of L. monocytogenes strains (Weiss et 
al., 2009). When using Tween 20 and lauric arginate as emulsifiers, 
nanoemulsions containing eugenol displayed similar antimicrobial activities 
to unencapsulated eugenol against both microorganisms (Weiss et al., 2009). 
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The aforementioned studies show the need for more detailed research on 
the formulation, design and application of nanoemulsions as antimicrobial 
delivery systems, in order to maximize the antimicrobial efficacy of the 
encapsulated compounds. 
This section focuses on the nanoencapsulation in nanoemulsion-based 
delivery systems of two antimicrobial compounds, a terpenes mixture 
extracted from Melaleuca alternifolia and D-limonene. It deals with the 
issues of formulation and fabrication in order to retain and possibly enhance 
the antimicrobial activity of the encapsulated compounds. The most 
promising formulations in terms of antimicrobial activity are tested at 
different concentrations in fruit juices inoculated with Lactobacillus 
delbrueckii, which can be considered as one of the potential spoilage 
microorganisms of fruit juices, in order to evaluate the possible shelf-life 
extension against the alteration of the quality parameters of the juices. 
 
VIII.2 Materials and methods 
VIII.2.1 Materials 
The antimicrobial compounds tested were D-Limonene (Sigma-Aldrich, 
Germany) and a mixture of terpenes extracted from Melaleuca alternifolia 
(provided by Istituto Superiore della Sanità, Italy). In the emulsion 
fabrication, sunflower oil (Sagra, Italy) and palm oil (Sigma-Aldrich, 
Germany) were used as organic phases, while soy lecithin Solec Ip (a 
generous gift from Solae Italia s.r.l., Italy), Tween 20 and glycerol 
monooleate (Sigma-Aldrich, Germany), and CLEARGUM® CO 01 (a 
generous gift from Roquette, Italy) were used as emulsifying agents. 
 
VIII.2.2 Preparation of nanoemulsions 
The sunflower oil or essential oil-in-water nanoemulsions were prepared 
using a High Pressure Homogenization (HPH) technique. Primary emulsions 
were obtained by High Shear Homogenization (HSH), using an Ultra Turrax 
T25 (IKA Labortechnik, Jahnke und Kunkel, Germany) at 24000 rpm for 
5 min. The primary emulsions were then subjected to HPH by passing them 
through a high pressure homogenizer Nano DeBEE Electric Bench-top 
Laboratory (BEE International, USA) ten times at 350 MPa. When palm oil 
was used as a lipid phase, the antimicrobial agents were dissolved in the 
melted lipid and, in order to prevent recrystallisation, the temperature during 
processing was always kept about 5-10 °C above the lipid melting point. 
Crystallization of the lipid droplets was attained by rapid cooling of the hot 
nanoemulsions in an ice bath at the end of the HPH processing. 
Droplet size distribution of the nanoemulsions produced was determined 
by photon correlation spectroscopy at 25 °C (HPPS, Malvern Instruments, 
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UK). Each measurement was replicated twice, with the means and the 
standard deviations being calculated. 
 
VIII.2.3 Determination of MIC and MBC 
Experiments were carried out on three different microbial strains grown 
to the stationary phase in an aerated incubator (Haeraeus Instruments): 
Saccharomyces cerevisiae, Escherichia coli, Lactobacillus delbrueckii.  
S. cerevisiae yeast was grown in MRS broth (Oxoid, UK) at 32 °C for 
48 h, E. coli in Tryptone Soya broth (Oxoid, UK) at 30 °C for 18-24 h, 
L. delbrueckii in MRS broth (Oxoid, UK) at 32 °C for 48 h.  
The Minimum Inhibitory Concentration (MIC) of the antimicrobial 
agents was evaluated for the three microbial strains, for the following 
concentrations of antimicrobial agents in culture media: 25, 10, 5.0, 1.0 and 
0.1 g/L. The sample were inoculated with 100 µl of a microbial suspension 
(107 CFU/ml) and incubated for 24 h at 32 °C for S. cerevisiae and 
L. delbrueckii and at 30 °C for E. coli. The MIC value was determined as the 
lowest concentration of the antimicrobial agent that inhibited the visible 
growth of the test microorganism, evaluating the absorbance of the sample 
with a spectrophotometer (Jasco V-650) in the range of 590-600 nm.  
The Minimum Bactericidal Concentration (MBC) was also determined 
following MIC determination. A sample of 1 ml was collected from each 
tested sample and inoculated on sterile Plate count agar (Oxoid, UK) for 
E. coli and MRS agar (Oxoid, UK) for S. cerevisiae and L. delbrueckii. The 
plates were incubated at 37 °C for 24 h. The highest dilution that yielded a 
decrease in microbial concentration in comparison to the control sample was 
considered as MBC. Each measurement was replicated three times. 
 
VIII.2.4 Kinetics of inactivation 
The inactivation kinetics of three microorganisms (S. cerevisiae, 
L. delbrueckii and E. coli) in the presence of an encapsulated terpenes 
mixture were carried out on two levels of antimicrobial concentration (1.0 
and 2.5 g/L), in comparison to a control, where terpenes were replaced by 
sunflower oil. 
The microorganisms, centrifuged at 5000 rpm for 10 min at 4 °C, were 
resuspended in 100 ml of sterile distilled water in test tubes, with 
nanoemulsions being added to the desired final antimicrobial concentrations. 
The test tubes were then incubated at 32 °C for S. cerevisiae and 
L. delbrueckii and at 30 °C for E. coli. After 30 min for the antimicrobial 
concentration of 2.5 g/L and after 90 min and 24 h for the antimicrobial 
concentration of 1.0 g/L, the surviving cells were evaluated by a standard 
plate count method. In brief, 1 ml of each sample was used to prepare 
decimal dilutions, which were plated in duplicate with Plate Count agar for 
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E. coli and MRS agar for S. cerevisiae and L. delbrueckii. The plates were 
incubated at 30 °C for 24 h for E. coli and at 32 °C for 48 h for S. cerevisiae 
and L. delbrueckii.  
Kinetics experiments were carried out in duplicate. From the linear 
regression of the common logarithm of the survival fraction vs. the exposure 
time to the antimicrobials, the decimal reduction time D, defined according 












VIII.2.5 GC-MS analysis 
The composition of the terpenes mixture after homogenization (either 
HSH or HPH) was evaluated through a gas chromatography-mass 
spectrometry method (GC-MS). The terpenes mixture was extracted by 
adding 4 ml of dichloromethane to 500 µl of nanoemulsion, followed by 
three vortex agitations of 10 s each. The organic phase was recovered with a 
Pasteur pipette and anhydrous sodium sulphate was added to remove any 
traces of water. The extract was micro-filtered and placed for 15 min under a 
nitrogen flow in order to completely evaporate the solvent. 2 µl of the 
resulting terpenes were added to 2 ml of n-pentane and analyzed by Focus-
GC-DSQ (Thermo Finnigan) gascromatograph, equipped with a capillary 
column Rtx-5Sil MS (30 m, ID 0.25 mm, film thickness 0.25 µm; Restek), 
using helium as a carrier gas (1 ml/min). The column temperature was kept 
at 40 °C for 3 min and then increased by 3 °C/min to 280 °C. The mass 
selective detector was used in the electron ionisation mode, with the mass 
range between 35 and 500 being scanned. The mass spectra were compared 
to both the NIST Mass Spectral Library as well as an in-house library for 
peak identification. 
 
VIII.2.6 Fluorescence microscopy 
Fluorescence microscopy was used to visualize the transport of 
nanoencapsulated antimicrobials through the cell membrane into 
S. cerevisiae. The fluorescence microscope consisted of a Eclipse TE2000S 
inverted microscope (Nikon), equipped with a B-2A filter (Excitation Filter 
Wavelengths: 450-490 nm, Dichromatic Mirror Cut-on Wavelength: 
500 nm, Barrier Filter Wavelengths: 515 nm cut-on), fitted with a high-
pressure mercury burner as a light source. The images were acquired with a 
digital camera (DS-5M Digital Sight Camera System, Nikon), through a 20x 
lens (Nikon). 
 Antimicrobial activity of nanoencapsulated essential oils 
 123
Nile red (Sigma-Aldrich, Germany) was used as a fluorescent lipophilic 
stain. It excites at 485 nm, and emits at 525 nm. The Nile Red was dissolved 
in ethanol at a concentration of 1 mg/ml; a sample of 100 µl of this solution 
were added to 1 ml of nanoemulsion to stain the oil droplets. 100 µl of 
nanoemulsion with Nile Red were subsequently added to 1 ml of culture 
medium containing 108 cfu/ml of yeast cells in a stationary phase to a final 
antimicrobial concentration of 5.0 g/L. At a fixed time (1 min, 30 min, 1 h, 
2 h, 3 h, 24 h), a drop of the sample was mounted onto a glass slide, enclosed 
with a cover slip and observed. 
 
VIII.2.7 Shelf life of fruit juices 
The effect of the addition of the encapsulated antimicrobial on the 
microbiological stability of two fruit juices, orange juice (Tropicana Pure 
Premium PepsiCo, France) and pear juice (Yoga, Italy), was evaluated over 
time. The juices were inoculated with 103 cfu/ml of Lactobacillus 
delbrueckii. Different concentrations (10, 5.0 and 1.0 g/L) of terpenes 
nanoemulsions were tested under accelerated shelf life conditions at 32 °C. 
The concentration of microorganisms in each sample expressed in 
CFU/ml was evaluated over time by standard plate count method, as 
previously described. Moreover, the evolution of color, pH and °Brix of the 
fruit juices over storage time was also evaluated by Chroma Meter (CR-
200b, Minolta), pH-meter (Basic 20+, Crison) and Abbe Refractometer 
(Atago) respectively. 
The color was measured registering the following parameters: L 
(brightness), a (red-green component) and b (yellow-blue component). The 
global color difference (∆E) was calculated with the following equation: 
( ) ( ) ( )222 baLE ∆+∆+∆=∆  (VIII.2) 
The values provided were the average of three replicates. 
 
VIII.3 Results 
VIII.3.1 Mechanisms of inactivation of encapsulated essential oils 
Different formulations and fabrication methods were used to produce 
stable nanoemulsions encapsulating the antimicrobial compounds. In 
general, the nanoemulsions contained 50 g/kg of the active compounds (a 
terpenes mixture or D-limonene), eventually mixed in the organic phase 
(palm oil or sunflower oil). Soy lecithin, modified starch (clear gum) or a 
mixture (50:50) of Tween 20 and glycerol monooleate were used as 
emulsifiers. 
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Table VIII.1 reports all those nanoemulsions, which resulted physically 
stable over 4 weeks with neither visible creaming nor significant variation of 
the mean droplet diameter. 
Only the lecithin-based nanoemulsions, whose mean droplet diameter 
ranged from 75 nm (High Pressure Homogenization processing, HPH) to 
175 nm (High Shear Homogenization processing, HSH), represented a stable 
delivery system for the terpenes mixture, without any additional organic 
phase. In contrast, the production of stable lecithin-based nanoemulsions 
(240 nm) required the blending of D-limonene with palm oil (1:1). 
 
Table VIII.1 Composition, dimension (Z-diameter) and production method 
of the tested nanoemulsions. 




50 g/kg terpenes 
10 g/kg soy lecithin 
940 g/kg water 
10 HPH passes 
at 300 MPa 
3°C 
74.4 ± 2.6 
T/SL-HSH 
50 g/kg terpenes 
10 g/kg soy lecithin 
940 g/kg water 
HSH  
at 24000 rpm 
for 5 min 
174.8 ± 5.7 
L/PO-SL 
50 g/kg D-limonene 
50 g/kg palm oil 
20 g/kg soy lecithin 
880 g/kg water 
10 HPH passes 
at 300 MPa 
30°C 
235.9 ± 9.6 
L/CG 
50 g/kg D-limonene 
100 g/kg clear gum 
850 g/kg water 
10 HPH passes 
at 300 MPa 
3°C 
365.7 ± 7.5 
L/SO-T20-GMO 
50 g/kg D-limonene 
50 g/kg sunflower oil 
15 g/kg Tween 20 
15 g/kg glycerol monooleate 
870 g/kg water 
10 HPH passes 
at 300 MPa 
3°C 
130.9 ± 1.3 
L/T20-GMO 
50 g/kg D-limonene 
7.5 g/kg Tween 20 
7.5 g/kg glycerol monooleate 
935 g/kg water 
10 HPH passes 
at 300 MPa 
3°C 
154.6 ± 1.4 
 
A stable nanoemulsion (365 nm) was obtained with pure D-limonene as 
the organic phase only when clear gum was used as an emulsifier. 
D-limonene was also encapsulated, alone or blended with sunflower oil 
(1:1), into stable delivery systems made of Tween 20 and glycerol 
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monooleate–based nanoemulsions, with a very fine mean droplet diameter 
(from 130 to 155 nm). 
To evaluate the activity of an antimicrobial agent the Minimum 
Inhibitory Concentration (MIC) and the Minimum Bactericidal 
Concentration (MBC) can be measured. When the antimicrobial agent is 
encapsulated, the MIC and MBC can provide information on the efficiency 
of the delivery system to transport the active compound across the cell 
membrane of the target microorganisms. 
Table VIII.2 reports the MIC and MBC values of a nanoencapsulated 
terpenes mixture as well as nanoencapsulated D-limonene in comparison to 
pure compounds. 
 
Table VIII.2 MIC and MBC measurements of pure and encapsulated 
essential oils on different microbial strains. 
 















5.0 5.0 5.0 25 10 10 
T/SL-HPH 1.0 5.0 10 10 1.0 5.0 
T/SL-HSH 5.0 5.0 5.0 10 1.0 5.0 
D-Limonene >25 >25 >25 >25 >25 >25 
L/CG 10 >25 10 >25 10 25 
L/PO-SL 10 >25 10 >25 10 >25 
L/SO-T20-GMO 5.0 >25 5.0 >25 5.0 >25 
L/T20-GMO 5.0 >25 25 >25 25 >25 
 
 
The MIC and MBC values of the antimicrobial agents encapsulated in 
nanoemulsions resulted always lower or equal to pure compounds, therefore 
suggesting the enhancement of transport mechanisms through the cell 
membrane of the target microorganisms. 
The effect of the encapsulation system on the antimicrobial activity of the 
terpenes mixture depended on the target microorganism. For S. cerevisiae, 
the MIC and MBC values were reduced from 10 g/L to 1.0 g/L and 5.0 g/L 
respectively when the terpenes mixture was encapsulated in both 
nanoemulsion T/SL-HPH and T/SL-HSH. For L. delbrueckii, the 
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nanoencapsulation caused a reduction of only the MBC values for both 
T/SL-HPH and T/SL-HSH from 25 to 10 g/L, while the MIC values 
remained unchanged at 5.0 g/L for nanoemulsion T/SL-HSH and increased 
to 10 g/L for nanoemulsion T/SL-HPH. Interestingly, encapsulation of the 
terpenes mixture did not significantly reduce the MIC and MBC values for 
E. coli. 
The antimicrobial activity of D-limonene is significantly lower than that 
of the terpenes mixture, with the MIC and MBC values being always higher 
than 25 g/L. Experimental measurements were intentionally limited to 
25 g/L due to higher concentrations being considered unsuitable for food 
applications. 
In contrast with what was observed with the terpenes mixture, the 
encapsulation of D-limonene never reduced the MBC values, but affected 
only the MIC values. 
For L/CG and L/PO-SL nanoemulsions, the MIC values were reduced 
from >25 g/L to 10 g/L for all the microorganisms. For nanoemulsion L/SO-
T20-GMO, the MIC reached the smallest value (5.0 g/L) for all the 
microorganisms, which is probably due to the fine droplet diameter of the 
delivery system. Whereas, nanoemulsion L/T20-GMO induced a reduction 
of the MIC value to 5.0 g/L for E. Coli and only to 25 g/L for the other 
microorganisms. 
The results reported in Table VIII.2 show that the effect of encapsulation 
on the different delivery systems tested depends on the active compounds. 
The encapsulation of the terpenes mixture enhances both the bacteriostatic 
and bactericidal activity (MIC values are close to MBC values) for selected 
microorganisms (S. Cerevisiae and E. coli). This is probably due to the fact 
that L. delbrueckii is, unlike the other tested microorganisms, a gram-
positive bacterium with a thick cell wall formed by 40 layers of 
peptidoglycan chains. In contrast, the encapsulation of D-limonene enhanced 
only its bacteriostatic activity (the MIC values were significantly smaller 
than the MBC values) on all the tested microorganisms. 
In particular, previous studies showed that the antimicrobial activity of 
cyclic hydrocarbons is limited by their solubility, being available for 
interaction with cells only those molecules which are dissolved in the 
aqueous phase (Sikkema et al., 1995). This implies that the effect of an 
antimicrobial compound would be expected to be maximal under conditions 
of maximum solubility: for example, essential oil components, such as 
carvacrol, need to be dissolved in concentrations approaching or exceeding 
their maximum solubility in order to exhibit bactericidal activity (Gill and 
Holley, 2006). In contrast, limonene, which is characterized by a very 
limited water solubility (at least 1 order of magnitude smaller than 
carvacrol), exhibits only a bacteriostatic activity unless its concentration in 
the aqueous phase is enhanced. It is possible to increase the concentration of 
limonene in the aqueous phase by changing the emulsion lipid phase, and 
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therefore acting on the partitioning on limonene between the two phases, or 
by choosing an emulsifier which is able to solubilize in micelle assemblies 
the limonene molecules. From the results obtained, no apparent difference 
could be observed when using a solid lipid such as palm oil on the limonene 
activity, despite the possibility that limonene may be expelled from the 
emulsion droplets by the solid fat crystallization. In contrast, the use of 
emulsifiers, such as the combination of Tween 20 and glycerol monooleate, 
resulted in a slight increase of the bacteriostatic activity of limonene, 
suggesting that the water solubility of limonene might have been increased 
by micelle solubilization. 
The bacteriostatic activity of D-limonene as well as the bactericidal 
activity of the terpenes mixture were visualized by fluorescence microscopy 
observations. Images of the S. cerevisiae cells exposed to the nanoemulsion 
L/CG (Figure VIII.1) as well as the nanoemulsion T/SL-HPH (Figure 
VIII.2), both loaded with fluorescent dye (Nile Red), were recorded after 
5 min and 24 h. 
 
 
Figure VIII.1 Brightfield (a and c) and fluorescence micrographs (b and d) 
of S. cerevisiae cells exposed to nanoemulsion L/CG captured by 
fluorescence microscopy after 5 min (a and b) and 24 h (c and d). 
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Under a fluorescent light, the nanoemulsion droplets cannot be 
distinguished when they are dispersed in an aqueous system due to their 
nanometric size, with only a fluorescent halo being observed. In contrast, 
when the nanoemulsion droplets accumulate in the cell membrane as well as 
the intracellular space, the yeast cells became fluorescent and can be 
observed. Figures VIII.1 and VIII.2 show that both nanoemulsions can 
readily permeate the cell membrane: after 5 min, the yeast cells became 
fluorescent, suggesting that the antimicrobial agents have reached the action 
sites. After 24 h, there was a significant difference between the 
nanoemulsion T/SL-HPH and L/CG. The yeast cells exposed to the terpenes 
mixture exhibited a shrunk cell membrane, which suggests their death 
probably due to the loss of intracellular material (Figure VIII.2). On the 
other hand, the yeast cells exposed to nanoencapsulated D-limonene did not 
show any apparent change in shape and size, therefore suggesting a merely 




Figure VIII.2 Brightfield (a and c) and fluorescence micrographs (b and d) 
of S. cerevisiae cells exposed to nanoemulsion T/SL-HPH captured by 
fluorescence microscopy after 5 min (a and b) and 24 h (c and d). 
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VIII.3.2 Kinetics of inactivation 
The inactivation kinetics of the three target microorganisms exposed to 
the terpenes mixture encapsulated in nanoemulsions T/SL-HPH and T/SL-
HSH were determined in water at two different antimicrobial concentrations 
(1.0 and 2.5 g/L). 
Table VIII.3 reports the decimal reduction time of inactivation, D, 
defined as the time required to reduce by an order of magnitude the number 
of surviving microorganisms, and calculated by the linear regression of the 
semi-log plots of inactivation of E. coli, L. delbrueckii and S. cerevisiae. 
 
Table VIII.3 The decimal reduction time of inactivation of target 
microorganisms exposed to the terpenes mixture encapsulated in T/SL-HPH 
and T/SL-HSH delivery systems. 
 
Decimal reduction time D [min] 
E. coli L. delbrueckii S. cerevisiae 
T/SL-HPH 
2.5 g/L 
7.57 ± 0.36 
R2 = 0.977 
10.2 ± 2.8 
R2 = 0.655 
312 ± 72 
R2 = 0.587 
T/SL-HPH 
1.0 g/L 
556 ± 542 
R2 = 0.215 
714 ± 12 




7.68 ± 0.14 
R2 = 0.966 
6.69 ± 0.38 
R2 = 0.834 
30.7 ± 2.2 
R2 = 0.924 
T/SL-HSH 
1.0 g/l 
909 ± 23 
R2 = 0.992 




While the control systems (nanoemulsions where the terpenes mixture 
was substituted by sunflower oil) did not cause any measurable microbial 
inactivation over 24 h (data not reported), the terpenes–loaded 
nanoemulsions inactivated the three microorganisms with characteristic 
times (D in Table VIII.3) of the order of minutes at 2.5 g/L and of hours at 
1.0 g/L. Interestingly, the nanoemulsion T/SL-HSH caused a faster 
inactivation than nanoemulsion T/SL-HPH, despite the larger mean droplet 
diameter: the decimal reduction time of nanoemulsion T/SL-HSH is always 
shorter than for nanoemulsion T/SL-HPH for L. delbrueckii and 
S. cerevisiae, while no significant difference can be observed for E. coli. 
Moreover, it can be observed that the larger droplet diameter system 
(nanoemulsion T/SL-HSH) induced also a higher reduction of the MIC and 
MBC values for L. delbrueckii (Table VIII.2). In contrast to what was 
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expected, a straightforward correlation between the efficiency of the 
antimicrobial delivery system and its mean droplet diameter is not possible. 
These unexpected results can be explained in terms of the degradation of 
some active compounds during HPH processing. Table VIII.4 reports the 
GC-MS analysis of the pure terpenes mixture, which was not subjected to 
any fluid dynamic stresses, and the analysis of the terpenes mixture as 
extracted from nanoemulsion T/SL-HPH, subjected to high intensity stresses 
during the HPH treatment, and from nanoemulsion T/SL-HSH, subjected to 
mild intensity stresses during the HSH treatment. 
GC-MS analysis revealed that, due to fluid dynamic stresses, both the 
HSH and HPH processing caused the degradation of some active 
compounds, such as α-fellandrene, terpinolene, p-cymene, thujene, δ-
terpinene, 2-carene/isoterpinolene, trans-2-caren-4-ol, carveol, thujol, 
carvacrol. Interestingly, only carvacrol, which is a compound with a well-
known antimicrobial activity (Ben Arfa et al., 2006, Veldhuizen et al., 2006), 
was significantly reduced when increasing the process intensity from HSH to 
HPH. Therefore, it can be assumed that the different performance observed 
for T/SL-HPH and T/SL-HSH, which share the same composition, is due to 
the fact that the theoretical higher delivery efficiency of nanoemulsion T/SL-
HPH, associated with its smaller mean droplet diameter, is counter-balanced 
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Table VIII.4 Composition of the pure terpenes mixture and the terpenes 











α-fellandrene 14.10 0.150 0.020 0.036 
terpinolene 14.63 1 0.07 0.12 
p-cymene 15.06 1.39 0.20 0.38 
thujene 15.28 0.30 0.06 0.09 
δ-terpinene 16.7 0.68 0.06 0.10 
2-carene/isoterpinolene 17.99 0.28 0.02 0.04 
trans-2-caren-4-ol 18.33 0.14 0.02 0.03 




20.12 0.15 0.30 0.36 
carveol 20.39 0.08 0.02 0.02 




21 0.04 0.10 0.14 
terpinen-4-ol 22.8 94.61 98.27 97.73 
5-coranol 23.95 0.05 0.06 0.09 
thujol 27.84 0.30 0.20 0.20 
carvacrol 29.21 0.43 0.12 0.05 
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VIII.3.3 Addition of encapsulated antimicrobial agents to fruit juices 
Nanoemulsion T/SL-HPH was added at different concentrations to two 
fruit juices (orange juice and pear juice) inoculated with L. delbrueckii in 
order to test the microbiological stability as well as the alteration of the 
chemical and physical characteristics of the juices stored at 32 °C. 
The results of the accelerated shelf life studies are reported in Figures 
VIII.3-VIII.4. Figure VIII.3 shows that for both fruit juices after 2 days, the 
total inactivation of the initial microbial load of 103 CFU/ml was already 
reached for the terpenes concentrations of 5.0 g/L and 10 g/L. At a terpenes 
concentration of 1.0 g/L, microorganism growth is delayed by 5 days in 
orange juice and 2 days in pear juice in comparison to the control. 
°Bx and pH were not significantly altered by the addition of the 
nanoemulsion. This was also observed during the storage period, unless 
significant microbial growth occurred, such as for the control sample and the 
1.0 g/L terpenes sample (Figure VIII.4a, b, c and d). 
In contrast, major color deviations were observed when 10 g/L 
nanoencapsulated terpenes were added to the juices, while the addition of the 
terpenes mixture at lower concentrations (5.0 and 1.0 g/L) can be considered 
acceptable, with it inducing much smaller color deviations (Figure VIII.4e 
and f). The color remained stable over the storage time for all those systems 
where no significant microbial growth occurred. 
 Antimicrobial activity of nanoencapsulated essential oils 
 133
 
Figure VIII.3 Inactivation curve of L. delbrueckii suspended in (a) orange 
juice and (b) pear juice treated with terpenes nanoemulsion T/SL-HPH at 
32 °C. Experimental data: control juice ( ), juice added with the 
nanoemulsion to a final concentration of 1.0 g/L ( ), 5.0 g/L ( ) and 10 g/L 
( ) of the terpenes mixture. 
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Figure VIII.4 Variation over time of (a and b) pH, (c and d) °Bx and (e and 
f) global color difference, ∆E, of (a, c and e) orange juice and (b, d and f) 
pear juice with different concentrations of terpenes nanoemulsion T/SL-HPH 
at 32 °C. Experimental data: control juice ( ), juice added with the 
nanoemulsion to a final concentration of 1.0 g/L ( ), 5.0 g/L ( ) and 10 g/L 
( ) of the terpenes mixture. 
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VIII.4 Conclusions 
In this section, the nanoencapsulation of two essential oils, a terpenes 
mixture extracted from Melaleuca alternifolia and D-limonene, was 
investigated as a method to improve the safety and quality of foods through 
the addition of natural preservatives. 
Nanoemulsions based on food grade ingredients were fabricated by high 
pressure homogenization processing at 300 MPa, obtaining physically stable 
antimicrobial delivery systems. In particular, lecithin-based nanoemulsion 
with a mean droplet diameter of 75 nm resulted as being a highly efficient 
carrier system for the terpenes mixture, while D-limonene was successfully 
nanoencapsulated pure using clear gum as emulsifier, or in a blend with 
palm oil using soy lecithin as emulsifier. 
The stable nanoemulsions produced were tested by MIC and MBC 
measurements on three target microorganisms (E. coli, L. delbrueckii and 
S. cerevisiae), in order to verify the ability of the delivery systems to 
enhance the bacteriostatic and bactericidal capability of the antimicrobials. 
The MIC and MBC values of the nanoencapsulated terpenes resulted 
always lower than or equal to the values of the unencapsulated mixture, 
suggesting the activation of passive transport mechanisms through the cell 
membrane of the tested microorganisms. On the other hand, the 
nanoencapsulation of D-limonene was able to reduce only the MIC values, 
without any significant variation of the MBC values in comparison to the 
unencapsulated D-limonene.  
The terpenes nanocapsules were tested in real systems, such as orange 
juice and pear juice, inoculated with L. delbrueckii. The addition of low 
concentrations of the nanoencapsulated terpenes was able to delay the 
microbial growth (1.0 g/L terpenes) or completely inactivate the 
microorganisms (5.0 g/L terpenes) while minimally altering the organoleptic 











The functional food and nutraceutical industries have consolidated in the 
last years a growing interest in nanotechnology, in order to improve delivery 
of bioactive compounds, as well as to create novel food functionalities. 
Nevertheless, the science, technology and engineering behind the existing 
nanotechnology applications are still at a basic level, in comparison to the 
potential they can express according to the current and prospective results of 
scientific research. 
This work highlights the potentialities of food-grade nanometric systems, 
such as nanoemulsions and solid lipid nanoparticles, to efficiently 
encapsulate and deliver bioactive compounds. In particular, novel 
formulations were developed to increase the solubility in aqueous systems of 
bioactive compounds, insoluble in water and poor soluble in oil. Curcumin 
was encapsulated in stearic acid-based nanoemulsions at a maximum 
concentration of 1000 mg/L, 1600 higher than its solubility in water. 
Moreover, the design of nanoemulsion-based delivery systems with a 
combined use of hydrophilic (sugar ester, defatted soy lecithin, polysorbate 
20) and lipophilic emulsifiers (soy lecithin, glycerol monooleate) was 
resulted an efficient method to encapsulate resveratrol and disperse it in 
aqueous systems at a concentration ten time higher than the therapeutic 
blood concentration (10 mg/L). The double layer of emulsifiers, limiting 
hydrophobic interactions, was also able to improve protection of 
thermolabile and photosensitive compounds against degradation under 
accelerated ageing and after gastro-intestinal digestion in comparison to 
unencapsulated compounds.  
For the first time the properties of food emulsifiers, in terms of interfacial 
properties and characteristic times of adsorption, have been correlated to the 
efficiency of the emulsification process. In particular, the high pressure 
homogenization process resulted to be controlled not only by disruption 
efficiency achieved in the homogenization valve, but also by capability of 
the emulsifiers used to prevent recoalescence phenomena of newly formed 
droplets by rapid absorption at the O/W interface. 
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From this work has appeared also that a specific design and formulation 
may add specific functionalities to the nanodelivery systems. For example, 
uptake and bioavailability may be enhanced on one side by the reduction of 
mean droplet diameter of delivery system at subcellular size, improving the 
passive transport mechanisms through the intestinal wall, on the other side 
by a suitable choice of the lipid phase, whose co-administration with the 
bioactive compounds, may promote their adsorption from intestinal cells. In 
this regard the results obtained demonstrated that the formulations with 
smaller mean droplet diameters (below 200 nm), resulting physically stable 
after the digestion process and allowing the resveratrol to reach the intestinal 
wall entrapped in the lipid droplets, have increased the cumulative amount of 
nanoencapsulated resveratrol transported from the apical to the basolateral 
side across Caco-2 cell monolayers. In particular, soy lecithin/sugar esters-
based nanoemulsion showed an higher permeability due to the presence of 
soy lecithin, which, having a structure similar to the phospholipid bilayers of 
the cellular membrane, favours the absorption and the entrapment of the oil 
droplets in the microvilli and their consequent transport through the cell 
membrane. 
Similarly, has been demonstrated that an efficient design of 
nanoemulsion-based delivery systems in terms of mean droplet diameters 
achieved and choice of emulsifier used can affect the possible mechanisms 
of antimicrobial action of nanoencapsulated essential oils. The antimicrobial 
activity of nanoencapsulated essential oils can be carried out through the 
transport of the antimicrobial compounds across the cellular membrane, 
where they are released and can act from the inner side on the cytoplasmic 
membrane, as well as through the controlled release of antimicrobial 
compounds in the aqueous phase from the nanoemulsion droplets, therefore 
maintaining the essential oils active in the food system over an extended 
period of time, despite their limited solubility in aqueous phase. Moreover, 
the results obtained showed that the addition of low concentrations of 
nanoencapsulated essential oils in real food was able to delay the microbial 
growth (1.0 g/L terpenes) or completely inactivate the microorganisms 
(5.0 g/L terpenes), while minimally altering the organoleptic properties of 
the fruit juices. 
In the future, seems possible to think to integrate consolidated top-down 
techniques, such as high pressure homogenization, with bottom-up 
approaches, based on thermodynamic self-assembling at molecular levels, in 
order to incorporate complex structures with advanced functionalities in 
unfavorable environments, such as most foods, during their manufacturing, 
storage and preparation. More efforts are also needed to enhance the ability 
of nano-engineered particles and emulsions to resist to the detrimental 
effects of processing conditions during food production, due to the 
thermolabile nature of the bioactive compounds and/or to the possibility of 
binding irreversibly to the food structure. The redesign of the processing 
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flow sheet and the optimization of the processing conditions for the 
production of foods supplemented with nanobioactive compounds are also a 
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